{"gname":"Washington University in St. Louis","grp_id":"11","rels":[{"rel_title":"Chemolithoautotrophic acidophile phenotyping by measuring metabolic byproduct formation in microplates","rel_doi":"10.64898\/2026.11.20.768213","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.20.768213","rel_abs":"Chemolithoautotrophic acidophiles can support several low-pH biotechnologies, but their phenotyping remains limited by throughput and inconsistent methods. This study used an assay to monitor metabolic byproduct formation using absorbance indicators in static, oxic cultures in 96-well microplates. In abiotic experiments, ferric iron and\/or pH measurements from 51 microplates containing simulant solutions span total iron concentrations of 0-1 M, pH 0.3-7.0, and incubation temperatures of 4-75 {degrees}C. Of these, 30 microplates tested different UV-transparency and gas-permeable membrane configurations. Another 12 microplates tested indicator compatibility with growth media containing ferrous iron and (in)soluble sulfur substrates. Biological experiments measured 438 microplates containing Acidithiobacillus ferrooxidans ATCC 23270, Acidithiobacillus thiooxidans ATCC 19377, or Leptospirillum ferriphilum DSM 14647 with chemical additives across 1,400 concentration conditions, yielding 142,038 time-course points, including abiotic controls. Measurements of apparent substrate oxidation and\/or growth from 96 culture tubes and 99 shake flasks provide context for microplate observations. The miniaturized assay and this dataset may be useful for microbiology, (critical-mineral) biotechnology development, and synthetic biology.","rel_num_authors":6,"rel_authors":[{"author_name":"Daniel A. Dailey","author_inst":"Columbia University"},{"author_name":"Mallori A. Herishko","author_inst":"Columbia University"},{"author_name":"Wei Wang","author_inst":"Columbia University"},{"author_name":"Lauren N. Murray","author_inst":"Columbia University"},{"author_name":"Sofia T. Bavaresco","author_inst":"Columbia University"},{"author_name":"Scott Banta","author_inst":"Columbia University"}],"rel_date":"2026-11-21","rel_site":"biorxiv"},{"rel_title":"Unexpected Long Range Actions of AAV8","rel_doi":"10.64898\/2026.11.20.767967","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.20.767967","rel_abs":"Adeno-associated virus vectors (AAVs) have broad utility in neuroscience. A variety of features, such as titer, capsid, enhancers and promoters, coding and non-coding elements, can be utilized to pursue diverse experimental ends. The net effects of titer and capsid have been used experimentally to pursue retrograde and anterograde studies, such as through the monosynaptic spread of high-titer AAV1. The literature on AAV8 is conflicting, with evidence for and against its long-range action outside of the infected starter population. Using the mouse corticopontocerebellar tract, we report that AAV8, when used at high titers, can be associated with long range recombination outside of the starter population. This phenomenon depended upon the viral titer and was influenced by the presence of other experimental injections. Surprisingly, separate injections of high-titer AAV8 recombinase and recombinase-reporter AAV8s gave rise to recombination across long distances in populations not known to be monosynaptically connected. Given the possibility of long range and emergent effects, we suggest that investigators empirically determine titer, capsid, and injection designs that reduce false positives and\/or indirect effects.","rel_num_authors":4,"rel_authors":[{"author_name":"Jessica M Lahr","author_inst":"Michigan State University"},{"author_name":"Julie Ly","author_inst":"Michigan State University"},{"author_name":"Elif Erdem","author_inst":"Michigan State University"},{"author_name":"Michael R Williams","author_inst":"Michigan State University"}],"rel_date":"2026-11-21","rel_site":"biorxiv"},{"rel_title":"Circulating gelsolin tracks disease stage in amyotrophic lateral sclerosis across four cohorts","rel_doi":"10.64898\/2026.11.18.26368465","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368465","rel_abs":"Amyotrophic lateral sclerosis is a fatal neurodegenerative disease with highly variable survival, and blood biomarkers beyond neurofilament light chain (NfL) are needed for prognosis and trial stratification. A biomarker of progress through an individualised disease course may be prognostic but independent of the rate of neurodegeneration. We analysed the serum proteome (5,401 proteins) and plasma and cerebrospinal fluid metabolomes (1,659 metabolites) of 94 patients with amyotrophic lateral sclerosis and 39 controls recruited in Sheffield, UK, and replicated findings in cohorts from Tel Aviv, Oxford and the United States (AnswerALS). We defined \"disease stage\" as the fraction of the onset-to-death interval elapsed at sampling. In contrast we define the rate of neurodegeneration by total survival time or the rate of symptom progression quantified using the D50 model of functional decline. Survival-associated proteins were enriched for stage associations in Sheffield (odds ratio = 5.1) and in the Oxford (2.9), and Tel Aviv (1.6) replication cohorts. Sixty-eight proteins not including NfL tracked stage across four cohorts, implicating systemic inflammation and muscle remodelling; the same biology is tracked by 149 plasma and 58 CSF stage-associated metabolites. Stage-associated proteins that rose with stage also rose with age in UK Biobank (17 of 17 age-associated proteins), and the proteomic age gap rose nominally with disease stage (partial Spearman r = 0.25, P = 0.027; BH-adjusted P = 0.055). Circulating gelsolin (GSN) fell with advancing disease in all four cohorts. NfL tracked disease aggressiveness (beta = 0.56, P < 0.001) but not stage (0.13, P = 0.056), whereas GSN tracked stage (-0.41, P <0.001) but not the rate of symptom progression (-0.08, P = 0.25). GSN explained 10% of the variance between patients in disease stage quantified by survival time and 19% of the variance in stage quantified by functional decline; this is comparable to the variance in the rate of neurodegeneration which is captured by circulating NfL. Accounting for disease stage separates markers of disease rate from markers of disease position, refining both biomarker discovery and biological interpretation in amyotrophic lateral sclerosis (ALS).","rel_num_authors":18,"rel_authors":[{"author_name":"Andrew Strange","author_inst":"University of Sheffield"},{"author_name":"Marcel Weinreich","author_inst":"University of Sheffield"},{"author_name":"Hadar Klimovski","author_inst":"Weizmann Institute of Science"},{"author_name":"Cory Holdom","author_inst":"University of Oxford"},{"author_name":"Alex Daniel","author_inst":"University of Sheffield"},{"author_name":"Mays Baidoun","author_inst":"University of Sheffield"},{"author_name":"Farah Mahiddine","author_inst":"University of Sheffield"},{"author_name":"Kari Wong","author_inst":"Metabolon Inc"},{"author_name":"Iddo Magen","author_inst":"Weizmann Institute of Science"},{"author_name":"Yurui Chen","author_inst":"Yale University School of Medicine"},{"author_name":"Martin Turner","author_inst":"University of Oxford"},{"author_name":"Kevin Talbot","author_inst":"University of Oxford"},{"author_name":"David G. Lester","author_inst":"University of Oxford"},{"author_name":"Alexander G. Thompson","author_inst":"University of Oxford"},{"author_name":"Eran Hornstein","author_inst":"Weizmann Institute of Science"},{"author_name":"Sai Zhang","author_inst":"Yale University School of Medicine"},{"author_name":"Johnathan Cooper-Knock","author_inst":"University of Sheffield"},{"author_name":"Pamela J. Shaw","author_inst":"University of Sheffield"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Circulating gelsolin tracks disease stage in amyotrophic lateral sclerosis across four cohorts","rel_doi":"10.64898\/2026.11.18.26368465","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368465","rel_abs":"Amyotrophic lateral sclerosis is a fatal neurodegenerative disease with highly variable survival, and blood biomarkers beyond neurofilament light chain (NfL) are needed for prognosis and trial stratification. A biomarker of progress through an individualised disease course may be prognostic but independent of the rate of neurodegeneration. We analysed the serum proteome (5,401 proteins) and plasma and cerebrospinal fluid metabolomes (1,659 metabolites) of 94 patients with amyotrophic lateral sclerosis and 39 controls recruited in Sheffield, UK, and replicated findings in cohorts from Tel Aviv, Oxford and the United States (AnswerALS). We defined \"disease stage\" as the fraction of the onset-to-death interval elapsed at sampling. In contrast we define the rate of neurodegeneration by total survival time or the rate of symptom progression quantified using the D50 model of functional decline. Survival-associated proteins were enriched for stage associations in Sheffield (odds ratio = 5.1) and in the Oxford (2.9), and Tel Aviv (1.6) replication cohorts. Sixty-eight proteins not including NfL tracked stage across four cohorts, implicating systemic inflammation and muscle remodelling; the same biology is tracked by 149 plasma and 58 CSF stage-associated metabolites. Stage-associated proteins that rose with stage also rose with age in UK Biobank (17 of 17 age-associated proteins), and the proteomic age gap rose nominally with disease stage (partial Spearman r = 0.25, P = 0.027; BH-adjusted P = 0.055). Circulating gelsolin (GSN) fell with advancing disease in all four cohorts. NfL tracked disease aggressiveness (beta = 0.56, P < 0.001) but not stage (0.13, P = 0.056), whereas GSN tracked stage (-0.41, P <0.001) but not the rate of symptom progression (-0.08, P = 0.25). GSN explained 10% of the variance between patients in disease stage quantified by survival time and 19% of the variance in stage quantified by functional decline; this is comparable to the variance in the rate of neurodegeneration which is captured by circulating NfL. Accounting for disease stage separates markers of disease rate from markers of disease position, refining both biomarker discovery and biological interpretation in amyotrophic lateral sclerosis (ALS).","rel_num_authors":18,"rel_authors":[{"author_name":"Andrew Strange","author_inst":"University of Sheffield"},{"author_name":"Marcel Weinreich","author_inst":"University of Sheffield"},{"author_name":"Hadar Klimovski","author_inst":"Weizmann Institute of Science"},{"author_name":"Cory Holdom","author_inst":"University of Oxford"},{"author_name":"Alex Daniel","author_inst":"University of Sheffield"},{"author_name":"Mays Baidoun","author_inst":"University of Sheffield"},{"author_name":"Farah Mahiddine","author_inst":"University of Sheffield"},{"author_name":"Kari Wong","author_inst":"Metabolon Inc"},{"author_name":"Iddo Magen","author_inst":"Weizmann Institute of Science"},{"author_name":"Yurui Chen","author_inst":"Yale University School of Medicine"},{"author_name":"Martin Turner","author_inst":"University of Oxford"},{"author_name":"Kevin Talbot","author_inst":"University of Oxford"},{"author_name":"David G. Lester","author_inst":"University of Oxford"},{"author_name":"Alexander G. Thompson","author_inst":"University of Oxford"},{"author_name":"Eran Hornstein","author_inst":"Weizmann Institute of Science"},{"author_name":"Sai Zhang","author_inst":"Yale University School of Medicine"},{"author_name":"Johnathan Cooper-Knock","author_inst":"University of Sheffield"},{"author_name":"Pamela J. Shaw","author_inst":"University of Sheffield"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Real-world adherence to guidelines in acute severe ulcerative colitis: automated assessment using large language models","rel_doi":"10.64898\/2026.11.18.26368431","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368431","rel_abs":"Background and Aims: Acute severe ulcerative colitis (ASUC) is a medical emergency which requires close guideline adherence for optimal outcomes. However, measuring real-world adherence to guidelines and identifying guideline deviations are labor-intensive. We assessed how well a large language model (LLM) based framework can measure real-world adherence to ASUC guidelines and identify reasons for deviations. Methods: The retrospective study focused on clinician adherence to the 2025 American College of Gastroenterology guidelines on ASUC. A multi-agent GPT-5 framework first reviewed inpatient health records to confirm ASUC status. Then for each guideline, it assessed whether it was applicable, recommended by consultants, ordered, or executed. This system was benchmarked against manual chart review. The framework was then applied to all the first seven days of all ASUC hospitalizations in 2019-2024 at UCSF. An additional LLM assessed clinical justification of guideline deviations. Results: The system reliably recognized ASUC hospitalizations (sensitivity: 0.93) and annotated the guideline cascade (overall accuracy: 0.95, N=60). Across 121 hospitalizations (104 patients), adherence was >80%. Deviations concentrated in deep vein thrombosis prophylaxis (DVTp) and timely rescue therapy. Particularly, DVTp broke down at execution despite appropriate recommendation and ordering, whereas \"avoidance\" recommendations were followed in practice but seldom explicitly documented. Overall, 62% of non-adherence was unjustified, mostly process delays in DVTp. Conclusions: Real-world ASUC care at a tertiary center was largely guideline-concordant, with actionable gaps in DVT prophylaxis execution and rescue therapy timing. A guideline-constrained LLM system enables scalable monitoring of clinical quality and creates the potential in simultaneously improving clinical care and guidelines.","rel_num_authors":7,"rel_authors":[{"author_name":"Ann-Kathrin Schalkamp","author_inst":"University of California, San Francisco"},{"author_name":"Mao-Yuan Chen","author_inst":"University of California, San Francisco"},{"author_name":"Aryan Ayati","author_inst":"University of California, San Francisco"},{"author_name":"Shadera Azzam","author_inst":"University of California, San Francisco"},{"author_name":"Banaz Shwan","author_inst":"University of California, San Francisco"},{"author_name":"Sara Lewin","author_inst":"University of California, San Francisco"},{"author_name":"Vivek Ashok Rudrapatna","author_inst":"University of California, San Francisco"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Tuberculosis Severity metrics poorly predict Two-Month Culture Conversion","rel_doi":"10.64898\/2026.11.19.26368488","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.19.26368488","rel_abs":"Abstract Objectives Among people with pulmonary tuberculosis (PTB), culture conversion (bacterial clearance) after two months of treatment is a critical indicator of response. However, predictors of culture conversion at two months are difficult to define and can be context specific. In this study, we evaluated how well two tuberculosis (TB) severity metrics, the chest Xray (CXR) Score and the Bandim TBScore associate with and predict two-month culture conversion. Methods The cohort contained 718 index PTB cases enrolled in The Kawempe Community Health Study (KCHS). We analyzed severity metrics, demographics, clinical, microbiological, radiological, household and behavioral data for their association with and their ability to predict culture conversion. Results Sixty-eight percent of participants culture converted at two months. The highest CXR Score category (odds ratio (OR) 0.51, 95% Confidence Interval (CI) 0.31, 0.84), smear grade at diagnosis (OR 0.42, 95% CI; 0.26, 0.62), pleural thickening (OR 0.41, 95% CI 0.17, 0.95) and current smoking (OR 0.31, 95% CI 0.09, 0.99) inversely associated with conversion. Both severity measures and the most parsimonious model poorly predicted culture conversion (all AUCs<0.70). Conclusion CXR Score, higher smear grade at diagnosis, pleural thickening, and current smoking inversely associated with culture conversion but provided limited utility for prediction. Keywords: Tuberculosis outcomes; Mycobacterium clearance; TB severity scores","rel_num_authors":11,"rel_authors":[{"author_name":"Lentlametse Mantshonyane","author_inst":"CaseWestern Reserve University"},{"author_name":"Penelope Benchek","author_inst":"Case Western Reserve University"},{"author_name":"LaShaunda Malone","author_inst":"Department of Medicine, Division of Infectious Diseases, Case Western Reserve University"},{"author_name":"Mary Nsereko","author_inst":"Makerere University Medical School: Makerere University College of Health Sciences"},{"author_name":"Hussein Kisingo","author_inst":"Makerere University Medical School: Makerere University College of Health Sciences"},{"author_name":"Daniel J. Tisch","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University"},{"author_name":"Fredrick R. Schumacher","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University"},{"author_name":"W. Henry Boom","author_inst":"Department of Medicine, Division of Infectious Diseases"},{"author_name":"Harriet Mayanja-Kizza","author_inst":"Makerere University"},{"author_name":"Catherine Stein","author_inst":"Case Western Reserve University,Department of Population and Quantitative Health Sciences,Department of Medicine, Division of Infectious Diseases"},{"author_name":"Scott M. Williams","author_inst":"Case Western Reserve University,Department of Population and Quantitative Health Sciences,Department of Medicine,Cleveland Institute for Computational Biology, "}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"UV-induced Mutations are Associated with Melanoma-Specific Mortality in Stage II\/III Melanomas from the InterMEL study","rel_doi":"10.64898\/2026.11.18.26368442","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368442","rel_abs":"The prognostic significance of tumor mutational burden (TMB) in melanoma remains controversial. One potential reason for the mixed results is that total TMB treats all mutations as biologically equivalent, despite evidence that different types of mutations contribute differently to a tumor's neo-antigenic profile. In particular, UV-induced and non-UV mutations may have distinct effects on tumor behavior and outcomes, but this hypothesis has been studied primarily in advanced-stage disease. We analyzed 656 stage II\/III tumors from the InterMEL study to evaluate whether UV TMB and non-UV TMB are associated with melanoma-specific mortality and clinicopathologic factors. Higher UV TMB was associated with improved outcomes, while non-UV TMB was not associated with mortality. These findings suggest that an association between total TMB and outcome may be driven disproportionately by mutations associated with UV mutagenesis. Although this has previously been reported in advanced melanomas, our work demonstrates that the prognostic relevance of UV TMB extends to stage II\/III tumors typically found in the clinical context. Whether this relationship reflects differences in tumor neo-antigenicity, immune recognition, or other biological properties remains to be determined.","rel_num_authors":43,"rel_authors":[{"author_name":"Adam Z. Reynolds","author_inst":"University of New Mexico"},{"author_name":"Li Luo","author_inst":"University of New Mexico"},{"author_name":"Ronglai Shen","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Arshi Arora","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Irene Orlow","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Klaus J Busam","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Cecilia Lezcano","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Tim K Lee","author_inst":"British Columbia Cancer Research Center"},{"author_name":"Eva Hernando","author_inst":"NYU Grossman School of Medicine"},{"author_name":"Ivan Gorlov","author_inst":"Baylor Medical Center"},{"author_name":"Christopher Amos","author_inst":"University of New Mexico"},{"author_name":"Marc S Ernstoff","author_inst":"National Cancer Institute"},{"author_name":"Venkat Seshan","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Anne E Cust","author_inst":"Melanoma Institute Australia"},{"author_name":"James S Wilmott","author_inst":"Melanoma Institute Australia"},{"author_name":"Graham Mann","author_inst":"Cleveland Clinic Foundation"},{"author_name":"Ismael A Vergara","author_inst":"Melanoma Institute Australia"},{"author_name":"Eduardo Nagore","author_inst":"Instituto Valenciano de Oncologia"},{"author_name":"Pauline Funchain","author_inst":"Stanford Medicine"},{"author_name":"Jennifer Ko","author_inst":"Cleveland Clinic Foundation"},{"author_name":"Sharon N Edmiston","author_inst":"Penn State University"},{"author_name":"Kathleen Conway","author_inst":"University of North Carolina"},{"author_name":"Paul B Googe","author_inst":"University of North Carolina"},{"author_name":"David Ollila","author_inst":"University of North Carolina"},{"author_name":"Jeffrey E Lee","author_inst":"MD Anderson Cancer Center"},{"author_name":"Judy R Rees","author_inst":"Dartmouth Cancer Center"},{"author_name":"Cheryl L Thompson","author_inst":"Case Western Reserve University"},{"author_name":"Meg Gerstenblith","author_inst":"Case Western Reserve University"},{"author_name":"Marcus Bosenberg","author_inst":"Yale University"},{"author_name":"Bonnie E Gould Rothberg","author_inst":"University of Miami Miller School of Medicine"},{"author_name":"Iman Osman","author_inst":"NYU Grossman School of Medicine"},{"author_name":"Yvonne Saenger","author_inst":"Columbia University Medical School"},{"author_name":"Matthew Schwartz","author_inst":"University of New Mexico"},{"author_name":"Tawny Boyce","author_inst":"University of New Mexico"},{"author_name":"Sheri L Holmen","author_inst":"University of Utah"},{"author_name":"Shaofeng Yang","author_inst":"Dartmouth Cancer Center"},{"author_name":"Elise Brunsgaard","author_inst":"University of Utah"},{"author_name":"Paul Bogner","author_inst":"Roswell Park Comprehensive Cancer Center"},{"author_name":"Pei Fen Kuan","author_inst":"Stony Brook University"},{"author_name":"Colin B Begg","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Nancy E Thomas","author_inst":"University of North Carolina"},{"author_name":"Marianne Berwick","author_inst":"University of New Mexico"},{"author_name":"- for the InterMEL Consortium","author_inst":""}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"UV-induced Mutations are Associated with Melanoma-Specific Mortality in Stage II\/III Melanomas from the InterMEL study","rel_doi":"10.64898\/2026.11.18.26368442","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368442","rel_abs":"The prognostic significance of tumor mutational burden (TMB) in melanoma remains controversial. One potential reason for the mixed results is that total TMB treats all mutations as biologically equivalent, despite evidence that different types of mutations contribute differently to a tumor's neo-antigenic profile. In particular, UV-induced and non-UV mutations may have distinct effects on tumor behavior and outcomes, but this hypothesis has been studied primarily in advanced-stage disease. We analyzed 656 stage II\/III tumors from the InterMEL study to evaluate whether UV TMB and non-UV TMB are associated with melanoma-specific mortality and clinicopathologic factors. Higher UV TMB was associated with improved outcomes, while non-UV TMB was not associated with mortality. These findings suggest that an association between total TMB and outcome may be driven disproportionately by mutations associated with UV mutagenesis. Although this has previously been reported in advanced melanomas, our work demonstrates that the prognostic relevance of UV TMB extends to stage II\/III tumors typically found in the clinical context. Whether this relationship reflects differences in tumor neo-antigenicity, immune recognition, or other biological properties remains to be determined.","rel_num_authors":43,"rel_authors":[{"author_name":"Adam Z. Reynolds","author_inst":"University of New Mexico"},{"author_name":"Li Luo","author_inst":"University of New Mexico"},{"author_name":"Ronglai Shen","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Arshi Arora","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Irene Orlow","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Klaus J Busam","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Cecilia Lezcano","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Tim K Lee","author_inst":"British Columbia Cancer Research Center"},{"author_name":"Eva Hernando","author_inst":"NYU Grossman School of Medicine"},{"author_name":"Ivan Gorlov","author_inst":"Baylor Medical Center"},{"author_name":"Christopher Amos","author_inst":"University of New Mexico"},{"author_name":"Marc S Ernstoff","author_inst":"National Cancer Institute"},{"author_name":"Venkat Seshan","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Anne E Cust","author_inst":"Melanoma Institute Australia"},{"author_name":"James S Wilmott","author_inst":"Melanoma Institute Australia"},{"author_name":"Graham Mann","author_inst":"Cleveland Clinic Foundation"},{"author_name":"Ismael A Vergara","author_inst":"Melanoma Institute Australia"},{"author_name":"Eduardo Nagore","author_inst":"Instituto Valenciano de Oncologia"},{"author_name":"Pauline Funchain","author_inst":"Stanford Medicine"},{"author_name":"Jennifer Ko","author_inst":"Cleveland Clinic Foundation"},{"author_name":"Sharon N Edmiston","author_inst":"Penn State University"},{"author_name":"Kathleen Conway","author_inst":"University of North Carolina"},{"author_name":"Paul B Googe","author_inst":"University of North Carolina"},{"author_name":"David Ollila","author_inst":"University of North Carolina"},{"author_name":"Jeffrey E Lee","author_inst":"MD Anderson Cancer Center"},{"author_name":"Judy R Rees","author_inst":"Dartmouth Cancer Center"},{"author_name":"Cheryl L Thompson","author_inst":"Case Western Reserve University"},{"author_name":"Meg Gerstenblith","author_inst":"Case Western Reserve University"},{"author_name":"Marcus Bosenberg","author_inst":"Yale University"},{"author_name":"Bonnie E Gould Rothberg","author_inst":"University of Miami Miller School of Medicine"},{"author_name":"Iman Osman","author_inst":"NYU Grossman School of Medicine"},{"author_name":"Yvonne Saenger","author_inst":"Columbia University Medical School"},{"author_name":"Matthew Schwartz","author_inst":"University of New Mexico"},{"author_name":"Tawny Boyce","author_inst":"University of New Mexico"},{"author_name":"Sheri L Holmen","author_inst":"University of Utah"},{"author_name":"Shaofeng Yang","author_inst":"Dartmouth Cancer Center"},{"author_name":"Elise Brunsgaard","author_inst":"University of Utah"},{"author_name":"Paul Bogner","author_inst":"Roswell Park Comprehensive Cancer Center"},{"author_name":"Pei Fen Kuan","author_inst":"Stony Brook University"},{"author_name":"Colin B Begg","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Nancy E Thomas","author_inst":"University of North Carolina"},{"author_name":"Marianne Berwick","author_inst":"University of New Mexico"},{"author_name":"- for the InterMEL Consortium","author_inst":""}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"UV-induced Mutations are Associated with Melanoma-Specific Mortality in Stage II\/III Melanomas from the InterMEL study","rel_doi":"10.64898\/2026.11.18.26368442","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368442","rel_abs":"The prognostic significance of tumor mutational burden (TMB) in melanoma remains controversial. One potential reason for the mixed results is that total TMB treats all mutations as biologically equivalent, despite evidence that different types of mutations contribute differently to a tumor's neo-antigenic profile. In particular, UV-induced and non-UV mutations may have distinct effects on tumor behavior and outcomes, but this hypothesis has been studied primarily in advanced-stage disease. We analyzed 656 stage II\/III tumors from the InterMEL study to evaluate whether UV TMB and non-UV TMB are associated with melanoma-specific mortality and clinicopathologic factors. Higher UV TMB was associated with improved outcomes, while non-UV TMB was not associated with mortality. These findings suggest that an association between total TMB and outcome may be driven disproportionately by mutations associated with UV mutagenesis. Although this has previously been reported in advanced melanomas, our work demonstrates that the prognostic relevance of UV TMB extends to stage II\/III tumors typically found in the clinical context. Whether this relationship reflects differences in tumor neo-antigenicity, immune recognition, or other biological properties remains to be determined.","rel_num_authors":43,"rel_authors":[{"author_name":"Adam Z. Reynolds","author_inst":"University of New Mexico"},{"author_name":"Li Luo","author_inst":"University of New Mexico"},{"author_name":"Ronglai Shen","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Arshi Arora","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Irene Orlow","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Klaus J Busam","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Cecilia Lezcano","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Tim K Lee","author_inst":"British Columbia Cancer Research Center"},{"author_name":"Eva Hernando","author_inst":"NYU Grossman School of Medicine"},{"author_name":"Ivan Gorlov","author_inst":"Baylor Medical Center"},{"author_name":"Christopher Amos","author_inst":"University of New Mexico"},{"author_name":"Marc S Ernstoff","author_inst":"National Cancer Institute"},{"author_name":"Venkat Seshan","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Anne E Cust","author_inst":"Melanoma Institute Australia"},{"author_name":"James S Wilmott","author_inst":"Melanoma Institute Australia"},{"author_name":"Graham Mann","author_inst":"Cleveland Clinic Foundation"},{"author_name":"Ismael A Vergara","author_inst":"Melanoma Institute Australia"},{"author_name":"Eduardo Nagore","author_inst":"Instituto Valenciano de Oncologia"},{"author_name":"Pauline Funchain","author_inst":"Stanford Medicine"},{"author_name":"Jennifer Ko","author_inst":"Cleveland Clinic Foundation"},{"author_name":"Sharon N Edmiston","author_inst":"Penn State University"},{"author_name":"Kathleen Conway","author_inst":"University of North Carolina"},{"author_name":"Paul B Googe","author_inst":"University of North Carolina"},{"author_name":"David Ollila","author_inst":"University of North Carolina"},{"author_name":"Jeffrey E Lee","author_inst":"MD Anderson Cancer Center"},{"author_name":"Judy R Rees","author_inst":"Dartmouth Cancer Center"},{"author_name":"Cheryl L Thompson","author_inst":"Case Western Reserve University"},{"author_name":"Meg Gerstenblith","author_inst":"Case Western Reserve University"},{"author_name":"Marcus Bosenberg","author_inst":"Yale University"},{"author_name":"Bonnie E Gould Rothberg","author_inst":"University of Miami Miller School of Medicine"},{"author_name":"Iman Osman","author_inst":"NYU Grossman School of Medicine"},{"author_name":"Yvonne Saenger","author_inst":"Columbia University Medical School"},{"author_name":"Matthew Schwartz","author_inst":"University of New Mexico"},{"author_name":"Tawny Boyce","author_inst":"University of New Mexico"},{"author_name":"Sheri L Holmen","author_inst":"University of Utah"},{"author_name":"Shaofeng Yang","author_inst":"Dartmouth Cancer Center"},{"author_name":"Elise Brunsgaard","author_inst":"University of Utah"},{"author_name":"Paul Bogner","author_inst":"Roswell Park Comprehensive Cancer Center"},{"author_name":"Pei Fen Kuan","author_inst":"Stony Brook University"},{"author_name":"Colin B Begg","author_inst":"Memorial Sloan Kettering Cancer Center"},{"author_name":"Nancy E Thomas","author_inst":"University of North Carolina"},{"author_name":"Marianne Berwick","author_inst":"University of New Mexico"},{"author_name":"- for the InterMEL Consortium","author_inst":""}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Automated echocardiography image quality assessment and its association with AI performance","rel_doi":"10.64898\/2026.11.19.26368489","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.19.26368489","rel_abs":"Background Echocardiographic image quality influences clinical interpretation, yet its definition remains subjective and its impact on artificial intelligence (AI) systems has not been systematically evaluated. We developed EchoQuality, a deep-learning model for automated echocardiography quality assessment, and quantified the effect of image quality on AI performance across a broad range of tasks. Methods A multidisciplinary co-creation process established a definition of echocardiographic image quality, which was used to annotate 6,474 videos for EchoQuality development and internal testing, and 1,000 videos for external testing. The impact of image quality on the performance of state-of-the-art AI models was subsequently assessed for the prediction of 12 measurements, and the detection of 5 moderate dysfunctions and 6 cardiac diseases across five international cohorts totalling 762,588 videos from 25,205 echocardiography studies. In addition, a quality-aware aggregation strategy was developed to mitigate the impact of low-quality images. Results EchoQuality achieved a performance comparable to the inter-observer agreement, while the agreement with an expert in a prospective, blinded best-clip selection experiment was 90.4%. In downstream AI uses, high-quality studies resulted in the highest performance in 97 of 122 (80%) of evaluations. The median performance gaps between high- and low-quality videos were 10% [5-20%] in the prediction of quantitative measurements (R2), 14% [7-20%] in the identification of moderate dysfunctions (sensitivity), 12% [3-20%] in the detection of diseases (sensitivity), 12% [9-15%] in view identification (accuracy), and 3% [2-5%] in left-ventricular segmentation (Dice score). Performance gaps were consistent across state-of-the-art models, datasets, and tasks. Finally, a quality-aware aggregation strategy improved performance in 88% (63 of 72) of the evaluations, with a median relative improvement of 5% [1-15%]. Conclusions EchoQuality provides an automated assessment of echocardiographic image quality, a major determinant of AI performance. Incorporating quality-awareness may improve the robustness and clinical reliability of echocardiographic AI systems.","rel_num_authors":25,"rel_authors":[{"author_name":"Pere Lopez-Gutierrez","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Juan Garrido-Oliver","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Mireia Bragulat-Arevalo","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Juan Pablo Betancur-Rengifo","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Nicholas Cauwenberghs","author_inst":"KU Leuven, Leuven, Belgium"},{"author_name":"Alberto Morales-Galan","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Marawan Elbatel","author_inst":"The Hong Kong University of Science and Technology, Hong Kong SAR, China"},{"author_name":"Machteld J. Boonstra","author_inst":"Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands"},{"author_name":"Francesca Ferrando","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Horacio Majul","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Lisandro Rivas Catoni","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Santiago Martin Grieve","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Stephan van der Zwaard","author_inst":"Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands"},{"author_name":"Yi Qin","author_inst":"The Hong Kong University of Science and Technology, Hong Kong SAR, China"},{"author_name":"Folkert W. Asselbergs","author_inst":"Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands"},{"author_name":"Tatiana Kuznetsova","author_inst":"KU Leuven, Leuven, Belgium"},{"author_name":"Gisela Teixido-Tura","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Alex P.W. Lee","author_inst":"The Chinese University of Hong Kong (Department of Medicine & Therapeutics), Hong Kong, China"},{"author_name":"Xiaomeng Li","author_inst":"The Hong Kong University of Science and Technology, Hong Kong SAR, China"},{"author_name":"Karim Lekadir","author_inst":"Artificial Intelligence in Medicine Lab (BCN-AIM), Universitat de Barcelona, Spain"},{"author_name":"Laura Galian-Gay","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Jose Rodriguez-Palomares","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Ignacio Ferreira-Gonzalez","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Lydia Dux-Santoy","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"},{"author_name":"Andrea Guala","author_inst":"Vall d Hebron Institut de Recerca, Barcelona, Spain"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Alignment and expansion in national adaptation of the WHO Model List of Essential Medicines: a cross-national analysis","rel_doi":"10.64898\/2026.11.19.26368472","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.19.26368472","rel_abs":"Background: The WHO Model List of Essential Medicines (EML) provides a common global reference for national medicines selection. National adaptation frequently involves both the adoption of WHO-recommended medicines and the addition of medicines beyond WHO EML, which have not been distinguished in comparative analyses. This study quantifies how countries adapt the WHO EML by distinguishing alignment from expansion, exploring country-level characteristics potentially associated with these dimensions. Methods: We compared national essential medicines lists (NEMLs) from 137 countries with the WHO EML. We constructed two independent measures: the Alignment Ratio, representing the proportion of WHO-recommended medicines included in each NEML, and the Expansion Ratio, representing the proportion of NEML medicines not included in the WHO EML. Countries were also classified into four adaptation modes based on combinations of alignment and expansion. Associations with country-level characteristics were examined using multivariable beta regression. Results: Countries displayed substantial heterogeneity in adaptation patterns, with representation across all four adaptation modes defined by alignment with and expansion beyond the WHO EML. Fifty countries were categorized as restrictive\/constrained adoption (low alignment, low expansion), thirty-five countries as normative dependence (high alignment, low expansion), sixteen countries as autonomous divergence (low alignment, high expansion) and thirty-six countries as capacity-driven expansion (high alignment, high expansion). Higher under-five mortality was associated with lower alignment ({beta} = -0.294; 95% CI: -0.497 to -0.091) and lower expansion ({beta} = -0.481; 95% CI: -0.697 to -0.264). Higher globalization index scores and more recent NEMLs were associated with higher alignment, but not expansion. Conclusion: While some countries closely followed the WHO EML with limited additions, a substantial proportion combined high alignment with extensive expansion beyond the WHO benchmark, suggesting that national adaptation often involves supplementation rather than substitution of WHO recommendations.","rel_num_authors":4,"rel_authors":[{"author_name":"Yukari Kohno","author_inst":"Global Studies Institute, University of Geneva, Geneva, Switzerland"},{"author_name":"Janne Estill","author_inst":"Institute of Global Health, University of Geneva, Geneva, Switzerland"},{"author_name":"Lorenzo Moja","author_inst":"Department of Medicines and Health Products Policies and Standards, World Health Organization"},{"author_name":"Olivia Keiser","author_inst":"University of Geneva Faculty of Medicine: Universite de Geneve Faculte de Medecine"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Building an Auditable Reference Standard for Clinical Information Extraction from Transesophageal Echocardiography Reports","rel_doi":"10.64898\/2026.11.19.26368500","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.19.26368500","rel_abs":"Objectives To develop an auditable, two-institution reference standard for intraoperative transesophageal echocardiography (TEE) reports and evaluate whether reviewer disagreement identifies limitations in the underlying clinical information model. Materials and Methods We selected 300 reports (150 per institution) from 925 at the University of Pennsylvania and University of Washington using random sampling and enrichment for challenging documentation. Four trained abstractors applied a shared 39-variable V1 codebook. Independent paired comparisons included 297 reports; three historical reports contributed only to the final reference standard. Categorical agreement used exact agreement and unweighted Cohen's {kappa}; numeric left-ventricular ejection fraction (LVEF) used exact agreement and mean absolute differences. Disagreements underwent structured expert adjudication and reason classification. Additional analyses assessed reviewer-pair, sampling-stratified, and population-weighted agreement. Results Among 11,583 formal reviewer-comparison cells, 10,293 (88.9%) were resolved by reviewer agreement and 1,290 (11.1%) required targeted expert adjudication (1,289 tasks). Codebook\/schema ambiguity (40.8%) and interpretation\/classification differences (25.2%) together accounted for 66.0% of targeted tasks. Adjudication was concentrated in aortic dissection, valve type, and post-intervention findings. Categorical {kappa} ranged from 0.364 to 0.960 and was inversely correlated with targeted-adjudication burden (Spearman {rho}=-0.884; 95% CI, -0.955 to -0.734). Sampling-weighted {kappa} changed by no more than 0.05 for 32 of 35 categorical variables. Discussion Structured adjudication identified recurring schema and interpretation challenges beyond individual abstraction errors, providing specific targets for information-model refinement. Conclusion As NLP and LLM-based abstraction tools move toward clinical use, the reference standards used to evaluate them require comparably rigorous development, adjudication, and independent validation.","rel_num_authors":10,"rel_authors":[{"author_name":"Emily J MacKay","author_inst":"Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"},{"author_name":"Michael S Kaplan","author_inst":"Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA"},{"author_name":"Mingyang Yuan","author_inst":"Lewis Katz School of Medicine, Temple University, Philadelphia, PA"},{"author_name":"Annie L Chen","author_inst":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"author_name":"Yujia Ge","author_inst":"Tufts University School of Medicine, Boston MA"},{"author_name":"Layla Canales","author_inst":"Villanova University, Villanova, PA"},{"author_name":"Emily Yu","author_inst":"State University of New York Downstate Health Sciences University, New York City, NY"},{"author_name":"Rohan Shad","author_inst":"Division of Cardiovascular Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"},{"author_name":"Bo Zhang","author_inst":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"author_name":"Alison M Pouch","author_inst":"Department of Radiology & Department of Bioengineering, University of Pennsylvania, Philadelphia, PA"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Evaluation of Semaphorin 3G (SEMA3G) as a biofluid biomarker of cerebral amyloid angiopathy: evidence from neurodegenerative disease and memory clinic cohorts","rel_doi":"10.64898\/2026.11.18.26368450","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368450","rel_abs":"Introduction: Cerebral amyloid angiopathy (CAA) is characterised by amyloid-beta (A{beta}) deposition in cerebral vessels, and frequently co-occurs with Alzheimer's disease (AD). Diagnosis based on MRI-based Boston criteria is not definitive, and CAA biofluid biomarkers are needed. Semaphorin 3G (SEMA3G) was recently shown to be selectively enriched in CAA-affected vessels, and correlated with CAA severity. We therefore evaluated SEMA3G as a biofluid biomarker of CAA. Methods: SEMA3G profiles were examined across diagnoses in the Global Neurodegeneration Proteomics Consortium dataset (GNPC) in cerebrospinal fluid (CSF) (N=1982) and plasma (N=6917). SEMA3G was then evaluated in the Healthy Brain Ageing (HBA) memory clinic cohort (N=161) with 3T MRI, where lobar cerebral microbleed burden was used as a proxy for CAA likelihood, with participants grouped by microbleed count (0, 1-2, or [&ge;]3). Results: CSF and plasma SEMA3G were significantly lower in AD and frontotemporal dementia (FTD) compared to cognitively unimpaired controls in GNPC, and were associated with hypertension. Longitudinally, plasma SEMA3G declined significantly over time in mild cognitive impairment (MCI) and AD. In the HBA cohort, plasma SEMA3G did not differ by cerebral microbleed burden on MRI, nor correlate with plasma A{beta} isoforms and white matter hyperintensities. Discussion: Although CSF and plasma SEMA3G levels were significantly lower in AD and FTD, plasma SEMA3G was not associated with CAA-associated MRI features in individuals at risk of AD. While these findings do not support plasma SEMA3G for identifying individuals with higher CAA-associated burden, its potential utility warrants further evaluation in genetically susceptible or neuropathologically confirmed CAA cohorts.","rel_num_authors":7,"rel_authors":[{"author_name":"Johannes C. Michaelian","author_inst":"Healthy Brain Ageing Program, Brain and Mind Centre, School of Psychology, Faculty of Science, The University of Sydney, Camperdown, NSW, 2050, Australia; Charl"},{"author_name":"Lisa Shi","author_inst":"Healthy Brain Ageing Program, Brain and Mind Centre, School of Psychology, Faculty of Science, The University of Sydney, Camperdown, NSW, 2050, Australia; Charl"},{"author_name":"Michael Barnett","author_inst":"Brain and Mind Centre, The University of Sydney, Camperdown, NSW, 2050, Australia; Sydney Neuroimaging Analysis Centre, Camperdown, NSW, 2050, Australia; Sydney"},{"author_name":"Dongang Wang","author_inst":"Brain and Mind Centre, The University of Sydney, Camperdown, NSW, 2050, Australia; Sydney Neuroimaging Analysis Centre, Camperdown, NSW, 2050, Australia; Sydney"},{"author_name":"Chenyu Wang","author_inst":"Brain and Mind Centre, The University of Sydney, Camperdown, NSW, 2050, Australia; Sydney Neuroimaging Analysis Centre, Camperdown, NSW, 2050, Australia; Sydney"},{"author_name":"Sharon L. Naismith","author_inst":"Healthy Brain Ageing Program, Brain and Mind Centre, School of Psychology, Faculty of Science, The University of Sydney, Camperdown, NSW, 2050, Australia; Charl"},{"author_name":"Eleanor Drummond","author_inst":"School of Medical Sciences, The University of Sydney, Camperdown, NSW, 2050, Australia; Brain and Mind Centre, The University of Sydney, Camperdown, NSW, 2050, "}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Accelerated vs. Daily TMS: Resting-State Functional Connectivity in a Within-Subjects Crossover Trial","rel_doi":"10.64898\/2026.11.17.26368336","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.17.26368336","rel_abs":"Importance: Accelerated protocols have emerged over the past two decades as a promising method of transcranial magnetic stimulation (TMS) administration that allows for shorter treatment duration and faster time to response. Although recent research has suggested accelerated TMS may be noninferior to daily TMS on clinical outcome measures, no studies have directly compared the neural effects of daily and accelerated TMS within the same participant group. Objective: Compare the neural effects of daily vs accelerated TMS applied to a personalized default mode network (DMN) target on bilateral parietal DMN connectivity in a transdiagnostic sample (n=36) before and after TMS. Design: Within-subjects crossover design. Setting: Vanderbilt University Medical Center, Nashville, TN. Participants: 36 individuals with a range of psychiatric conditions were enrolled (e.g., psychosis, depression, anxiety). Data from 34 participants are included in analysis. Intervention: 5 daily sessions of DMN-targeted continuous theta burst stimulation (cTBS) with pre-\/post neuroimaging. After a washout period (mean =379.26 days), these same participants returned for 5 accelerated sessions of DMN-targeted cTBS in one day with pre-\/post neuroimaging. Main Outcome and Measure: To compare the neural effects of accelerated versus traditional daily TMS schedules, the primary outcome measure was change in resting-state bilateral parietal DMN connectivity between pre-TMS and post-TMS. Results: Across all participants and both treatment schedules, DMN-targeted cTBS reduced bilateral parietal DMN connectivity (t(90.16)=-2.07, p=0.0416). TMS schedule did not did not have a statistically significant effect in DMN connectivity change(t(31.27) = -0.44, p = 0.67) . Psychosis diagnosis did not affect bilateral parietal DMN connectivity change (t(28.34)=-0.53, p=0.601). However, older age was associated with greater reduction in bilateral parietal DMN connectivity across the entire sample (t(26.91)=-2.21, p=0.036). Conclusion and Relevance: This study suggests accelerated and daily TMS protocols may have comparable neural effects across psychiatric diagnoses. Understanding the effects of TMS schedule is critical for protocol design and clinical TMS application. Trial Registration: NCT07155096 (https:\/\/clinicaltrials.gov\/study\/NCT07155096), NCT06389266 (https:\/\/clinicaltrials.gov\/study\/NCT06389266)","rel_num_authors":8,"rel_authors":[{"author_name":"Jillian Connolly","author_inst":"Vanderbilt University Medical Center"},{"author_name":"Sophia H Blyth","author_inst":"Vanderbilt University Medical Center"},{"author_name":"Libby C Tunison","author_inst":"Vanderbilt University Medical Center"},{"author_name":"Maxwell J Roeske","author_inst":"Vanderbilt University Medical Center"},{"author_name":"Simon Vandekar","author_inst":"Vanderbilt University Medical Center"},{"author_name":"Baxter P Rogers","author_inst":"Vanderbilt University Medical Center"},{"author_name":"Roscoe O Brady Jr.","author_inst":"Beth Israel Deaconess Medical Center"},{"author_name":"Heather Burrell Ward","author_inst":"Vanderbilt University Medical Center"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Plasma neurodegeneration biomarkers and clinical progression in early sporadic Parkinson's disease","rel_doi":"10.64898\/2026.11.18.26368420","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368420","rel_abs":"Objectives: Plasma neurodegeneration biomarkers offer an opportunity to characterize Parkinson's disease (PD) biology. The objective of this study was to investigate such biomarkers in deeply-phenotyped participants in Parkinson's Precision Medicine Initiative (PPMI). Methods: Baseline plasma samples from early (<2 years since diagnosis) sporadic PD participants with a positive CSF alpha-synuclein seed amplification assay (aSyn-SAA) and healthy controls (HC) with a negative aSyn-SAA test were utilized. Plasma P-tau217 (Roche Diagnostics), neurofilament light chain (NfL, Quanterix), glial fibrillary acidic protein (GFAP, Quanterix), and (PD only) amyloid-beta (A{beta}) levels (40 and 42, C2N Diagnostics) were measured. Clinical features at baseline and over up to 11 years were compared across biomarker tertiles in models controlling for age, sex, and baseline outcome variable. Results: The cohort was 97 HC and 523 PD and participants. Median [IQR] biomarker values (pg\/mL) for HC and PD were P-tau217: 0.14 [0.06 -0.75], 0.15 [0.06 -0.90]; NfL: 10.6 [3.13 -49.85], 12.26 [3.77-62.67]; GFAP: 66.56 [19.75 -403.48], 87.19 [14.55 -531.82]; and in PD A{beta}40: 391.32 [209.95 -538.38]; A{beta}42: 42.74[27.75 -68.55]. No biomarkers differed between HC and PD. In PD, biomarkers were associated with age. In PD only, higher baseline levels of P-tau217 and NfL were associated with greater hazards of a worse cognitive and balance outcome. P-tau217, NfL, and GFAP levels were associated with change in cognitive score over time. Interpretation: Plasma P-tau217, NfL and GFAP levels in early, sporadic PD with confirmed synucleinopathy predict future cognitive and functional impairment, and these findings can inform clinical research design and clinical care.","rel_num_authors":28,"rel_authors":[{"author_name":"Thomas F Tropea","author_inst":"Institute for Neurodegenerative Disorders; New Haven, CT, USA"},{"author_name":"David G Coughlin","author_inst":"Department of Neurosciences, University of California San Diego; San Diego, CA, USA"},{"author_name":"Sarah M. Brooker","author_inst":"Department of Neurology, Northwestern University, Chicago"},{"author_name":"Krittika Chatterjee","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Noah S. Johnson","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Micah Marshall","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Anuprita Nair","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Javier E. Flores","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"David-Erick Lafontant","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Christopher S Coffey","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Kristopher M. Kirmess","author_inst":"C2N Diagnostics, LLC; St. Louis, MO, USA"},{"author_name":"Tim West","author_inst":"C2N Diagnostics, LLC; St. Louis, MO, USA"},{"author_name":"Philip B. Verghese","author_inst":"C2N Diagnostics, LLC; St. Louis, MO, USA"},{"author_name":"Kristen A. Russ","author_inst":"Department of Medical and Molecular Genetics, Indiana University; Indianapolis, IN, USA"},{"author_name":"Amanda Morris","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Ming Lu","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Leonardo Iaccarino","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Patricia Aldea-Stevenson","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Matthew Flitter","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Rose Beck","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Samantha Hutten","author_inst":"The Michael J. Fox Foundation for Parkinsons Research; New York, New York, USA"},{"author_name":"Lana M. Chahine","author_inst":"Department of Neurology, University of California San Franscisco, San Franscico PA"},{"author_name":"Daniel Weintraub","author_inst":"Department of Psychiatry, University of Pennsylvania Perelman School of Medicine; Philadelphia, PA, USA"},{"author_name":"Tatiana Foroud","author_inst":"Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis"},{"author_name":"Tanya Simuni","author_inst":"Department of Neurology, Northwestern University, Chicago"},{"author_name":"Kenneth Marek","author_inst":"Institute for Neurodegenerative Disorders; New Haven, CT, USA"},{"author_name":"Kalpana Merchant","author_inst":"Department of Neurology, Northwestern University, Chicago"},{"author_name":"- The Parkinson's Precision Medicine Initiative","author_inst":""}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Plasma neurodegeneration biomarkers and clinical progression in early sporadic Parkinson's disease","rel_doi":"10.64898\/2026.11.18.26368420","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368420","rel_abs":"Objectives: Plasma neurodegeneration biomarkers offer an opportunity to characterize Parkinson's disease (PD) biology. The objective of this study was to investigate such biomarkers in deeply-phenotyped participants in Parkinson's Precision Medicine Initiative (PPMI). Methods: Baseline plasma samples from early (<2 years since diagnosis) sporadic PD participants with a positive CSF alpha-synuclein seed amplification assay (aSyn-SAA) and healthy controls (HC) with a negative aSyn-SAA test were utilized. Plasma P-tau217 (Roche Diagnostics), neurofilament light chain (NfL, Quanterix), glial fibrillary acidic protein (GFAP, Quanterix), and (PD only) amyloid-beta (A{beta}) levels (40 and 42, C2N Diagnostics) were measured. Clinical features at baseline and over up to 11 years were compared across biomarker tertiles in models controlling for age, sex, and baseline outcome variable. Results: The cohort was 97 HC and 523 PD and participants. Median [IQR] biomarker values (pg\/mL) for HC and PD were P-tau217: 0.14 [0.06 -0.75], 0.15 [0.06 -0.90]; NfL: 10.6 [3.13 -49.85], 12.26 [3.77-62.67]; GFAP: 66.56 [19.75 -403.48], 87.19 [14.55 -531.82]; and in PD A{beta}40: 391.32 [209.95 -538.38]; A{beta}42: 42.74[27.75 -68.55]. No biomarkers differed between HC and PD. In PD, biomarkers were associated with age. In PD only, higher baseline levels of P-tau217 and NfL were associated with greater hazards of a worse cognitive and balance outcome. P-tau217, NfL, and GFAP levels were associated with change in cognitive score over time. Interpretation: Plasma P-tau217, NfL and GFAP levels in early, sporadic PD with confirmed synucleinopathy predict future cognitive and functional impairment, and these findings can inform clinical research design and clinical care.","rel_num_authors":28,"rel_authors":[{"author_name":"Thomas F Tropea","author_inst":"Institute for Neurodegenerative Disorders; New Haven, CT, USA"},{"author_name":"David G Coughlin","author_inst":"Department of Neurosciences, University of California San Diego; San Diego, CA, USA"},{"author_name":"Sarah M. Brooker","author_inst":"Department of Neurology, Northwestern University, Chicago"},{"author_name":"Krittika Chatterjee","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Noah S. Johnson","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Micah Marshall","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Anuprita Nair","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Javier E. Flores","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"David-Erick Lafontant","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Christopher S Coffey","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Kristopher M. Kirmess","author_inst":"C2N Diagnostics, LLC; St. Louis, MO, USA"},{"author_name":"Tim West","author_inst":"C2N Diagnostics, LLC; St. Louis, MO, USA"},{"author_name":"Philip B. Verghese","author_inst":"C2N Diagnostics, LLC; St. Louis, MO, USA"},{"author_name":"Kristen A. Russ","author_inst":"Department of Medical and Molecular Genetics, Indiana University; Indianapolis, IN, USA"},{"author_name":"Amanda Morris","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Ming Lu","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Leonardo Iaccarino","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Patricia Aldea-Stevenson","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Matthew Flitter","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Rose Beck","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Samantha Hutten","author_inst":"The Michael J. Fox Foundation for Parkinsons Research; New York, New York, USA"},{"author_name":"Lana M. Chahine","author_inst":"Department of Neurology, University of California San Franscisco, San Franscico PA"},{"author_name":"Daniel Weintraub","author_inst":"Department of Psychiatry, University of Pennsylvania Perelman School of Medicine; Philadelphia, PA, USA"},{"author_name":"Tatiana Foroud","author_inst":"Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis"},{"author_name":"Tanya Simuni","author_inst":"Department of Neurology, Northwestern University, Chicago"},{"author_name":"Kenneth Marek","author_inst":"Institute for Neurodegenerative Disorders; New Haven, CT, USA"},{"author_name":"Kalpana Merchant","author_inst":"Department of Neurology, Northwestern University, Chicago"},{"author_name":"- The Parkinson's Precision Medicine Initiative","author_inst":""}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Plasma neurodegeneration biomarkers and clinical progression in early sporadic Parkinson's disease","rel_doi":"10.64898\/2026.11.18.26368420","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368420","rel_abs":"Objectives: Plasma neurodegeneration biomarkers offer an opportunity to characterize Parkinson's disease (PD) biology. The objective of this study was to investigate such biomarkers in deeply-phenotyped participants in Parkinson's Precision Medicine Initiative (PPMI). Methods: Baseline plasma samples from early (<2 years since diagnosis) sporadic PD participants with a positive CSF alpha-synuclein seed amplification assay (aSyn-SAA) and healthy controls (HC) with a negative aSyn-SAA test were utilized. Plasma P-tau217 (Roche Diagnostics), neurofilament light chain (NfL, Quanterix), glial fibrillary acidic protein (GFAP, Quanterix), and (PD only) amyloid-beta (A{beta}) levels (40 and 42, C2N Diagnostics) were measured. Clinical features at baseline and over up to 11 years were compared across biomarker tertiles in models controlling for age, sex, and baseline outcome variable. Results: The cohort was 97 HC and 523 PD and participants. Median [IQR] biomarker values (pg\/mL) for HC and PD were P-tau217: 0.14 [0.06 -0.75], 0.15 [0.06 -0.90]; NfL: 10.6 [3.13 -49.85], 12.26 [3.77-62.67]; GFAP: 66.56 [19.75 -403.48], 87.19 [14.55 -531.82]; and in PD A{beta}40: 391.32 [209.95 -538.38]; A{beta}42: 42.74[27.75 -68.55]. No biomarkers differed between HC and PD. In PD, biomarkers were associated with age. In PD only, higher baseline levels of P-tau217 and NfL were associated with greater hazards of a worse cognitive and balance outcome. P-tau217, NfL, and GFAP levels were associated with change in cognitive score over time. Interpretation: Plasma P-tau217, NfL and GFAP levels in early, sporadic PD with confirmed synucleinopathy predict future cognitive and functional impairment, and these findings can inform clinical research design and clinical care.","rel_num_authors":28,"rel_authors":[{"author_name":"Thomas F Tropea","author_inst":"Institute for Neurodegenerative Disorders; New Haven, CT, USA"},{"author_name":"David G Coughlin","author_inst":"Department of Neurosciences, University of California San Diego; San Diego, CA, USA"},{"author_name":"Sarah M. Brooker","author_inst":"Department of Neurology, Northwestern University, Chicago"},{"author_name":"Krittika Chatterjee","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Noah S. Johnson","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Micah Marshall","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Anuprita Nair","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Javier E. Flores","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"David-Erick Lafontant","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Christopher S Coffey","author_inst":"Department of Biostatistics, University of Iowa, Iowa City, IA"},{"author_name":"Kristopher M. Kirmess","author_inst":"C2N Diagnostics, LLC; St. Louis, MO, USA"},{"author_name":"Tim West","author_inst":"C2N Diagnostics, LLC; St. Louis, MO, USA"},{"author_name":"Philip B. Verghese","author_inst":"C2N Diagnostics, LLC; St. Louis, MO, USA"},{"author_name":"Kristen A. Russ","author_inst":"Department of Medical and Molecular Genetics, Indiana University; Indianapolis, IN, USA"},{"author_name":"Amanda Morris","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Ming Lu","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Leonardo Iaccarino","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Patricia Aldea-Stevenson","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Matthew Flitter","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Rose Beck","author_inst":"Eli Lilly and Company; Indianapolis, IN, USA"},{"author_name":"Samantha Hutten","author_inst":"The Michael J. Fox Foundation for Parkinsons Research; New York, New York, USA"},{"author_name":"Lana M. Chahine","author_inst":"Department of Neurology, University of California San Franscisco, San Franscico PA"},{"author_name":"Daniel Weintraub","author_inst":"Department of Psychiatry, University of Pennsylvania Perelman School of Medicine; Philadelphia, PA, USA"},{"author_name":"Tatiana Foroud","author_inst":"Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis"},{"author_name":"Tanya Simuni","author_inst":"Department of Neurology, Northwestern University, Chicago"},{"author_name":"Kenneth Marek","author_inst":"Institute for Neurodegenerative Disorders; New Haven, CT, USA"},{"author_name":"Kalpana Merchant","author_inst":"Department of Neurology, Northwestern University, Chicago"},{"author_name":"- The Parkinson's Precision Medicine Initiative","author_inst":""}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study","rel_doi":"10.64898\/2026.11.18.26368418","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368418","rel_abs":"Background: Individuals of African genetic ancestry are at high risk for heart failure (HF), which is often preceded by cardiac structural and functional abnormalities. Nevertheless, little is known about cardiac structure and function among Afro-Caribbeans residing in Tobago. This study aimed to investigate the epidemiology of cardiac structure and function among African Caribbeans in Tobago. Methods: A total of 924 participants (41-83 years) underwent clinical evaluation and transthoracic echocardiography. Images were analyzed for left ventricular (LV) mass index (MI), left atrial volume index, diastolic dysfunction (DD), LV ejection fraction (LVEF), global longitudinal strain (GLS), E\/e' ratio, E\/A ratio, and other echocardiographic measures. Cardiac structure and function were evaluated by age, sex, and HF stage. Results: The mean age was 61.7 years, with 61.4% women, 47.8% obesity, and 20.2% diabetes. Average systolic blood pressure was approximately 140 mmHg, and 76.7% had hypertension. Abnormal LV geometry was present in 77.1% of participants, predominantly concentric remodeling (69.5%). The prevalence of DD was 13.4%, LVEF <50% was 1.5%, and abnormal GLS ([&le;]-18%) was 5.2%. Women had significantly higher E\/e' ratios and a higher prevalence of Stage A and Stage B HF, whereas men had a higher prevalence of symptomatic (Stage C) HF. Participants aged 65-83 years had significantly higher E\/e' ratio, concentric remodeling, and LV hypertrophy than those aged 41-57 years. Conclusions: Women and older adults have higher LV structural abnormalities and DD than men and younger adults. These results will be helpful to inform public health priorities related to cardiovascular health in Tobago.","rel_num_authors":11,"rel_authors":[{"author_name":"Nirmalendu Deb Nath","author_inst":"Michigan State University, Department of Medicine, Grand Rapids, MI, USA"},{"author_name":"Iva Miljkovic","author_inst":"University of Pittsburgh, Department of Epidemiology, Pittsburgh, PA, USA"},{"author_name":"Rain Katz","author_inst":"University of Pittsburgh, Department of Epidemiology, Pittsburgh, PA, USA"},{"author_name":"James Hosner","author_inst":"Michigan State University, Department of Medicine, Grand Rapids, MI, USA"},{"author_name":"Ravinder R Mallugari","author_inst":"Vanderbilt University Medical Center, Vanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Nashville, TN, "},{"author_name":"Ryan K Cvejkus","author_inst":"University of Pittsburgh, Department of Epidemiology, Pittsburgh, PA, USA"},{"author_name":"Lauren A Cruz","author_inst":"Michigan State University, Department of Medicine, Grand Rapids, MI, USA"},{"author_name":"Victor Wheeler","author_inst":"Tobago Health Research Office, Scarborough, Tobago, Trinidad and Tobago"},{"author_name":"Clifford N Thomas","author_inst":"Premier Heart Care Ltd., Port of Spain, Trinidad, Trinidad and Tobago"},{"author_name":"Deepak K Gupta","author_inst":"Vanderbilt University Medical Center, Vanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Nashville, TN, "},{"author_name":"Allison L Kuipers","author_inst":"Michigan State University, Department of Medicine, Grand Rapids, MI, USA"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study","rel_doi":"10.64898\/2026.11.18.26368418","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368418","rel_abs":"Background: Individuals of African genetic ancestry are at high risk for heart failure (HF), which is often preceded by cardiac structural and functional abnormalities. Nevertheless, little is known about cardiac structure and function among Afro-Caribbeans residing in Tobago. This study aimed to investigate the epidemiology of cardiac structure and function among African Caribbeans in Tobago. Methods: A total of 924 participants (41-83 years) underwent clinical evaluation and transthoracic echocardiography. Images were analyzed for left ventricular (LV) mass index (MI), left atrial volume index, diastolic dysfunction (DD), LV ejection fraction (LVEF), global longitudinal strain (GLS), E\/e' ratio, E\/A ratio, and other echocardiographic measures. Cardiac structure and function were evaluated by age, sex, and HF stage. Results: The mean age was 61.7 years, with 61.4% women, 47.8% obesity, and 20.2% diabetes. Average systolic blood pressure was approximately 140 mmHg, and 76.7% had hypertension. Abnormal LV geometry was present in 77.1% of participants, predominantly concentric remodeling (69.5%). The prevalence of DD was 13.4%, LVEF <50% was 1.5%, and abnormal GLS ([&le;]-18%) was 5.2%. Women had significantly higher E\/e' ratios and a higher prevalence of Stage A and Stage B HF, whereas men had a higher prevalence of symptomatic (Stage C) HF. Participants aged 65-83 years had significantly higher E\/e' ratio, concentric remodeling, and LV hypertrophy than those aged 41-57 years. Conclusions: Women and older adults have higher LV structural abnormalities and DD than men and younger adults. These results will be helpful to inform public health priorities related to cardiovascular health in Tobago.","rel_num_authors":11,"rel_authors":[{"author_name":"Nirmalendu Deb Nath","author_inst":"Michigan State University, Department of Medicine, Grand Rapids, MI, USA"},{"author_name":"Iva Miljkovic","author_inst":"University of Pittsburgh, Department of Epidemiology, Pittsburgh, PA, USA"},{"author_name":"Rain Katz","author_inst":"University of Pittsburgh, Department of Epidemiology, Pittsburgh, PA, USA"},{"author_name":"James Hosner","author_inst":"Michigan State University, Department of Medicine, Grand Rapids, MI, USA"},{"author_name":"Ravinder R Mallugari","author_inst":"Vanderbilt University Medical Center, Vanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Nashville, TN, "},{"author_name":"Ryan K Cvejkus","author_inst":"University of Pittsburgh, Department of Epidemiology, Pittsburgh, PA, USA"},{"author_name":"Lauren A Cruz","author_inst":"Michigan State University, Department of Medicine, Grand Rapids, MI, USA"},{"author_name":"Victor Wheeler","author_inst":"Tobago Health Research Office, Scarborough, Tobago, Trinidad and Tobago"},{"author_name":"Clifford N Thomas","author_inst":"Premier Heart Care Ltd., Port of Spain, Trinidad, Trinidad and Tobago"},{"author_name":"Deepak K Gupta","author_inst":"Vanderbilt University Medical Center, Vanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Nashville, TN, "},{"author_name":"Allison L Kuipers","author_inst":"Michigan State University, Department of Medicine, Grand Rapids, MI, USA"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Evaluation of urine lipoarabinomannan and host response signatures for culture-negative tuberculosis using composite criteria and Bayesian Latent Class Analysis","rel_doi":"10.64898\/2026.11.18.26368340","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368340","rel_abs":"Abstract Background: Culture-negative TB is a major diagnostic challenge, and the lack of a reliable reference standard hinders evaluation of non-sputum diagnostic tests. We compared composite reference criteria and Bayesian latent class analysis to examine how different culture-negative TB definitions affect disease classification and evaluations of two non-sputum biomarkers: urine lipoarabinomannan (uLAM) and host transcriptional response signatures (HRS). Methods: Urine and blood samples from 112 sputum culture-negative and 55 culture-positive symptomatic adults evaluated for tuberculosis from South Africa, Uganda, and Kenya, alongside 17 controls with other respiratory conditions, were analyzed using uLAM and HRS assays. Sensitivity and specificity were estimated for each assay based on three reference criteria: composite microbiological, composite clinical, and a latent class model. Results: Positive classification proportions were 0.29 (32\/112) and 0.46 (51\/112) for the composite criteria and 0.20 (22\/112) for the latent class model, with the Bayesian model estimating a prevalence of 0.31 (95%CrI 0.11-0.64). Sensitivity and specificity for uLAM ranged from 0.06-0.13 and 0.92-0.96, respectively. Sensitivity and specificity for HRS ranged from 0.47-0.78 and 0.56-0.69, respectively. uLAM results were significantly associated with microbiological positivity (OR=5.38, 95%CI=1.63-13.02). Conclusion: Three distinct reference frameworks identified different individuals as having culture-negative TB while producing index assay sensitivity and specificity estimates with overlapping confidence and credible intervals, leading to similar conclusions regarding biomarker utility. This supports the use of complementary reference approaches to assess robustness to disease classification uncertainty in heterogeneous conditions such as culture-negative TB.","rel_num_authors":17,"rel_authors":[{"author_name":"Robert N Reiss","author_inst":"Rutgers New Jersey School of Medicine"},{"author_name":"Kattya Lopez Tamara","author_inst":"Rutgers New Jersey Medical School"},{"author_name":"William Honnen","author_inst":"Rutgers New Jersey Medical School"},{"author_name":"Nisha Modi","author_inst":"Rutgers New Jersey Medical School"},{"author_name":"Lesly Suarez Caceres","author_inst":"Rutgers New Jersey Medical School"},{"author_name":"Nandini Dendukuri","author_inst":"RI-MUHC: Research Institute of the McGill University Health Centre"},{"author_name":"Ian Schiller","author_inst":"RI-MUHC: Research Institute of the McGill University Health Centre"},{"author_name":"Vaishnavi Satish Kaipilyawar","author_inst":"Rutgers New Jersey Medical School"},{"author_name":"Christie Eichberg","author_inst":"Medical University of South Carolina"},{"author_name":"Lydia Nakiyingi","author_inst":"Makerere University Infectious Diseases Institute"},{"author_name":"Chad Centner","author_inst":"University of Cape Town Faculty of Health Sciences"},{"author_name":"Susan Dorman","author_inst":"Medical University of South Carolina"},{"author_name":"Jerrold Ellner","author_inst":"Rutgers New Jersey Medical School"},{"author_name":"William Evan Johnson","author_inst":"Rutgers New Jersey Medical School"},{"author_name":"Padmini Salgame","author_inst":"Rutgers New Jersey Medical School"},{"author_name":"Abraham Pinter","author_inst":"Rutgers New Jersey Medical School,"},{"author_name":"Yingda Linda Xie","author_inst":"Rutgers New Jersey Medical School"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Automated Screening for Generalized Anxiety Disorder Using Voice Analysis and Machine Learning","rel_doi":"10.64898\/2026.11.18.26367837","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26367837","rel_abs":"This study evaluated machine learning models for screening elevated generalized anxiety symptoms from remotely collected neutral read speech in 1,788 adults from Botswana, Ghana, Nigeria, and Tanzania. Elevated symptoms were defined by Generalized Anxiety Disorder 7-item (GAD-7) questionnaire scores [&ge;] 5. Nine classifiers were assessed across nine scenarios defined by speech-task configuration (short sentence, long passage, or both tasks) and sex stratification under participant-separated, repeated nested cross-validation (CV). Acoustic-only models used the extended Geneva Minimalistic Acoustic Parameter Set, and context-augmented models added age, self-reported health, and sex where applicable. With feature selection, the highest mean area under the receiver operating characteristic curve (AUCROC) was 0.594 for acoustic-only models and 0.699 for context-augmented models, the latter in the female-only combined-task scenario. Shapley additive explanations (SHAP) identified fundamental frequency descriptors as prominent acoustic predictors, while health status and age were the leading predictors in context-augmented models. Performance varied across scenarios, and feature selection provided no consistent benefit. Secondary regression poorly estimated continuous symptom severity. These findings indicate limited discrimination from neutral speech acoustics alone and improved performance with participant context, warranting external validation.","rel_num_authors":10,"rel_authors":[{"author_name":"Arman Khoshnevis","author_inst":"Department of Mechanical Engineering, Michigan State University"},{"author_name":"Mohsen Zayernouri","author_inst":"Department of Mechanical Engineering, Michigan State University"},{"author_name":"Leapetswe Malete","author_inst":"Department of Kinesiology, Michigan State University"},{"author_name":"Dale Joachim","author_inst":"Acoustic Footprints"},{"author_name":"Chelsi Ricketts","author_inst":"Faculty of Kinesiology and Physical Education, University of Toronto"},{"author_name":"Reginald Ocansey","author_inst":"Department of Physical Education and Sport Studies, University of Ghana"},{"author_name":"Rosemary Chizobam Muomah","author_inst":"Department of Psychological Medicine, University of Nigeria"},{"author_name":"Dawn Tladi","author_inst":"Department of Sports Science, University of Botswana"},{"author_name":"Joyce Sifa Ndabi","author_inst":"Department of Sports Science, University of Dar es Salaam"},{"author_name":"Maryam Naghibolhosseini","author_inst":"Department of Communicative Sciences and Disorders, Michigan State University"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Brain Cell-Type-Specific X-Chromosome Gene Regulation Reveals Sex-Biased Candidate Genes in Neurodegeneration","rel_doi":"10.64898\/2026.11.18.26368437","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368437","rel_abs":"The impact of X-chromosome dosage on gene regulation in specific brain cell-types may importantly shape sex differences in neurodegenerative diseases but remains poorly resolved. We therefore mapped X-chromosome genetic effects on gene expression, i.e. cis-expression quantitative trait loci (cis-eQTL), across seven brain cell-types from 423 old-age individuals. We identified 212 X-linked genes whose expression was genetically regulated, with the majority being cell-type specific. Notably, 10 of these genes (~5%) showed sex-heterogeneous genetic regulation. Through sex-differential expression analyses we further discovered 101 sex-biased genes that were predominantly female-upregulated most strikingly in microglia. Sex-biased gene expression showed both shared and distinct cell-type effects, appearing most divergent in non-neuronal populations. Many female-biased genes overlapped known escape-from-X-inactivation genes and were enriched for links to Alzheimer's disease. Finally, we integrated our resource with X-chromosome-wide association studies of neurodegenerative diseases through causal inference approaches including transcriptome-wide association, mendelian randomization, and colocalization analyses to nominate 11 candidate causal genes, linked to their respective cell-types and sex-informed mechanisms, for Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. Altogether, our findings suggest escape from X chromosome inactivation may contribute to sex differences in neurodegeneration and provide a resource to advance sex-informed insights into disease pathogenesis and therapeutic opportunities.","rel_num_authors":11,"rel_authors":[{"author_name":"Youjie Zeng","author_inst":"Washington University in St. Louis"},{"author_name":"Noah Cook","author_inst":"Washington University in St. Louis"},{"author_name":"Masashi Fujita","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Matt Johnson","author_inst":"Washington University in St. Louis"},{"author_name":"Aliza P. Wingo","author_inst":"University of California, Davis"},{"author_name":"Thomas S. Wingo","author_inst":"University of California, Davis"},{"author_name":"Alex R. DeCasien","author_inst":"National Institute on Aging, National Institutes of Health"},{"author_name":"Cyril Pottier","author_inst":"Washington University in St. Louis"},{"author_name":"Carlos Cruchaga","author_inst":"Washington University in St. Louis"},{"author_name":"Vilas Menon","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Michael E. Belloy","author_inst":"Washington University in St. Louis"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Brain Cell-Type-Specific X-Chromosome Gene Regulation Reveals Sex-Biased Candidate Genes in Neurodegeneration","rel_doi":"10.64898\/2026.11.18.26368437","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368437","rel_abs":"The impact of X-chromosome dosage on gene regulation in specific brain cell-types may importantly shape sex differences in neurodegenerative diseases but remains poorly resolved. We therefore mapped X-chromosome genetic effects on gene expression, i.e. cis-expression quantitative trait loci (cis-eQTL), across seven brain cell-types from 423 old-age individuals. We identified 212 X-linked genes whose expression was genetically regulated, with the majority being cell-type specific. Notably, 10 of these genes (~5%) showed sex-heterogeneous genetic regulation. Through sex-differential expression analyses we further discovered 101 sex-biased genes that were predominantly female-upregulated most strikingly in microglia. Sex-biased gene expression showed both shared and distinct cell-type effects, appearing most divergent in non-neuronal populations. Many female-biased genes overlapped known escape-from-X-inactivation genes and were enriched for links to Alzheimer's disease. Finally, we integrated our resource with X-chromosome-wide association studies of neurodegenerative diseases through causal inference approaches including transcriptome-wide association, mendelian randomization, and colocalization analyses to nominate 11 candidate causal genes, linked to their respective cell-types and sex-informed mechanisms, for Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. Altogether, our findings suggest escape from X chromosome inactivation may contribute to sex differences in neurodegeneration and provide a resource to advance sex-informed insights into disease pathogenesis and therapeutic opportunities.","rel_num_authors":11,"rel_authors":[{"author_name":"Youjie Zeng","author_inst":"Washington University in St. Louis"},{"author_name":"Noah Cook","author_inst":"Washington University in St. Louis"},{"author_name":"Masashi Fujita","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Matt Johnson","author_inst":"Washington University in St. Louis"},{"author_name":"Aliza P. Wingo","author_inst":"University of California, Davis"},{"author_name":"Thomas S. Wingo","author_inst":"University of California, Davis"},{"author_name":"Alex R. DeCasien","author_inst":"National Institute on Aging, National Institutes of Health"},{"author_name":"Cyril Pottier","author_inst":"Washington University in St. Louis"},{"author_name":"Carlos Cruchaga","author_inst":"Washington University in St. Louis"},{"author_name":"Vilas Menon","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Michael E. Belloy","author_inst":"Washington University in St. Louis"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Amyotrophic lateral sclerosis progression is tracked in plasma by systemic proteins independent of motor neurons","rel_doi":"10.64898\/2026.11.15.26368153","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.15.26368153","rel_abs":"Blood biomarkers that change as patients with amyotrophic lateral sclerosis (ALS) decline would allow progression to be monitored more objectively. Plasma proteomic studies have identified proteins that differ between patients and controls, but which plasma proteins change as patients decline, and whether they come from motor neurons, is unknown. Here, we leveraged the Answer ALS cohort, with serial SomaScan plasma proteomics, repeated ALS Functional Rating Scale-Revised assessments, and induced pluripotent stem cell-derived motor neurons (iMNs) from the same patients. At baseline, 77 plasma proteins differed between 245 patients and 76 controls. These were dominated by muscle proteins, including PDLIM3, ACTN2, and MYOM2, and reflected disease severity. Using a two-stage longitudinal design, we identified 72 progression markers whose within-patient change tracked the rate of functional decline, led by CLEC3B, ANTXR2, and ART3. These were largely distinct from the most elevated muscle proteins and were secreted or shed proteins spread across many tissues. Both sets replicated in the independent Target ALS cohort. A motor neuron expression map built from the iMNs showed that motor neuron proteins were underrepresented in both sets and that expression in iMNs did not predict tracking of decline. Baseline serum neurofilament light chain (NfL) predicted how quickly patients declined but its change did not track decline, whereas change in the progression markers did so within every stratum of baseline NfL. Neither tracked decline in the fastest progressing patients. This positions baseline NfL for prognosis and stratification and systemic plasma proteins for monitoring.","rel_num_authors":2,"rel_authors":[{"author_name":"Caitlin Finney","author_inst":"Westmead Institute for Medical Research"},{"author_name":"Artur Shvetcov","author_inst":"Westmead Institute for Medical Research"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Pathologic aggregation of \u03b1-synuclein and tau in the gut mirrors the brain, in both Lewy body disease and non-synucleinopathies","rel_doi":"10.64898\/2026.11.19.26367659","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.19.26367659","rel_abs":"Seeded aggregation of -synuclein and tau in the gastrointestinal tract is a potential biomarker and window into disease pathogenesis, but its quantitative relationship to the brain is unknown. Here, various regions of the gut and brain from autopsies of Lewy body disease and other diagnoses were tested for seeded aggregation of -synuclein and an Alzheimer's disease-related tau species, tau-dGAE. Gut seeding of -synuclein (51.8 {+\/-} 16.8 vs 112.6 {+\/-} 23.0 hours) and tau-dGAE (28.5 {+\/-} 2.6 vs 31.7 {+\/-} 2.9 hours) was faster in Lewy body disease than non-Lewy cases and was correlated with seeding in frontal cortex and midbrain\/medulla (Pearson's r from 0.75 - 0.63). Seeding of -synuclein in gut tissue was also correlated with loss of nigral pigment, pigmented neurons, Lewy bodies, and tyrosine hydroxylase-positive neurons as well as -synuclein in the dorsal motor nucleus of the vagus (r values from 0.76 - 0.49). Seeding of tau-dGAE in duodenum (but not brain) was faster in Lewy body disease compared to non-Lewy cases (28.5 {+\/-} 2.6 vs 31.7 {+\/-} 2.9 hours). Tau seeded aggregation in duodenum was correlated with tau-dGAE seeded aggregation in hippocampus and frontal cortex (r values from 0.58 - 0.55) and with tau and amyloid immunohistochemistry in the hippocampus, mainly for cases of Lewy body disease. Seeding for -synuclein and tau-dGAE in the gut correlated with seeding in the brain regardless of disease status. Overall data show a quantitative mirroring of peripheral and central seeded aggregation and neuropathology and demonstrate its utility for studies of pathogenesis and clinical biomarkers.","rel_num_authors":12,"rel_authors":[{"author_name":"Gregory Scott","author_inst":"Portland VA Medical Center, Oregon Health and Science University"},{"author_name":"Allison Quinn","author_inst":"Portland VA Medical Center, Oregon Health and Science University"},{"author_name":"Savanah Sicard","author_inst":"Portland VA Medical Center, Oregon Health and Science University"},{"author_name":"Anna Bui","author_inst":"Oregon Health and Science University, Portland State University"},{"author_name":"Madison Christopher","author_inst":"Oregon Health and Science University"},{"author_name":"Alaaeddin Alrohaibani","author_inst":"LSU Health Shreveport"},{"author_name":"Peter Kay","author_inst":"StressMarq Biosciences Inc"},{"author_name":"Kristin Piche","author_inst":"StressMarq Biosciences Inc"},{"author_name":"Ariel Louwrier","author_inst":"StressMarq Biosciences Inc."},{"author_name":"Ursula Sandau","author_inst":"Oregon Health and Science University"},{"author_name":"Randy Woltjer","author_inst":"Oregon Health and Science University"},{"author_name":"Joseph Quinn","author_inst":"Oregon Health and Science University"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Modeling spontaneous hepatitis C virus clearance by age, sex, IFNL4 genotype, and infection history: Implications for simulations of elimination and vaccine trials","rel_doi":"10.64898\/2026.11.18.26368407","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368407","rel_abs":"Background and Aims: The probability of hepatitis C virus (HCV) clearance is mediated by an interaction between numerous factors. However, variation in spontaneous HCV clearance was previously modeled using relatively simple approaches with fixed probabilities by sex. Here, we developed a literature-informed clearance algorithm that considers age, sex, interferon lambda 4 (IFNL4) genotype, and infection history to model the probability of HCV clearance in vulnerable populations, such as people who inject drugs (PWID), and in controlled human infection (CHI) models for future HCV vaccines. Methods: We modeled HCV clearance probabilities for three infection-history pathways: first infection, reinfection after spontaneous clearance, and reinfection after direct-acting antiviral (DAA) cure. Logistic and cumulative-hazard equations assigned person-specific clearance probabilities in the first two pathways. The post-DAA pathway used fixed clearance probabilities. We tested the algorithm using HepCEP (Hepatitis C Elimination in PWID), an agent-based simulator. Results: First-infection clearance probabilities ranged from 0.13 to 0.51 across eight age, sex, and IFNL4 genotype subgroups. Clearance probabilities for reinfection after spontaneous clearance ranged from 0.20 to 0.80 at literature point estimates. Across 100 runs, the mean assigned clearance probabilities were 0.27 for first infections and 0.52 for reinfections after spontaneous clearance, compared with literature inputs of 0.26 and 0.52, respectively. Probabilities varied across subgroups and runs. Conclusion: Simulations reproduced the algorithm's intended clearance heterogeneity and uncertainty by age, sex, IFNL4 genotype, and infection history, which may support models of HCV elimination in vulnerable populations and CHI model development for future HCV vaccines.","rel_num_authors":9,"rel_authors":[{"author_name":"Keshav R. Gandhi","author_inst":"Loyola University Chicago; University of Illinois Chicago"},{"author_name":"Sophia Mao","author_inst":"University of Illinois Chicago"},{"author_name":"Eric Tatara","author_inst":"University of Chicago; Argonne National Laboratory"},{"author_name":"Jonathan Ozik","author_inst":"University of Chicago; Argonne National Laboratory"},{"author_name":"Basmattee Boodram","author_inst":"University of Illinois Chicago"},{"author_name":"Scott J. Cotler","author_inst":"Loyola University Chicago"},{"author_name":"Marian Major","author_inst":"Food and Drug Administration"},{"author_name":"Alexander Gutfraind","author_inst":"Loyola University Chicago; University of Illinois Chicago"},{"author_name":"Harel Dahari","author_inst":"Loyola University Chicago"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Modeling spontaneous hepatitis C virus clearance by age, sex, IFNL4 genotype, and infection history: Implications for simulations of elimination and vaccine trials","rel_doi":"10.64898\/2026.11.18.26368407","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.18.26368407","rel_abs":"Background and Aims: The probability of hepatitis C virus (HCV) clearance is mediated by an interaction between numerous factors. However, variation in spontaneous HCV clearance was previously modeled using relatively simple approaches with fixed probabilities by sex. Here, we developed a literature-informed clearance algorithm that considers age, sex, interferon lambda 4 (IFNL4) genotype, and infection history to model the probability of HCV clearance in vulnerable populations, such as people who inject drugs (PWID), and in controlled human infection (CHI) models for future HCV vaccines. Methods: We modeled HCV clearance probabilities for three infection-history pathways: first infection, reinfection after spontaneous clearance, and reinfection after direct-acting antiviral (DAA) cure. Logistic and cumulative-hazard equations assigned person-specific clearance probabilities in the first two pathways. The post-DAA pathway used fixed clearance probabilities. We tested the algorithm using HepCEP (Hepatitis C Elimination in PWID), an agent-based simulator. Results: First-infection clearance probabilities ranged from 0.13 to 0.51 across eight age, sex, and IFNL4 genotype subgroups. Clearance probabilities for reinfection after spontaneous clearance ranged from 0.20 to 0.80 at literature point estimates. Across 100 runs, the mean assigned clearance probabilities were 0.27 for first infections and 0.52 for reinfections after spontaneous clearance, compared with literature inputs of 0.26 and 0.52, respectively. Probabilities varied across subgroups and runs. Conclusion: Simulations reproduced the algorithm's intended clearance heterogeneity and uncertainty by age, sex, IFNL4 genotype, and infection history, which may support models of HCV elimination in vulnerable populations and CHI model development for future HCV vaccines.","rel_num_authors":9,"rel_authors":[{"author_name":"Keshav R. Gandhi","author_inst":"Loyola University Chicago; University of Illinois Chicago"},{"author_name":"Sophia Mao","author_inst":"University of Illinois Chicago"},{"author_name":"Eric Tatara","author_inst":"University of Chicago; Argonne National Laboratory"},{"author_name":"Jonathan Ozik","author_inst":"University of Chicago; Argonne National Laboratory"},{"author_name":"Basmattee Boodram","author_inst":"University of Illinois Chicago"},{"author_name":"Scott J. Cotler","author_inst":"Loyola University Chicago"},{"author_name":"Marian Major","author_inst":"Food and Drug Administration"},{"author_name":"Alexander Gutfraind","author_inst":"Loyola University Chicago; University of Illinois Chicago"},{"author_name":"Harel Dahari","author_inst":"Loyola University Chicago"}],"rel_date":"2026-11-20","rel_site":"medrxiv"},{"rel_title":"Caenorhabditis elegans HLH-30\/TFEB has age-dependent effects on the transcriptome and is required for normal progeny number and larval survival under basal growth conditions","rel_doi":"10.64898\/2026.11.19.767989","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767989","rel_abs":"Background: The transcription factor TFEB\/HLH-30 is a well-established regulator of autophagy and lysosomal biogenesis during starvation and stress, and it plays important roles in development and homeostasis. Our previous work demonstrated that Caenorhabditis elegans HLH-30 also functions under basal physiological conditions in mature neurons, where it promotes the expansion of endo-lysosomal degradative capacity during early adulthood. These findings raised the question of whether HLH-30 promotes lysosomal gene expression more broadly during early adulthood, and, more generally, whether its basal transcriptional functions depend on animal age. To address these questions, we analyzed the impact of hlh-30 loss on the transcriptome at two larval stages, L1 and L4, and two adult ages, Day 3 and Day 6, in hermaphrodites grown under basal conditions. Results: We identified modest effects of hlh-30 loss on the transcriptome that varied by stage\/age. Enrichment analyses of genes downregulated in hlh-30 mutants identified functions related to defense response at L1 and in adulthood, and to cuticle development in adulthood. On the other hand, a role for hlh-30 in the basal expression of autophagy genes was exclusively detected in L1 larvae. A subset of genes encoding cathepsins showed decreased expression in the adult hlh-30 mutant; however, our results indicate that HLH-30 is not broadly required for basal expression of most lysosome biogenesis genes in adulthood. We also detected a trend toward reduced expression of genes involved in germline function at the L4 stage, when spermatogenesis occurs, and found that loss of hlh-30 resulted in reduced sperm and progeny numbers. In addition, we found that hlh-30 is required for full progeny survival through larval development. Finally, we identified a gene with increased expression at all four stages in the hlh-30 mutant, the germline transcription factor-encoding ztf-28. Knockdown of ztf-28 partially suppressed the reductions in progeny number and survival, suggesting that its increased expression contributes to these phenotypes. Conclusions: This study reveals roles for HLH-30 in transcriptome regulation under basal growth conditions that vary in both magnitude and content by animal age. Further, it demonstrates a previously unappreciated requirement for HLH-30 in promoting progeny number and survival, broadening our understanding of the physiological roles of this conserved transcription factor.","rel_num_authors":6,"rel_authors":[{"author_name":"Ruiling Zhong","author_inst":"University of Wisconsin-Madison"},{"author_name":"Sherlyn P. Wijaya","author_inst":"University of Wisconsin-Madison"},{"author_name":"Ray A. O. Sinurat","author_inst":"University of Chicago"},{"author_name":"Serenity D. Her","author_inst":"University of Wisconsin-Madison"},{"author_name":"Qiyue Ying","author_inst":"University of Wisconsin-Madison"},{"author_name":"Claire E Richardson","author_inst":"University of Wisconsin - Madison"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Molecular Conformer Sampling Beyond Generations","rel_doi":"10.64898\/2026.11.19.767840","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767840","rel_abs":"Sampling the low-energy conformational states available to a molecule is a fundamental problem in computational chemistry and drug discovery, since molecular properties and downstream design decisions depend on the relevant three-dimensional geometries rather than on a single structure. Recent diffusion and flow-based generative models can efficiently sample conformer candidates from molecular graphs, but under a fixed output budget their samples do not cover the full set of relevant conformational states of a molecule, while practical benchmarks and downstream applications require a small ensemble that is both diverse and physically plausible. We present a post-generation selection framework that turns candidate pools from frozen, pre-trained generators into compact conformer ensembles without any retraining or fine-tuning of the underlying generator. The framework offers two selectors that share the same candidate pool and the same learned reference-likelihood classifier: CovSelect, a coverage-maximizing selector that greedily reaches as many distinct reference states as the pool allows, and RefSelect, a tunable selector that trades some of that coverage for higher precision and, at its balanced setting, matches or exceeds strong generative baselines on both measures at once. On the full GEOM-DRUGS test set, CovSelect reaches 91.33% mean recall (98.36% median), outperforming every raw generator we compare against, and RefSelect at its balanced setting exceeds the strongest raw baseline, DMT-L, on both recall and precision. Finally, across several out of distribution benchmarks (QMugs, pepconf, and Platinum), CovSelect substantially outperforms all raw generative baselines in recall and precision.","rel_num_authors":4,"rel_authors":[{"author_name":"Alvand Vahediahmar","author_inst":"Columbia University"},{"author_name":"Aaron Zweig","author_inst":"Columbia University"},{"author_name":"Mingxuan Zhang","author_inst":"Columbia University"},{"author_name":"Elham Azizi","author_inst":"Columbia University"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"A genetic toolkit of visible mutants for Caenorhabditis briggsae","rel_doi":"10.64898\/2026.11.19.767928","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767928","rel_abs":"Caenorhabditis briggsae is a widely used model for comparative genetic studies involving C. elegans. Genetic analysis in C. briggsae depends on mutations with clear, easily recognizable phenotypes, yet most mutants reported so far have been mentioned only as names and linkage groups, without underlying experimental data. This study reports 183 C. briggsae mutants belonging to 11 phenotypic classes, which represent the most comprehensive collection to date. Almost all mutants were recovered in EMS screens of the reference strain AF16. Our analysis revealed that 121 mutations define 55 loci and 62 remain unassigned. A combination of complementation tests, linkage tests, two- and three-factor crosses, and polymorphism-based mappings helped place 51 loci and 15 further mutations to the six linkage groups. We report the supporting data, map distances, linkage groups, and corrections to several earlier assignments. Twenty-three loci correspond to molecularly identified orthologs of C. elegans genes, including six for which we report genetic, rescue, or sequence evidence here. The levamisole-resistant mutants fall into at least three complementation groups, two of which correspond to Cbr-unc-38 and Cbr-unc-29 (levamisole-sensitive nicotinic acetylcholine receptor a and non-a subunit, respectively). Transgene rescue experiments identify Cbr-dpy-1 (mucin-like), Cbr-sma-6 (TGFb type receptor kinase), and Cbr-unc-4 (homeodomain transcription factor), genes that have long been in use as genetic markers. In all cases, molecularly identified genes are located on the same chromosome as their C. elegans orthologs, although gene order within chromosomes differs. The strains, map, and underlying data provide a resource for genetic and comparative studies in Caenorhabditis nematodes.","rel_num_authors":12,"rel_authors":[{"author_name":"Robert Johnsen","author_inst":"Simon Fraser University"},{"author_name":"Allan Mah","author_inst":"Simon Fraser University"},{"author_name":"Bavithra Thillainathan","author_inst":"McMaster University"},{"author_name":"Takao Inoue","author_inst":"California Institute of Technology"},{"author_name":"Michael Ailion","author_inst":"University of Washington"},{"author_name":"Shahla Gharib","author_inst":"California Institute of Technology"},{"author_name":"B. Nagagireesh","author_inst":"McMaster University"},{"author_name":"Dharitri Sarma","author_inst":"McMaster University"},{"author_name":"Astha Tejpal","author_inst":"McMaster University"},{"author_name":"David Baillie","author_inst":"Simon Fraser University"},{"author_name":"Paul W. Sternberg","author_inst":"California Institute of Technology"},{"author_name":"Bhagwati P. Gupta","author_inst":"McMaster University"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Endogenous activation of multiple stress-response pathways during meiosis promotes gamete fitness","rel_doi":"10.64898\/2026.11.18.767631","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767631","rel_abs":"Gametogenesis, the process of meiosis coupled to gamete formation, transforms diploid progenitor cells into haploid gametes through extensive cellular remodeling and rewiring of gene expression. Several stress-responsive transcription factors (TFs) are upregulated during gametogenesis, but whether the cellular mechanisms that handle environmental stress also support the success of this developmental process is largely unexplored. Here, we show that four stress-responsive TFs, Hsf1, Skn7, and the paralogs Msn2 and Msn4, are endogenously active during budding yeast gametogenesis in the absence of external stress and drive distinct gene expression programs. Simultaneous meiotic depletion of Msn2, Msn4, and Skn7 compromise the fitness of the resulting gametes. We identified just two TF-dependent targets, the antioxidant genes TSA1 and AHP1, as important for gamete fitness, directly connecting TF activity to the protection of meiotic progeny. Our results demonstrate that the activation of canonical stress-response regulators is built into the meiotic program and suggest that such pathways can be repurposed during development to safeguard cellular health.","rel_num_authors":5,"rel_authors":[{"author_name":"Alena L Bishop","author_inst":"University of California Berkeley"},{"author_name":"Silvan Spiri","author_inst":"University of California Berkeley"},{"author_name":"Defne Yalcin","author_inst":"University of California Berkeley"},{"author_name":"Gloria Brar","author_inst":"University of California Berkeley"},{"author_name":"Elcin Unal","author_inst":"University of California Berkeley"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Neural mechanisms of lightness constancy","rel_doi":"10.64898\/2026.11.19.767952","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767952","rel_abs":"Object-specific variables are entangled in sensory input. For example, lightness, whether a surface is white or black, not only depends on the surface reflectance but also on the incident illumination. The brain must thus perform inference to achieve a reliable percept of lightness irrespective of illumination (lightness constancy). Whether this results from simple luminance contrast operations early in the visual system or computations at higher levels remains unresolved. We find that neural lightness signals only appear in the extragranular layers of cortical Area V4, and dominate for shadow regions, as opposed to the comparison of local and surrounding luminance (simultaneous contrast). This suggests that lightness is computed downstream from simultaneous contrast, ruling out simple low-level mechanisms, and instead supporting mid-level anchoring theory.","rel_num_authors":4,"rel_authors":[{"author_name":"Fatemeh Didehvar","author_inst":"Washington University in St. Louis"},{"author_name":"Robbe Vanstiphout","author_inst":"Washington University in St. Louis"},{"author_name":"Patrick Cavanagh","author_inst":"Dartmouth College"},{"author_name":"Tom P. Franken","author_inst":"Washington University in St. Louis"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Overexpression of \u03b1 synuclein in Midbrain Dopamine Neurons Drives Learning Deficits in Mice","rel_doi":"10.64898\/2026.11.19.767936","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767936","rel_abs":"Parkinson disease (PD) is diagnosed based on core motor features. However, changes in cognitive function are often already present. Cognitive symptoms include changes in executive function, including organization, planning, multi-tasking, and flexible decision-making. These early cognitive deficits have been difficult to model and remain understudied. Here, we investigated whether AAV-based overexpression of wild-type human alpha-synuclein (syn) in midbrain dopaminergic neurons can produce deficits in learning and behavioral flexibility. We found that syn mice develop progressive impairment in basic action-outcome learning. In addition, we found that syn mice show impairments in behavioral flexibility during probabilistic reversal learning. Together, these findings demonstrate that syn overexpression in midbrain dopaminergic neurons is sufficient to drive cognitive decline. Our early-stage PD model offers a temporal window to dissect cellular and circuits mechanisms underlying non-motor manifestations of PD.","rel_num_authors":10,"rel_authors":[{"author_name":"Berenice Coutant","author_inst":"UC San Francisco"},{"author_name":"Xiaowen Zhuang","author_inst":"UC San Francisco"},{"author_name":"Jillian Seiler","author_inst":"Northwestern University"},{"author_name":"Jacob Nadel","author_inst":"Northwestern University"},{"author_name":"Kasandra Romo","author_inst":"UC San Francisco"},{"author_name":"Yuhong Fu","author_inst":"University of Sydney"},{"author_name":"Robert L Edwards","author_inst":"UCSF"},{"author_name":"Glenda Halliday","author_inst":"The University of Sydney"},{"author_name":"Talia Lerner","author_inst":"Northwestern University"},{"author_name":"Alexandra B Nelson","author_inst":"UC San Francisco"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Overexpression of \u03b1 synuclein in Midbrain Dopamine Neurons Drives Learning Deficits in Mice","rel_doi":"10.64898\/2026.11.19.767936","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767936","rel_abs":"Parkinson disease (PD) is diagnosed based on core motor features. However, changes in cognitive function are often already present. Cognitive symptoms include changes in executive function, including organization, planning, multi-tasking, and flexible decision-making. These early cognitive deficits have been difficult to model and remain understudied. Here, we investigated whether AAV-based overexpression of wild-type human alpha-synuclein (syn) in midbrain dopaminergic neurons can produce deficits in learning and behavioral flexibility. We found that syn mice develop progressive impairment in basic action-outcome learning. In addition, we found that syn mice show impairments in behavioral flexibility during probabilistic reversal learning. Together, these findings demonstrate that syn overexpression in midbrain dopaminergic neurons is sufficient to drive cognitive decline. Our early-stage PD model offers a temporal window to dissect cellular and circuits mechanisms underlying non-motor manifestations of PD.","rel_num_authors":10,"rel_authors":[{"author_name":"Berenice Coutant","author_inst":"UC San Francisco"},{"author_name":"Xiaowen Zhuang","author_inst":"UC San Francisco"},{"author_name":"Jillian Seiler","author_inst":"Northwestern University"},{"author_name":"Jacob Nadel","author_inst":"Northwestern University"},{"author_name":"Kasandra Romo","author_inst":"UC San Francisco"},{"author_name":"Yuhong Fu","author_inst":"University of Sydney"},{"author_name":"Robert L Edwards","author_inst":"UCSF"},{"author_name":"Glenda Halliday","author_inst":"The University of Sydney"},{"author_name":"Talia Lerner","author_inst":"Northwestern University"},{"author_name":"Alexandra B Nelson","author_inst":"UC San Francisco"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Origin tracing and detection lag in the first Aedes albopictus invasion of mainland Australia and a long-term genomic dataset of mosquito incursions","rel_doi":"10.64898\/2026.11.19.767973","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767973","rel_abs":"Proactive management of invasive species aims to prevent and eradicate new incursions before they establish. Genomic data can assist proactive management around how to deploy resources and when to change strategies, and has been used effectively in managing Aedes albopictus (Asian tiger mosquito) in the Australian Northern Peninsula Area over the past decade. This study characterises the first major incursion of Ae. albopictus on the Australian mainland, and contrasts this with long-term genomic monitoring of this species within the Torres Strait Islands (TSI). First, we genomically traced the mainland incursion, which was detected in Cape York, Queensland, to the nearest infested island, Muralug (Prince of Wales). Strong genetic drift patterns in the incursion are suggestive of recent inbreeding, and point to a lag between incursion and detection of at least two mosquito generations. This stands in stark contrast with incursions within the TSI, which showed no evidence of inbreeding, suggesting no detection lag in the TSI. We genomically traced n=63 incursions detected in the TSI between 2019-2026, including n=44 newly sequenced samples; this used an expanded reference databank containing samples from one island, Muralug, that had not been available in previous tracing. Including Muralug greatly improved tracing success from ~50% to 77.8-92.1%. We observed no reduction in tracing success when whole genome and reduced representation sequencing datasets were combined in analysis, indicating composite approaches are viable. Together these findings demonstrate the value of genomic databanks for long-term incursion monitoring, provided these capture a sufficient proportion of genetic variation.","rel_num_authors":6,"rel_authors":[{"author_name":"Thomas Schmidt","author_inst":"University of Sydney"},{"author_name":"Odwell Muzari","author_inst":"Cairns Public Health Unit, Cairns and Hinterland HHS, Queensland Health, Australia"},{"author_name":"Nancy Endersby-Harshman","author_inst":"The University of Melbourne"},{"author_name":"Christopher Paton","author_inst":"Cairns Public Health Unit, Cairns and Hinterland HHS, Queensland Health, Australia"},{"author_name":"Joe Davis","author_inst":"Cairns Public Health Unit, Cairns and Hinterland HHS, Queensland Health, Australia"},{"author_name":"Gerhard Ehlers","author_inst":"Cairns Public Health Unit, Cairns and Hinterland HHS, Queensland Health, Australia"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Centimeter-sized Human Vitreous Organoids from Pluripotent Stem Cells","rel_doi":"10.64898\/2026.11.19.767433","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767433","rel_abs":"The vitreous, the largest intraocular tissue, provides a transparent light path and maintains the intraocular homeostasis. The reconstitution of the vitreous in vitro or in vivo remains an unsolved biomedical challenge. Here, we discovered a common feature, the \"growth edge\", constituted primarily of fibroblasts and their secreted proteins in human and mouse vitreous development. By leveraging the transforming growth factor beta signaling, we then generated centimeter-scale vitreous-like organoids (VOs) through stepwise differentiation from human pluripotent stem cells (hPSCs). The VOs exhibited striking similarity to human vitreous in terms of physical transparency, vitreoretinal interface, molecular composition, biological profiles and regenerative transplantability. Lines of evidence supported that fibroblasts are the key cell hub for vitreous development. Finally, VOs with a transthyretin (TTR) mutation recapitulated the vitreous phenotypes of human patients with vitreous amyloidosis. Together, vitreous organoid technology opens avenues for future studies of human vitreous development, disease modeling, and regenerative therapeutics for a broad spectrum of human vitreoretinal diseases.","rel_num_authors":12,"rel_authors":[{"author_name":"Xiao Zhang","author_inst":"Beijing Institute of Ophthalmology"},{"author_name":"Kangxin Jin","author_inst":"Beijing Institute of Ophthalmology"},{"author_name":"Xiao Lin","author_inst":"Beijing Institute of Ophthalmology"},{"author_name":"Fanying Zeng","author_inst":"Department of Obstetrics and Gynecology, West China Second University"},{"author_name":"Hai-Long He","author_inst":"Beijing Institute of Ophthalmology"},{"author_name":"Mingxia Du","author_inst":"Beijing Institute of Ophthalmology"},{"author_name":"Dongdong Zhao","author_inst":"Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences"},{"author_name":"Yue Zhang","author_inst":"Beijing Institute of Ophthalmology"},{"author_name":"Wen Wang","author_inst":"Beijing Institute of Ophthalmology"},{"author_name":"Ping Liu","author_inst":"West China Airport Hospital"},{"author_name":"Changhao Bi","author_inst":"Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences"},{"author_name":"Zi-Bing Jin","author_inst":"Beijing Institute of Ophthalmology"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Unraveling molecular mechanisms for specification of blastomere identity and neural fate in the annelid Capitella teleta","rel_doi":"10.64898\/2026.11.13.766470","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.13.766470","rel_abs":"The evolution of central nervous systems remains highly debated as we incorporate data on developmental mechanisms in understudied taxa. Yet how this process occurs in the third major bilaterian clade called Spiralia (e.g., annelids, mollusks) remains inconclusive. Using blastomere isolations, we previously found that in the annelids Capitella teleta and Platynereis dumerilii, ectodermal blastomeres fated to generate the brain and ventral nerve cord can form neural tissue after being isolated. However, in C. teleta, nerve cord formation can be inhibited or rescued by other blastomeres. To ascertain the molecular mechanisms underlying this process, we performed RNAseq on isolated blastomeres in C. teleta at the 8-, 16- and 32-cell stages and found differential expression of components of canonical Wnt signaling across the animal-vegetal axis when conditional neural specification is occurring. Furthermore, asymmetrical localization of TALE and FOX transcripts along the embryonic axis suggests a role in establishing blastomere identity, as observed in mollusks. Our data suggest the integration of an ancestral gene regulatory network of FOXQ2-cWnt and lineage-specific genes during early development, linked to the emergence of spiral cleavage.","rel_num_authors":3,"rel_authors":[{"author_name":"Johnny Davila-Sandoval","author_inst":"Georg-August-Universitat Gottingen"},{"author_name":"Javier F Tabima","author_inst":"Clark University"},{"author_name":"Neva Meyer","author_inst":"Clark University"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"A GPNMB-associated lysosomal program tracks neurodegeneration across the DAM continuum","rel_doi":"10.64898\/2026.11.20.767890","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.20.767890","rel_abs":"Frontotemporal dementia (FTD) and Alzheimer's disease (AD) profoundly remodel microglial states, yet how the heterogeneity of disease-associated microglia (DAM) relates to neurodegeneration remains incompletely understood. Using a progranulin (PGRN) and TMEM106B-deficient mouse model recapitulating key features of frontotemporal lobar degeneration (FTLD), including lysosomal impairment, we demonstrated that CSF1R inhibition reduced microgliosis yet accelerated neurodegeneration, suggesting a protective microglia contribution under lysosomal stress. Single-cell transcriptomics revealed that increasing Gpnmb expression within DAM was associated with a shift from immune and inflammatory processes toward a lysosomal, autolysosomal, and lipid-catabolic program. Across disease models, engagement of the GPNMB-associated program correlated with neurodegeneration. Consistently, A{beta}-driven models with limited neurodegeneration exhibited prominent DAM activation but comparatively limited GPNMB expression and engagement of this program. The GPNMB-associated program was TREM2-dependent, while loss of TREM2 signaling under lysosomal stress was associated with exacerbated neuronal damage. Conversely, lysosomal rescue markedly reduced the GPNMB-associated program, demonstrating its reversibility. CSF proteomics identified a convergent lysosomal and microglial signature across models overlapping with alterations reported in human FTD. Together, GPNMB marks reversible, TREM2-regulated lysosomal transcriptional adaptation along the DAM continuum that scales with lysosomal burden and neurodegenerative severity, consistent with a potentially protective microglial response under lysosomal stress.","rel_num_authors":45,"rel_authors":[{"author_name":"Georg Werner","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Jonas Schulte-Schrepping","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Ramona Rodde","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Johannes Gnaerich","author_inst":"Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universitaet Muenchen; Munich, Germany"},{"author_name":"Elena De Domenico","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Georg Kislinger","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Karsten Nalbach","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Lina Dinkel","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Johannes C.M. Schlachetzki","author_inst":"Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA."},{"author_name":"Selina Hummel","author_inst":"Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universitaet Muenchen; Munich, Germany"},{"author_name":"Astrid F. Feiten","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Patricia Hoffelner","author_inst":"Department of Physiological Genomics, Biomedical Center (BMC), Ludwig-Maximilians-Universitaet Muenchen, Planegg-Martinsried, Germany"},{"author_name":"Brigitte Nuscher","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Marvin Reich","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Inaki Paris","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Samira Parhizkar","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Alessio Colombo","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Stephan A. Mueller","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Michael Willem","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Sven Lammich","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Christian Schrader","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Jannis B. Spintge","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Danilo Prtvar","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Alessio Ricci","author_inst":"Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany"},{"author_name":"Stefan Roth","author_inst":"Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany"},{"author_name":"Matthew J.","author_inst":"Denali Therapeutics Inc., South San Francisco, USA."},{"author_name":"Todd Logan","author_inst":"Denali Therapeutics Inc., South San Francisco, USA."},{"author_name":"Benedikt Wefers","author_inst":"Institute of Developmental Genetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg, Germany"},{"author_name":"Wolfgang Wurst","author_inst":"Institute of Developmental Genetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg, Germany"},{"author_name":"Regina Feederle","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Arthur Liesz","author_inst":"Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany"},{"author_name":"Dieter Edbauer","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Marc D. Beyer","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Antje Grosche","author_inst":"Department of Physiological Genomics, Biomedical Center (BMC), Ludwig-Maximilians-Universitaet Muenchen, Planegg-Martinsried, Germany"},{"author_name":"Kohichi Kawahara","author_inst":"Niigata University of Pharmacy and Medical and Life Sciences, Department of Bioanalytical Chemistry, Niigata City, 956-8603, Japan"},{"author_name":"Christopher Glass","author_inst":"Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA."},{"author_name":"Gilbert Di","author_inst":"Denali Therapeutics Inc., South San Francisco, USA."},{"author_name":"Sabina Tahirovic","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Stefan F. Lichtenthaler","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Mikael Simons","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Martina Schifferer","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Matthias Brendel","author_inst":"Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universitaet Muenchen; Munich, Germany"},{"author_name":"Christian Haass","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Anja Capell","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Joachim L. Schultze","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"A GPNMB-associated lysosomal program tracks neurodegeneration across the DAM continuum","rel_doi":"10.64898\/2026.11.20.767890","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.20.767890","rel_abs":"Frontotemporal dementia (FTD) and Alzheimer's disease (AD) profoundly remodel microglial states, yet how the heterogeneity of disease-associated microglia (DAM) relates to neurodegeneration remains incompletely understood. Using a progranulin (PGRN) and TMEM106B-deficient mouse model recapitulating key features of frontotemporal lobar degeneration (FTLD), including lysosomal impairment, we demonstrated that CSF1R inhibition reduced microgliosis yet accelerated neurodegeneration, suggesting a protective microglia contribution under lysosomal stress. Single-cell transcriptomics revealed that increasing Gpnmb expression within DAM was associated with a shift from immune and inflammatory processes toward a lysosomal, autolysosomal, and lipid-catabolic program. Across disease models, engagement of the GPNMB-associated program correlated with neurodegeneration. Consistently, A{beta}-driven models with limited neurodegeneration exhibited prominent DAM activation but comparatively limited GPNMB expression and engagement of this program. The GPNMB-associated program was TREM2-dependent, while loss of TREM2 signaling under lysosomal stress was associated with exacerbated neuronal damage. Conversely, lysosomal rescue markedly reduced the GPNMB-associated program, demonstrating its reversibility. CSF proteomics identified a convergent lysosomal and microglial signature across models overlapping with alterations reported in human FTD. Together, GPNMB marks reversible, TREM2-regulated lysosomal transcriptional adaptation along the DAM continuum that scales with lysosomal burden and neurodegenerative severity, consistent with a potentially protective microglial response under lysosomal stress.","rel_num_authors":45,"rel_authors":[{"author_name":"Georg Werner","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Jonas Schulte-Schrepping","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Ramona Rodde","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Johannes Gnaerich","author_inst":"Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universitaet Muenchen; Munich, Germany"},{"author_name":"Elena De Domenico","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Georg Kislinger","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Karsten Nalbach","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Lina Dinkel","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Johannes C.M. Schlachetzki","author_inst":"Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA."},{"author_name":"Selina Hummel","author_inst":"Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universitaet Muenchen; Munich, Germany"},{"author_name":"Astrid F. Feiten","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Patricia Hoffelner","author_inst":"Department of Physiological Genomics, Biomedical Center (BMC), Ludwig-Maximilians-Universitaet Muenchen, Planegg-Martinsried, Germany"},{"author_name":"Brigitte Nuscher","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Marvin Reich","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Inaki Paris","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Samira Parhizkar","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Alessio Colombo","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Stephan A. Mueller","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Michael Willem","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Sven Lammich","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Christian Schrader","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Jannis B. Spintge","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Danilo Prtvar","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Alessio Ricci","author_inst":"Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany"},{"author_name":"Stefan Roth","author_inst":"Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany"},{"author_name":"Matthew J.","author_inst":"Denali Therapeutics Inc., South San Francisco, USA."},{"author_name":"Todd Logan","author_inst":"Denali Therapeutics Inc., South San Francisco, USA."},{"author_name":"Benedikt Wefers","author_inst":"Institute of Developmental Genetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg, Germany"},{"author_name":"Wolfgang Wurst","author_inst":"Institute of Developmental Genetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg, Germany"},{"author_name":"Regina Feederle","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Arthur Liesz","author_inst":"Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany"},{"author_name":"Dieter Edbauer","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Marc D. Beyer","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"},{"author_name":"Antje Grosche","author_inst":"Department of Physiological Genomics, Biomedical Center (BMC), Ludwig-Maximilians-Universitaet Muenchen, Planegg-Martinsried, Germany"},{"author_name":"Kohichi Kawahara","author_inst":"Niigata University of Pharmacy and Medical and Life Sciences, Department of Bioanalytical Chemistry, Niigata City, 956-8603, Japan"},{"author_name":"Christopher Glass","author_inst":"Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA."},{"author_name":"Gilbert Di","author_inst":"Denali Therapeutics Inc., South San Francisco, USA."},{"author_name":"Sabina Tahirovic","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Stefan F. Lichtenthaler","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Mikael Simons","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Martina Schifferer","author_inst":"Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE) Munich, Germany"},{"author_name":"Matthias Brendel","author_inst":"Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universitaet Muenchen; Munich, Germany"},{"author_name":"Christian Haass","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Anja Capell","author_inst":"Metabolic Biochemistry, Biomedical Center (BMC), LMU Medizin, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany"},{"author_name":"Joachim L. Schultze","author_inst":"Systems Medicine, Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE), Bonn, Germany"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"The creatine transporter SLC6A8 is an immune pressure-exposed metabolic vulnerability in acute myeloid leukemia","rel_doi":"10.64898\/2026.11.18.767047","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767047","rel_abs":"Chemotherapy imposes metabolic pressure that generates persisting tumor cell states, but whether these adaptations also shape immune evasion is poorly understood. Here, we identify creatine accumulation as a conserved feature of chemotherapy-persisting acute myeloid leukemia (AML) across mouse and human models. Stable-isotope tracing and genetic perturbation show that this is driven predominantly by SLC6A8-mediated creatine uptake rather than de novo synthesis. SLC6A8 was dispensable for AML proliferation and chemotherapy resistance but strongly promoted leukemia persistence under T cell pressure. This effect was independent of phosphocreatine generation and canonical energetic buffering. Instead, SLC6A8 deficiency increased cytokine-driven STAT1 signaling and chromatin remodeling, inducing the expression of antigen-presentation and co-stimulatory molecules, such as MHC-II, CD40, and CD80. Thus, creatine uptake via SLC6A8 is a non-canonical metabolic adaptation that restrains immune-driven remodeling and enables AML immune evasion. These findings link a therapy-induced metabolic adaptation to cytokine responsiveness and reveal SLC6A8 as a targetable vulnerability.","rel_num_authors":25,"rel_authors":[{"author_name":"Petya Apostolova","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland and Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Tatjana Gremelspacher","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland"},{"author_name":"Anthony Sonrel","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland and Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Hui Hao-Shen","author_inst":"Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Minsun Cha","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"Massimo Andreis","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland and Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Hanke Gwendolyn Bauersachs","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland"},{"author_name":"Jacob L Martin","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"David E Sanin","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"Johannes Tossounidis","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland and Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Alejandro Gomez-Auli","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Katarzyna Buczak","author_inst":"Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland"},{"author_name":"Lukas M Braun","author_inst":"Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"author_name":"Jonathan D Curtis","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"David O'Sullivan","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Franziska M Uhl","author_inst":"Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"author_name":"Gerhard Mittler","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Livius Penter","author_inst":"Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow-Klinikum, Berlin, Charite Universitaetsmedizin Berlin, corporate member of Freie Unive"},{"author_name":"Judith B Zaugg","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland"},{"author_name":"Robert Zeiser","author_inst":"Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"author_name":"Edward J Pearce","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"Joerg M Buescher","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Joy Edwards-Hicks","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Beth Kelly","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"Erika L Pearce","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"The creatine transporter SLC6A8 is an immune pressure-exposed metabolic vulnerability in acute myeloid leukemia","rel_doi":"10.64898\/2026.11.18.767047","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767047","rel_abs":"Chemotherapy imposes metabolic pressure that generates persisting tumor cell states, but whether these adaptations also shape immune evasion is poorly understood. Here, we identify creatine accumulation as a conserved feature of chemotherapy-persisting acute myeloid leukemia (AML) across mouse and human models. Stable-isotope tracing and genetic perturbation show that this is driven predominantly by SLC6A8-mediated creatine uptake rather than de novo synthesis. SLC6A8 was dispensable for AML proliferation and chemotherapy resistance but strongly promoted leukemia persistence under T cell pressure. This effect was independent of phosphocreatine generation and canonical energetic buffering. Instead, SLC6A8 deficiency increased cytokine-driven STAT1 signaling and chromatin remodeling, inducing the expression of antigen-presentation and co-stimulatory molecules, such as MHC-II, CD40, and CD80. Thus, creatine uptake via SLC6A8 is a non-canonical metabolic adaptation that restrains immune-driven remodeling and enables AML immune evasion. These findings link a therapy-induced metabolic adaptation to cytokine responsiveness and reveal SLC6A8 as a targetable vulnerability.","rel_num_authors":25,"rel_authors":[{"author_name":"Petya Apostolova","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland and Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Tatjana Gremelspacher","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland"},{"author_name":"Anthony Sonrel","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland and Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Hui Hao-Shen","author_inst":"Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Minsun Cha","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"Massimo Andreis","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland and Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Hanke Gwendolyn Bauersachs","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland"},{"author_name":"Jacob L Martin","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"David E Sanin","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"Johannes Tossounidis","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland and Division of Hematology, University Hospital Basel, Basel, Switzerland"},{"author_name":"Alejandro Gomez-Auli","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Katarzyna Buczak","author_inst":"Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland"},{"author_name":"Lukas M Braun","author_inst":"Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"author_name":"Jonathan D Curtis","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"David O'Sullivan","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Franziska M Uhl","author_inst":"Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"author_name":"Gerhard Mittler","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Livius Penter","author_inst":"Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow-Klinikum, Berlin, Charite Universitaetsmedizin Berlin, corporate member of Freie Unive"},{"author_name":"Judith B Zaugg","author_inst":"Department of Biomedicine, University of Basel, Basel, Switzerland"},{"author_name":"Robert Zeiser","author_inst":"Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"author_name":"Edward J Pearce","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"Joerg M Buescher","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Joy Edwards-Hicks","author_inst":"Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany"},{"author_name":"Beth Kelly","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"author_name":"Erika L Pearce","author_inst":"Bloomberg-Kimmel Institute for Cancer Immunotherapy and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"The genetic basis of adaptation to continuous environmental gradients informs predictions about climate change responses","rel_doi":"10.64898\/2026.11.19.767859","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767859","rel_abs":"A central goal of evolutionary genetics is to determine how environmental pressures maintain adaptive genetic variation, and evaluate how this variation is encoded in the genome. We leveraged two powerful approaches to identify genomic regions associated with climatic adaptation, test the genetic basis of climatic adaptation, and predict genomic responses to novel climates: genome-wide association studies (GWAS) of climate niche parameters derived from demographic models and genome-environment associations (GEA) of climatic factors with 2,737,409 loci. The GWAS found 319 unique single nucleotide polymorphisms (SNPs) associated with climate niche parameters derived from demographic models using multi-year manipulative field experiments with Boechera stricta. The GEA detected 154 unique SNPs linked to climatic variation, with only one SNP found in both approaches. Local adaptation via adult survival arose primarily through conditional neutrality, as local alleles outperformed foreign alleles at only one end of the climatic gradient, rather than genetic trade-offs. Candidate genes near these loci were implicated in stress responses. Contrary to expectations, increasing temperatures and accelerating snowmelt timings did not augment the absolute fitness of low elevation genotypes. We found non-linear fitness functions for seedling recruitment at multiple SNPs detected via GWAS, with both conditional neutrality and genetic trade-offs evident in different portions of the climatic gradient. Local maladaptation arose exclusively in GEA SNPs. Our analyses revealed that the hot and dry conditions projected under climate change may rapidly exceed the tolerance of this species. However, we identified 47 SNPs at which evolutionary rescue or assisted migration could ameliorate the reduction in fitness under climate change.","rel_num_authors":4,"rel_authors":[{"author_name":"Derek Arlen Denney","author_inst":"Michigan State University"},{"author_name":"Emily Josephs","author_inst":"Michigan State University"},{"author_name":"Megan DeMarche","author_inst":"University of Georgia"},{"author_name":"Jill T Anderson","author_inst":"University of Georgia"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Comprehensive identification of bacterial and archaeal habitat associations using IndicPiper","rel_doi":"10.64898\/2026.11.19.767919","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767919","rel_abs":"Taxa that are prevalent and abundant in a particular habitat more so than other habitats can be considered indicators of that habitat. In addition to providing basic natural history information, indicator taxa can be used to verify metadata assignments in large public databases, identify potential contamination, and assess contributions of different source populations to a sink population. Despite these potential applications, a comprehensive database of microbial indicator taxa for major habitats of interest does not yet exist. Here we present IndicPiper, a database and methodology that uses the Sandpiper database combined with indicator taxa analysis to identify the habitat associations of bacterial and archaeal genera. IndicPiper includes a clearly defined methodology and set of functions such that any user with a list of habitats of interest could run the functions and generate their own database. IndicPiper uses the Genome Taxonomy Database (GTDB) for taxonomy, and the provided database or custom databases can be used to analyze any prokaryotic sample-by-taxa abundance table, including those from shotgun metagenomic and 16S rRNA marker gene sequencing. After presenting the methodology and results, we then present three applications of IndicPiper on actual modern and ancient DNA sequencing datasets. We used IndicPiper to assess the contribution of different source habitats to Lake Tjornin sediments in Iceland over the past 2000 years, to paired indoor and outdoor dust samples from homes across the U.S, and to freshwater samples across the Willamette River watershed in Oregon, USA.","rel_num_authors":3,"rel_authors":[{"author_name":"Clifton P Bueno de Mesquita","author_inst":"University of Colorado"},{"author_name":"Ben J. Woodcroft","author_inst":"Queensland University of Technology"},{"author_name":"Noah Fierer","author_inst":"University of Colorado"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"HCM-mutation G716R in \u03b2-myosin alters contractile function and responsiveness to mavacamten of human ventricular myofibrils","rel_doi":"10.64898\/2026.11.19.767856","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767856","rel_abs":"Effects of the hypertrophic cardiomyopathy (HCM) associated mutation Gly716Arg in {beta}-myosin at the sarcomeric level are unresolved. To further understand HCM-pathomechanisms in relation to modern treatment, we investigated the effect of this mutation in subcellular myofibrils isolated from HCM-patient myocardium compared to myofibrils from healthy donor hearts and tested how mavacamten influences force-related parameters. Mavacamten is a state-of-the-art myosin inhibitor aimed to treat ventricular hypercontractility of symptomatic HCM patients. Compared with donor myofibrils, patient myofibrils developed similar isometric forces, while kinetics of maximum force generation and particularly of relaxation were slower. Relaxation impairment was exacerbated when patient myofibrils were incompletely relaxed to mimic residual diastolic calcium levels. Inhibitory effects of mavacamten were dependent on force activation level and significantly less efficient in patient myofibrils. While the drug accelerated full relaxation of donor myofibrils, the slowing down effect of the mutation was not reversed by the drug in patient myofibrils. At partial relaxation, impairment was further aggravated by mavacamten in patient myofibrils. This study suggests that HCM-associated mutation G716R in {beta}-myosin does not evoke gain-of-function in human left ventricular myofibrils, and impaired relaxation could not be rescued by mavacamten. Our findings suggest that HCM-associated mutations may modulate myofibrillar sensitivity to mavacamten, providing a potential mechanistic explanation for differences in treatment response. Studies such as the present one highlight the importance of mutation-dependent sarcomeric properties in understanding variability in responses to myosin modulators and potentially informing more individualized treatment strategies.","rel_num_authors":7,"rel_authors":[{"author_name":"Anja Brunkhorst","author_inst":"Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany"},{"author_name":"Tim Holler","author_inst":"Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany"},{"author_name":"Birgit Piep","author_inst":"Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany"},{"author_name":"Antonio Francino","author_inst":"Hospital Clinic, Cardiology Department, Barcelona, Spain"},{"author_name":"Cristobal Guillermo dos Remedios","author_inst":"Bosch Institute, Department of Anatomy, University of Sydney, Sydney, Australia"},{"author_name":"Theresia Kraft","author_inst":"Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany"},{"author_name":"Bogdan Iorga","author_inst":"Institute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Behavioral Plasticity and Dispersal of Free Swimming Coral Larvae via Vertical Tracking Microscopy","rel_doi":"10.64898\/2026.11.19.767947","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767947","rel_abs":"Coral larvae disperse and seek suitable sites for settlement while undergoing rapid development, making this period central to reef connectivity, recruitment, and recovery. Yet how the accompanying changes in larval morphology, ciliary activity, and swimming behavior shape dispersal remains poorly understood. Here, using vertical tracking microscopy, we follow individual Acropora millepora larvae over hundreds of body lengths at successive developmental stages while resolving body morphology. We show a developmental progression from buoyant rise to upward- and downward-directed gravitactic swimming, followed by weaker gravitactic alignment at later stages, accompanied by body elongation and increasingly structured ciliary flows. Integrating these kinematics into a minimal, data-driven model, we separate buoyant drift from active swimming and estimate the propulsion costs of vertical migration and lateral spreading. Buoyancy supports early ascent without propulsion expenditure, while the model predicts lower costs of descent and lateral spreading at late developmental stages. Simulations in fluctuating flow, assuming no flow sensing, predict that directed swimming weakens when flow-induced rotation acts on timescales comparable to intrinsic heading relaxation. Together, these results reveal how development reorganizes the physical drivers of larval motion in ways that may support the transition from dispersal to settlement, providing a basis for incorporating developmental changes in swimming into models of coral larval dispersal.","rel_num_authors":8,"rel_authors":[{"author_name":"Ian Ho","author_inst":"Department of Bioengineering, Stanford University, Stanford, CA 94305, USA"},{"author_name":"Qing Zhang","author_inst":"Department of Bioengineering, Stanford University, Stanford, CA 94305, USA"},{"author_name":"Benjamin Foster","author_inst":"Department of Bioengineering, Stanford University, Stanford, CA 94305, USA"},{"author_name":"Elora H. Lopez-Nandam","author_inst":"Institute for Biodiversity Science and Sustainability, California Academy of Sciences, San Francisco, California"},{"author_name":"Pranav Vyas","author_inst":"Department of Bioengineering, Stanford University, Stanford, CA 94305, USA"},{"author_name":"Shayle Matsuda","author_inst":"Daniel P. Haerther Center for Conservation and Research, John G. Shedd Aquarium, Chicago, IL, USA; Institute for Biodiversity Science and Sustainability, Califo"},{"author_name":"Rebecca Albright","author_inst":"Institute for Biodiversity Science and Sustainability, California Academy of Sciences, San Francisco, California"},{"author_name":"Manu Prakash","author_inst":"Department of Bioengineering, Stanford University, Stanford, CA 94305, USA"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Tissue-specific mucociliary regulatory programs in the healthy human endocervix and ectocervix","rel_doi":"10.64898\/2026.11.19.767467","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767467","rel_abs":"The cervix is a dynamic mucosal barrier in the female reproductive tract that balances inflammatory and anti inflammatory functions to regulate physiologically critical functions, including pregnancy, sperm transport, fertility, and protection of the upper reproductive tract from infection. Despite its central role in reproduction, the cellular and transcriptional organization of the healthy human cervix remains incompletely characterized, including how clinical sampling methods influence the epithelial populations recovered and how cervical mucociliary programs compare with those of pulmonary epithelium. We performed single-nucleus RNA sequencing (snRNAseq) on paired Tischler punch biopsy and endocervical curettage (ECC) samples from four healthy, exogenous hormone-naive donors to generate a dedicated transcriptomic map of the healthy human cervix followed by an integrative computational analysis framework combining differential expression, functional enrichment, cell to cell communication, cross-tissue mapping, and regulon activity inference. This approach identified ten cell types spanning epithelial, stromal, vascular, and immune cell populations and found that sampling method strongly influenced cellular composition and transcriptional state as Tischler punch biopsy preferentially recovered basal and suprabasal epithelial populations, whereas ECC enriched for secretory and ciliated epithelial cell types. Cross-tissue comparison with publicly available healthy lung epithelial transcriptomics dataset revealed conserved mucociliary cell types alongside tissue-divergent transcriptional programs, including distinct regulation of ion transport and mucin associated genes. Together, these findings demonstrate the importance of sampling modality in resolving cervical epithelial heterogeneity, and reveal tissue-specialized mucociliary regulatory programs underlying cervical mucus biology and fertility regulation.","rel_num_authors":7,"rel_authors":[{"author_name":"Alliya Parvez","author_inst":"Dartmouth College"},{"author_name":"Olha Kholod","author_inst":"Dartmouth College"},{"author_name":"Larkin Lucy","author_inst":"Oregon Health & Science University"},{"author_name":"Rachel Looney","author_inst":"Oregon Health & Science University"},{"author_name":"Tammy C. T. Lan","author_inst":"Harvard University"},{"author_name":"Leo L. Han","author_inst":"Oregon Health & Science University"},{"author_name":"Brittany A. Goods","author_inst":"The University of Melbourne"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Beyond the tripartite genome: a widespread, mobile and gene-rich accessory plasmidome expands the genomic landscape of the model symbiont Sinorhizobium meliloti","rel_doi":"10.64898\/2026.11.19.767906","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767906","rel_abs":"Sinorhizobium meliloti is one of the best-studied nitrogen-fixing symbionts, yet research has focused almost entirely on its chromosome and two megaplasmids, pSymA and pSymB. Many strains carry additional accessory plasmids, but these large, pSymA-like elements are rarely recovered from short-read assemblies, leaving a hidden part of the genome unexplored. By sequencing 346 strains with long reads, we recovered 386 accessory plasmids from 76% of strains, with 318 absent from public databases, showing that accessory plasmids are the rule and not the exception. These plasmids were large (34-749 kb), including the largest accessory plasmid reported in S. meliloti, and most were mobilizable or conjugative (relaxases in 85% and mating-pair formation systems in 75% of plasmid clusters), equipping them to move between strains. RepA typing defined 13 replicon groups unique to Sinorhizobium, which could serve as a framework for tracking these plasmids in natural populations. We also found evidence of plasmid expansion by fusion, and one ~315 kb plasmid was a cointegrate of two smaller plasmids from our collection. About two-thirds of plasmid gene families were absent from the main replicons, including defense systems, the anti-restriction protein ArdC, and biosynthetic gene clusters, 53% of which had never been observed before. Overturning the view that S. meliloti lacks restriction-modification systems, we found them in 153 genomes, including on 32 accessory plasmids. Most inferred gene transfers stayed within the family Rhizobiaceae. Accessory plasmids thus form a large, mobile and largely unexplored gene pool that may shape how this model symbiont competes and adapts.","rel_num_authors":11,"rel_authors":[{"author_name":"Juan Jose Picon-Cossio","author_inst":"Stowers Institute for Medical Research, Kansas City, Missouri, USA"},{"author_name":"Samantha G. Crossman","author_inst":"Stowers Institute for Medical Research, Kansas City, Missouri, USA"},{"author_name":"Andrew J. Price","author_inst":"Stowers Institute for Medical Research, Kansas City, Missouri, USA"},{"author_name":"Sean McGrath","author_inst":"Stowers Institute for Medical Research, Kansas City, Missouri, USA"},{"author_name":"Tania Gupta","author_inst":"North Dakota State University, Fargo, North Dakota, USA"},{"author_name":"Barney Geddes","author_inst":"North Dakota State University, Fargo, North Dakota, USA"},{"author_name":"Maria Alejandra Gil-Polo","author_inst":"The Pennsylvania State University, University Park, Pennsylvania, USA"},{"author_name":"Kayla Clouse","author_inst":"The Pennsylvania State University, University Park, Pennsylvania, USA"},{"author_name":"Sohini Guha","author_inst":"The Pennsylvania State University, University Park, Pennsylvania, USA"},{"author_name":"Liana Burghardt","author_inst":"The Pennsylvania State University, University Park, Pennsylvania, USA"},{"author_name":"Siva Sankari","author_inst":"Stowers Institute for Medical Research, Kansas City, Missouri, USA"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"HiFi long-read metagenomics reshapes genome-resolved interpretations of activated sludge microbiome","rel_doi":"10.64898\/2026.11.18.767492","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767492","rel_abs":"Genome-resolved metagenomics is widely used to characterize activated sludge microbiomes and infer the microbial processes underpinning system performance. However, the reliability of metabolic inferences drawn from fragmented short-read (SR) genomes remains insufficiently examined. Using (near-)complete genomes reconstructed from HiFi long-read (LR) sequencing as references, we traced genome recovery through SR assembly and post-assembly processing. Assembly fragmentation and subsequent sequence loss during post-assembly processing compromised the recovery of high-quality genomes despite adequate sequencing depth and breadth of coverage. This incomplete recovery biased inferences regarding denitrification modularity, underestimating complete denitrifier populations and distorting the inferred balance between N2O producers and reducers. Poor recovery of nitrifier and Ca. Accumulibacter genomes, exacerbated by population microdiversity and structurally complex genomic regions, precluded reliable inferences regarding nitrification and phosphorus accumulation. Our findings caution against uncritical interpretation of SR-based microbiome-function linkages and highlight the value of incorporating HiFi LR sequencing into genome-resolved metagenomic analyses.","rel_num_authors":6,"rel_authors":[{"author_name":"Min Joon Song","author_inst":"Korea Advanced Institute of Science & Technology (KAIST)"},{"author_name":"Taeho Yun","author_inst":"Korea Advanced Institute of Science & Technology (KAIST)"},{"author_name":"Sojung Yoon","author_inst":"Korea Advanced Institute of Science & Technology (KAIST)"},{"author_name":"Ju Yong Lee","author_inst":"Korea Advanced Institute of Science & Technology (KAIST)"},{"author_name":"Ameet J Pinto","author_inst":"Georgia Institute of Technology"},{"author_name":"Sukhwan Yoon","author_inst":"Korea Advanced Institute of Science & Technology (KAIST)"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"MLE EEG Toolbox: A Personal AI Laboratory Assistant for Literature-Informed and Reproducible M\/EEG Research","rel_doi":"10.64898\/2026.11.18.767737","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767737","rel_abs":"Electrophysiological research increasingly relies on complex analytical workflows, yet integrating methodological evidence, computational execution and reproducibility remains challenging. Here we introduce MLE EEG Toolbox, a framework for building a personal AI laboratory assistant for electroencephalography (EEG) and magnetoencephalography (MEG) research. The toolbox integrates locally deployed AI, natural-language-guided analysis, literature retrieval and methodological comparison, and reproducible computational workflows. A constrained language model translates research instructions into validated, researcher-approved operations, while literature-informed guidance supports parameter selection and protocol reconstruction. Computational provenance enables transparent inspection and replay of analytical workflows. The assistant achieved action-selection accuracies of 85.6% for EEG and 95.5% for MEG, while 142 cross-platform tests demonstrated close numerical agreement. Applications to public EEG and MEG datasets illustrated integrated spectral, network, decoding and source analyses. Running on standard personal computers without external AI APIs or token charges, MLE EEG Toolbox provides an accessible, researcher-controlled environment that connects methodological knowledge with reproducible electrophysiological analysis.","rel_num_authors":11,"rel_authors":[{"author_name":"Xiaobo Liu","author_inst":"McGill University"},{"author_name":"Wenjian Chen","author_inst":"Huaqiao University"},{"author_name":"Bin Wan","author_inst":"University Hospitals of Geneva"},{"author_name":"Sanwang Wang","author_inst":"Peking University Sixth Hospital"},{"author_name":"Zhiyang Lin","author_inst":"Huaqiao University"},{"author_name":"Xihan Zhang","author_inst":"Yale University"},{"author_name":"Li Dong","author_inst":"University of Electronic Science and Technology of China"},{"author_name":"Shiang Hu","author_inst":"Anhui University"},{"author_name":"Xianwei Guo","author_inst":"Minjiang University"},{"author_name":"Ruifang Cui","author_inst":"Huzhou Normal University"},{"author_name":"Ruiyang Ge","author_inst":"University of Macau"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Koopman Analysis Reveals Collective Modes Governing Cellular Dynamics","rel_doi":"10.64898\/2026.11.18.767672","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767672","rel_abs":"Living systems are complex nonlinear systems that operate far from thermodynamic equilibrium, and this nonlinearity makes their dynamics difficult to analyze. Several linearization techniques have been developed to address this problem, but most are local. Koopman operator theory is a powerful alternative that linearizes a system globally. Here we show that it not only achieves global linearization but also reveals collective modes that govern the dynamics of complex, out-of-equilibrium nonlinear systems. Applying the approach to whole-cell dynamical models, we find that these collective modes have physical and biological significance and relate to distinct processes in the cell cycle and in cell-state transitions. Collective and normal modes are widespread in many-body systems, particularly in condensed matter (e.g., magnons, phonons, hydrodynamic modes) and in macromolecular dynamics (e.g., normal mode analysis). By demonstrating that such modes also exist in cell-state transition dynamics, and in non-equilibrium nonlinear systems more generally, we offer a new theoretical-physics perspective on these systems. The collective modes separate into slow and fast modes. Long-term dynamics are governed by a few dominant slow modes that form a slow manifold of much lower dimension than the original state space. Thus, although the cell is a very high-dimensional system, its cell-cycle dynamics ultimately reduce to a low-dimensional space. Each mode comprises the coordinated behavior of groups of genes and reflects the structure of the underlying gene regulatory network. The modes can also be decomposed into terms that behave like damped harmonic oscillators, drawing an analogy between the modes of a nonlinear system and the normal modes of many-body systems. Finally, our analysis suggests that the dominant modes are closely associated with biological processes in the cell cycle, including mitosis, spindle checkpoint signaling, and DNA replication and repair.","rel_num_authors":5,"rel_authors":[{"author_name":"Swapnil Dutta","author_inst":"University of Pittsburgh"},{"author_name":"Wenqing Yu","author_inst":"Peking University"},{"author_name":"Zhiqian Zheng","author_inst":"University of Pittsburgh"},{"author_name":"Amitava Giri","author_inst":"University of Pittsburgh"},{"author_name":"Jianhua Xing","author_inst":"University of Pittsburgh"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Ionic waves drive fluid flow by inducing spatiotemporal porosity variations in the brain interstitial space","rel_doi":"10.64898\/2026.11.18.766825","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.766825","rel_abs":"We develop a model of interstitial fluid (ISF) dynamics in the brain driven by traveling ionic waves. The cortex is modeled as a 2D porous sheet with an absorbent matrix. A prescribed 10% sinusoidal porosity variation induces mean flow of O(1) {micro}m\/s, even without an imposed pressure gradient. Including perivascular spaces (PVSs) increases the velocity and pressure gradient, and yields volumetric flux through arterial and venous PVSs, with maximum magnitude of 2 x 10-2 {micro}L min-1 mm-1. We show analytically, in the large-wavelength limit, that the porosity variation enters the pressure field as first- and second-order corrections. We then simulate a physiologically realistic spreading depolarization (SD) wave, finding that the induced porosity variation raises the mean ISF pressure to 4 mmHg, which falls to -0.7 mmHg during recovery. SD yields a peak velocity of O(10-2) {micro}m\/s and a peak flux of 3 x 10-3 {micro}L min-1 mm-1, and transiently stalls the PVS-driven flow. Although the SD wave produces a larger porosity change than the prescribed wave, it evolves slowly and drives weaker flow.","rel_num_authors":2,"rel_authors":[{"author_name":"Drik Sarkar","author_inst":"Iowa State University"},{"author_name":"Saikat Mukherjee","author_inst":"Iowa State University"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Large-scale Nanopore sequencing resolves species diversity and distribution of European Ulva","rel_doi":"10.64898\/2026.11.17.767378","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.17.767378","rel_abs":"The green algal genus Ulva is widespread and ecologically important in European coastal ecosystems. However, species diversity and distributions remain poorly resolved due to phenotypic plasticity and historical taxonomic uncertainty. By adopting a large-scale sampling and barcoding effort, we provide a unique continent-scale assessment of Ulva species diversity and distribution. We developed a novel high-throughput Oxford Nanopore Technologies sequencing strategy, pooling 768 samples (eight 96-well plates) per run and sequencing tufA and ITS simultaneously. Nanopore barcoding was accurate and efficient, with 96.3% of samples yielding at least one informative marker. Consensus sequences showed 99.4-100% similarity to Sanger sequences. By analysing 3,657 samples from 30 countries, we identified 46 species with contrasting distribution patterns and substantially expanded their known geographic ranges. This includes numerous country-level first records and the first records of Ulva howensis outside Australia and U. meridionalis within the study area. Five non-indigenous Ulva species were also detected, including widespread occurrences of U. australis. However, 10 species could not be assigned to named taxa because suitable reference sequences were unavailable or unreliable, highlighting persistent taxonomic gaps in public databases. Our findings demonstrate the power of coordinated, high-throughput molecular surveys to resolve cryptic marine biogeography at continent scales. The resulting high-resolution spatial baseline facilitates the early detection of non-indigenous species and range expansions. It also enables coastal managers to monitor invasion pathways, evaluate ecosystem risks associated with opportunistic bloom-forming taxa, and detect climate-driven distribution shifts across European waters.","rel_num_authors":182,"rel_authors":[{"author_name":"Luna M. van der Loos","author_inst":"Naturalis Biodiversity Center"},{"author_name":"Sofie D'hondt","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Emma Coulembier Vandelannoote","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Quinten Bafort","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Griet Casteleyn","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Pinar Akdogan Sirin","author_inst":"Fatsa Faculty of Marine Science, Department of Fisheries Technology Engineering, Ordu University, 52400, Fatsa, Ordu, Turkiye"},{"author_name":"Stefano Accoroni","author_inst":"Department of Life and Environmental Sciences, Universita Politecnica delle Marche, Italy"},{"author_name":"Umair Ahsan","author_inst":"Department of Plant and Animal Production, Burdur Vocational School of Food, Agriculture and Livestock, Burdur Mehmet Akif Ersoy University, Turkiye"},{"author_name":"Gerli Albert","author_inst":"Estonian Marine Institute, University of Tartu, Maealuse 14, 12618, Tallinn, Estonia"},{"author_name":"Francisco Arenas","author_inst":"CIIMAR - Interdisciplinary Centre of Marine and Environmental Research, FCUP - Faculty of Science, University of Porto, Portugal"},{"author_name":"Simona Armeli Minicante","author_inst":"Consiglio Nazionale delle Ricerche, Istituto di Scienze Marine (CNR-ISMAR), Venice, Italy"},{"author_name":"Edlira Aruci","author_inst":"Department of Biotechnologies, Chemistry and Pharmacy, University of Siena, Siena, Italy"},{"author_name":"Georgios Bakratsas","author_inst":"Laboratory of Biotechnology, Department of Biological Applications and Technologies, University of Ioannina, Ioannina, Greece"},{"author_name":"Karina Balina","author_inst":"Institute of Microbiology and Biotechnology, University of Latvia, Jelgavas iela 1, Riga, Latvia"},{"author_name":"Francisco R. Barboza","author_inst":"Estonian Marine Institute, University of Tartu, Maealuse 14, 12618, Tallinn, Estonia"},{"author_name":"Ieva Barda","author_inst":"Latvian Institute of Aquatic Ecology, Agency of Daugavpils University, Riga, Latvia"},{"author_name":"Angela Bartolo","author_inst":"Institute of Earth Systems, University of Malta, Malta"},{"author_name":"Inka Bartsch","author_inst":"Alfred-Wegener Institute, Helmholtz Centre for Polar and Marine Research, Am Handelshafen 12, 27570 Bremerhaven, Germany"},{"author_name":"Jakob Becker","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Zahira Belattmania","author_inst":"Phycology, Blue Biodiversity and Biotechnology RU, Laboratory of Plant Biotechnology, Ecology and Ecosystem Valorization CNRST Labeled Research Unit N10, Facult"},{"author_name":"Giulia Bellanti","author_inst":"Department of Life and Environmental Sciences, Universita Politecnica delle Marche, Italy"},{"author_name":"Ricardo Bermejo","author_inst":"Department of Ecology and Geology, University of Malaga, Bulevar Pasteur, 31, sn, 29010 Malaga, Spain"},{"author_name":"Fabrizio Bernardi Aubry","author_inst":"Consiglio Nazionale delle Ricerche, Istituto di Scienze Marine (CNR-ISMAR), Venice, Italy"},{"author_name":"Anaelle Bizien","author_inst":"Universite Brest, CNRS, IRD, Ifremer, LEMAR, IUEM, F-29280 Plouzane, France"},{"author_name":"Aurelie Blanfune","author_inst":"Aix Marseille University, University of Toulon, CNRS, IRD, MIO (Mediterranean Institute of Oceanography), Marseille, France"},{"author_name":"Jonas Blomme","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Michael Bo Rasmussen","author_inst":"Aarhus University, C.F. Mollers Alle 3, 8000 Aarhus, Denmark"},{"author_name":"Teis Boderskov","author_inst":"Aarhus University, C.F. Mollers Alle 3, 8000 Aarhus, Denmark"},{"author_name":"Kruno Bonacic","author_inst":"Department of applied ecology, University of Dubrovnik, Croatia"},{"author_name":"Nathalie Bourgougnon","author_inst":"Laboratoire de Biotechnologie et Chimie Marines, Universite Bretagne Sud, EMR CNRS 6076, IUEM, 56000 Vannes, France"},{"author_name":"Paul Brazier","author_inst":"Natural Resources Wales, Maes Y Ffynnon, Ffordd Penrhos, Bangor, Gwynedd, LL57 2DW, United Kingdom"},{"author_name":"Juliet Brodie","author_inst":"Natural History Museum, Research, Cromwell Road, London SW7 5BD, United Kingdom"},{"author_name":"Annette Bruhn","author_inst":"Aarhus University, C.F. Mollers Alle 3, 8000 Aarhus, Denmark"},{"author_name":"Francis Bunker","author_inst":"MarineSeen, Estuary Cottage, Bentlass, Hundleton, Pembrokeshire SA71 5RN, United Kingdom"},{"author_name":"Thomas Burel","author_inst":"Univ Brest, CNRS, IRD, Ifremer, LEMAR, F-29280 Plouzane, France"},{"author_name":"Julie Camus","author_inst":"Laboratoire des Sciences Appliquees de Cherbourg, UNICAEN, Normandie Universite, France"},{"author_name":"Joao Canning-Clode","author_inst":"MARE - Marine and Environmental Sciences Centre, ARNET Aquatic Research Network"},{"author_name":"Alexander Chemodanov","author_inst":"Tel Aviv University, School of Mechanical Engineering, Tel Aviv, Israel"},{"author_name":"Gercende Courtois de Vicose","author_inst":"IU-ECOAQUA, GIA, Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain"},{"author_name":"Javier Cremades","author_inst":"BioCost Research Group, Facultade de Ciencias and Centro Interdisciplinar de Quimica e Bioloxia (CICA), Universdade da Coruna, A Coruna, Spain"},{"author_name":"Ajit Dake","author_inst":"Marine Biology and Biotechnology Program, Department of Life Sciences, Ben-Gurion University of the Negev, Eilat Campus, Hatmarim Blvd. 162, EilatPOB 653, Beer-"},{"author_name":"Thibaut de Bettignies","author_inst":"PatriNat (OFB, MNHN), Museum national d'Histoire naturelle, Paris, France"},{"author_name":"Bruno de Reviers","author_inst":"Institut Systematique Evolution Biodiversite (ISYEB), Museum national d Histoire Naturelle, CNRS, Sorbonne Universite, EPHE, Paris, France"},{"author_name":"Nathalie De Somer","author_inst":"ANEMOON Foundation, Netherlands"},{"author_name":"Gonzalo Del Olmo","author_inst":"Institute of Marine Research (IIM-CSIC), Spain"},{"author_name":"Julian Di Giandomenico","author_inst":"Department of Life and Environmental Sciences, Universita Politecnica delle Marche, Italy"},{"author_name":"Pilar Diaz-Tapia","author_inst":"CRETUS, Bioaplic Research Group, Universidade de Santiago de Compostela, Spain"},{"author_name":"Aires M. Duarte","author_inst":"CIIMAR - Interdisciplinary Centre of Marine and Environmental Research, FCUP - Faculty of Science, University of Porto, Portugal"},{"author_name":"Luisa Dusedau","author_inst":"Alfred-Wegener Institute, Helmholtz Centre for Polar and Marine Research, Am Handelshafen 12, 27570 Bremerhaven, Germany"},{"author_name":"Hannah Earp","author_inst":"The Dove Marine Laboratory, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom"},{"author_name":"Marco Faasse","author_inst":"Eurofins AquaSense, Korringaweg 7, 4401NT, Yerseke, The Netherlands"},{"author_name":"Annalisa Falace","author_inst":"Department of Life Sciences, University of Trieste, Italy"},{"author_name":"Stefania Finotto","author_inst":"Consiglio Nazionale delle Ricerche, Istituto di Scienze Marine (CNR-ISMAR), Venice, Italy"},{"author_name":"Daniela Freitas","author_inst":"Greenaqua Lda. Rua Dr Joao Graca SN. EN109 Km 66.2. 3840-403, Vagos, Portugal"},{"author_name":"Daniela Gabriel","author_inst":"CIBIO - Research centre in Biodiversity and genetic resources, Portugal"},{"author_name":"Regis Gallon","author_inst":"Laboratoire des Sciences Appliquees de Cherbourg, UNICAEN, Normandie Universite, France"},{"author_name":"Sara Garcia Poza","author_inst":"Departamento de Biotecnologia-Instituto Tecnologico de Canarias, Spain"},{"author_name":"Veronica Garcia-Redondo","author_inst":"BioCost Research Group, Facultad de Ciencias and Centro Interdisciplinar de Quimica e Bioloxia (CICA), University of A Coruna, A Coruna, Spain"},{"author_name":"Sindri Gislason","author_inst":"Southwest Iceland Nature Research Centre (SINRC), 245 Sudurnesjabaer, Iceland"},{"author_name":"Franz Goecke","author_inst":"Norwegian University of Life Sciences (NMBU), Norway"},{"author_name":"Alexander Goldberg","author_inst":"Tel Aviv University, School of Mechanical Engineering, Tel Aviv, Israel"},{"author_name":"Juan Luis Gomez Pinchetti","author_inst":"Spanish Bank of Algae, Institute of Oceanography and Global Change, University of Las Palmas de Gran Canaria, Spain"},{"author_name":"Lior Guttman","author_inst":"The Department of Blue Biotechnologies and Sustainable Mariculture, Leon H. Charney School of Marine Science, University of Haifa, Haifa, Israel"},{"author_name":"Jack Hall","author_inst":"Estonian Marine Institute, University of Tartu, Maealuse 14, 12618, Tallinn, Estonia"},{"author_name":"Peter Hantz","author_inst":"Eotvos Lorand University, Dept. of Organic Chemistry, Budapest, Hungary"},{"author_name":"Svenja Heesch","author_inst":"Applied Ecology & Phycology, Institute for Biological Sciences, University of Rostock, Albert-Einstein-Strasse 3, 18059 Rostock, Germany"},{"author_name":"Mathieu Helias","author_inst":"Laboratoire des Sciences Appliquees de Cherbourg, UNICAEN, Normandie Universite, France"},{"author_name":"Laurie Hofmann","author_inst":"Alfred-Wegener Institute, Helmholtz Centre for Polar and Marine Research, Am Handelshafen 12, 27570 Bremerhaven, Germany"},{"author_name":"Lasse Hornbek Nielsen","author_inst":"Pure Algae, Denmark"},{"author_name":"Vivian Husa","author_inst":"Institute of Marine Research, Norway"},{"author_name":"Ljiljana Ivesa","author_inst":"Ruder Boskovic Institute, Center for Marine Research, Rovinj, Croatia"},{"author_name":"Charlotte Jennings","author_inst":"The Dove Marine Laboratory, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom"},{"author_name":"Sergi Joher","author_inst":"Centre Oceanografic de les Balears, Instituto Espanol de Oceanografia (COB-IEO), CSIC. Parc Bit, Complex Balear de Recerca. Thomas Edison 5, planta baixa. 07121"},{"author_name":"Veronika Valt","author_inst":"Department of Botany, Charles University, Prague, Czech Republic"},{"author_name":"Mart Karremans","author_inst":"ANEMOON Foundation, Netherlands"},{"author_name":"Petros Katapodis","author_inst":"Laboratory of Biotechnology, Department of Biological Applications and Technologies, University of Ioannina, Ioannina, Greece"},{"author_name":"Manfred Kaufmann","author_inst":"Faculty of Life Sciences, University of Madeira, Portugal"},{"author_name":"Ioannis Kefalas","author_inst":"Fisheries Research Institute (ELGO-DIMITRA), Nea Peramos, Kavala, Greece"},{"author_name":"Abigail Kennedy","author_inst":"University of Aberdeen, Scotland, United Kingdom"},{"author_name":"Maximilian Knips","author_inst":"Friedrich Schiller University Jena, Institute for Inorganic and Analytical Chemistry, Germany"},{"author_name":"Jessica Knoop","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Maria Kosmidou","author_inst":"Fisheries Research Institute (ELGO-DIMITRA), Nea Peramos, Kavala, Greece"},{"author_name":"Jonne Kotta","author_inst":"Estonian Marine Institute, University of Tartu, Maealuse 14, 12618, Tallinn, Estonia"},{"author_name":"Frithjof Kupper","author_inst":"University of Aberdeen, Scotland, United Kingdom"},{"author_name":"Kristoffer Larsen-Ledet","author_inst":"Aarhus University, C.F. Mollers Alle 3, 8000 Aarhus, Denmark"},{"author_name":"Gwenaelle Le Blay","author_inst":"Universite Brest, CNRS, IRD, Ifremer, LEMAR, IUEM, F-29280 Plouzane, France"},{"author_name":"Line Le Gall","author_inst":"Institut Systematique Evolution Biodiversite (ISYEB), Museum national d Histoire Naturelle, CNRS, Sorbonne Universite, EPHE, Paris, France"},{"author_name":"Vincent Le Garrec","author_inst":"Univ Brest, CNRS, IRD, Observatoire, IUEM, F-29280 Plouzane, France"},{"author_name":"Delphie Le Thoer","author_inst":"Cellule de Suivi du Littoral Normand (CSLN), France"},{"author_name":"Kitte Linding Gerlich","author_inst":"Aarhus University, C.F. Mollers Alle 3, 8000 Aarhus, Denmark"},{"author_name":"Kate Lock","author_inst":"Natural Resources Wales, Skomer MCZ, Martins Haven, Pembrokeshire Wales SA623BJ, United Kingdom"},{"author_name":"Ana Lokovsek","author_inst":"Marine Biology Station Piran, National Institute of Biology, Slovenia"},{"author_name":"Felix Lopez Figueroa","author_inst":"University of Malaga, Instituto Andaluz de Biotecnologia y Desarrollo Azul (IBYDA), Loma de San Julian, 2 , 29004 Malaga"},{"author_name":"Petra Lucic","author_inst":"Institute of Oceanography and Fisheries, Split, Croatia"},{"author_name":"Christine Maggs","author_inst":"School of Biological Sciences, Queen's University Belfast, 19 Chlorine Gardens, Belfast BT9 5DL, Northern Ireland, United Kingdom"},{"author_name":"Erik-jan Malta","author_inst":"Aquaculture Technology Centre, CTAQUA, Muelle Comcercial SN, 11500, El Puerto de Santa Maria, Spain"},{"author_name":"Francesco Paolo Mancuso","author_inst":"Department of Earth and Marine Sciences (DiSTeM), Palermo, Italy"},{"author_name":"Antonio Manghisi","author_inst":"University of Messina, Italy"},{"author_name":"Luisa Mangialajo","author_inst":"Universite Cote d Azur, CNRS, ECOSEAS, France"},{"author_name":"Anna Maria Mannino","author_inst":"Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STeBiCeF), Palermo, Italy"},{"author_name":"Oana Alina Marin","author_inst":"National Institute for Marine Research and Development \"Grigore Antipa\" (NIMRD), Constanta, Romania"},{"author_name":"Joana Micael","author_inst":"Southwest Iceland Nature Research Centre (SINRC), 245 Sudurnesjabaer, Iceland"},{"author_name":"David Milla-Figueras","author_inst":"University of the Azores, Institute of Marine Sciences - OKEANOS, Rua Professor Doutor Frederico Machado 4, 9900-140 Horta, Portugal"},{"author_name":"Davide Moccia","author_inst":"Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy"},{"author_name":"Catia Monteiro","author_inst":"CIBIO - Research centre in Biodiversity and genetic resources, Portugal"},{"author_name":"Pip Moore","author_inst":"The Dove Marine Laboratory, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom"},{"author_name":"Marina Morabito","author_inst":"University of Messina, Italy"},{"author_name":"Ignacio Moreu","author_inst":"University of Malaga, Instituto Andaluz de Biotecnologia y Desarrollo Azul (IBYDA), Bulevar Pasteur, 31, sn, 29010 Malaga, Spain"},{"author_name":"Liam Morrison","author_inst":"School of Natural Sciences, Ryan Institute, University of Galway, Ireland"},{"author_name":"Rob Mrowicki","author_inst":"Natural History Museum, Research, Cromwell Road, London SW7 5BD, United Kingdom"},{"author_name":"Konstantinia Nakou","author_inst":"Fisheries Research Institute (ELGO-DIMITRA), Nea Peramos, Kavala, Greece"},{"author_name":"Yvonne Nemcova","author_inst":"Department of Botany, Charles University, Prague, Czech Republic"},{"author_name":"Francesca Neri","author_inst":"Department of Life and Environmental Sciences, Universita Politecnica delle Marche, Italy"},{"author_name":"africa N.G. De la Morena","author_inst":"Department of Ecology and Geology, University of Malaga, Bulevar Pasteur, 31, sn, 29071 Malaga, Spain"},{"author_name":"Wiebe Nijland","author_inst":"Department of Physical Geography, Utrecht University, Netherlands"},{"author_name":"Anne-Marin Nisumaa-Comeau","author_inst":"Universite Cote d Azur, CNRS, ECOSEAS, France"},{"author_name":"Louka Noyen","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Kristiina Nurkse","author_inst":"Estonian Marine Institute, University of Tartu, Maealuse 14, 12618, Tallinn, Estonia"},{"author_name":"Sotiris Orfanidis","author_inst":"Fisheries Research Institute (ELGO-DIMITRA), Nea Peramos, Kavala, Greece"},{"author_name":"Martina Orlando-Bonaca","author_inst":"Marine Biology Station Piran, National Institute of Biology, Slovenia"},{"author_name":"Apostolos Papadimitriou","author_inst":"Fisheries Research Institute (ELGO-DIMITRA), Nea Peramos, Kavala, Greece"},{"author_name":"Evangelos Papadimitriou","author_inst":"Fisheries Research Institute (ELGO-DIMITRA), Nea Peramos, Kavala, Greece"},{"author_name":"Viviana Pasquini","author_inst":"Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy"},{"author_name":"Sauvann Paulino","author_inst":"Universite Brest, CNRS, IRD, Ifremer, LEMAR, IUEM, F-29280 Plouzane, France"},{"author_name":"Sofie Peeters","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Viviana Pena","author_inst":"BioCost Research Group, Facultad de Ciencias and Centro Interdisciplinar de Quimica e Bioloxia (CICA), University of A Coruna, A Coruna, Spain"},{"author_name":"Carolina Pena-Martin","author_inst":"Departemento Ciencies Ambientals i Recursos Naturals. Universitat d'Alacant, Spain"},{"author_name":"Rui Pereira","author_inst":"A4F, Algafuel. Estrada Paco do Lumiar, Campus do Lumiar Ed E RC. 1649-038, Lisbon, Portugal"},{"author_name":"Frank Perk","author_inst":"ANEMOON Foundation, Netherlands"},{"author_name":"Francesca Petrucci","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Laura Piazzese","author_inst":"MARE - Marine and Environmental Sciences Centre, ARNET Aquatic Research Network, Agencia Regional para o Desenvolvimento da Investigacao, Tecnologia e Inovacao "},{"author_name":"Addis Pierantonio","author_inst":"Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy"},{"author_name":"Jose Pintado","author_inst":"Institute of Marine Research (IIM-CSIC), Vigo, Galicia, Spain"},{"author_name":"Emeline Poisson","author_inst":"Cellule de Suivi du Littoral Normand (CSLN), France"},{"author_name":"Laura Prigge","author_inst":"CIBIO - Research centre in Biodiversity and genetic resources, Portugal"},{"author_name":"Raquel Quinta","author_inst":"S2AQUA - Collaborative Laboratory, Association for a Sustainable and Smart Aquaculture, Portugal"},{"author_name":"Celine Rebours","author_inst":"Moreforsking AS, Borgundveien 340, 6009 Alesund, Norway"},{"author_name":"Maggie Reddy","author_inst":"School of Chemical and Biological Sciences, Ryan Institute, University of Galway, Ireland"},{"author_name":"Simon Redlich","author_inst":"Friedrich Schiller University Jena, Institute for Inorganic and Analytical Chemistry, Germany"},{"author_name":"Kelli Richardon","author_inst":"Estonian Marine Institute, University of Tartu, Maealuse 14, 12618, Tallinn, Estonia"},{"author_name":"Esben Rimi Christiansen","author_inst":"Pure Algae, Denmark"},{"author_name":"Fabio Rindi","author_inst":"Dipartimento di Scienze della Vita e dell Ambiente, Universita Politecnica delle Marche, Ancona, Italy"},{"author_name":"Pedro Rodrigues","author_inst":"Rif Field Station, 675 Raufarhofn, Iceland"},{"author_name":"Valerie Rodrigues","author_inst":"Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, Gogerddan, Aberystwyth, SY23 3EE, United Kingdom"},{"author_name":"Conxi Rodriguez-Prieto","author_inst":"Universitat de Girona, Facultat de Ciencies, Ma Aurelia Capmany 69, 17003, Girona, Spain"},{"author_name":"Florence Rousseau","author_inst":"Institut Systematique Evolution Biodiversite (ISYEB), Museum national d Histoire Naturelle, CNRS, Sorbonne Universite, EPHE, Paris, France"},{"author_name":"Andrzej Rybak","author_inst":"Department of Hydrobiology, Institute of Environmental Biology, Faculty of Biology, Adam Mickiewicz University, Poznan, Uniwersytetu Poznanskiego 6, PL 61-614 P"},{"author_name":"Brahim Sabour","author_inst":"Phycology, Blue Biodiversity and Biotechnology RU, Laboratory of Plant Biotechnology, Ecology and Ecosystem Valorization CNRST Labeled Research Unit N10, Facult"},{"author_name":"Marta Sanson","author_inst":"Departamento Botanica, Ecologia y Fisiologia Vegetal, Universidad de La Laguna, Canary Islands, Spain"},{"author_name":"Susanne Schafer","author_inst":"MARE - Marine and Environmental Sciences Centre, ARNET Aquatic Research Network, Agencia Regional para o Desenvolvimento da Investigacao, Tecnologia e Inovacao "},{"author_name":"Muki Shpigel","author_inst":"The Leon H. Carney School of Marine Sciences, University of Haifa, Israel"},{"author_name":"Marco Sigovini","author_inst":"Consiglio Nazionale delle Ricerche, Istituto di Scienze Marine (CNR-ISMAR), Venice, Italy"},{"author_name":"Clara Simon","author_inst":"School of Chemical and Biological Sciences, Ryan Institute, University of Galway, Ireland"},{"author_name":"Nathalie Simon","author_inst":"Station Biologique de Roscoff, Sorbonne University and CNRS, Roscoff, France"},{"author_name":"Kjersti Sjotun","author_inst":"Department of Biological Sciences, University of Bergen, Bergen, Norway"},{"author_name":"Stamatia Spyrou","author_inst":"Laboratory of Biotechnology, Department of Biological Applications and Technologies, University of Ioannina, Ioannina, Greece"},{"author_name":"Haralambos Stamatis","author_inst":"Laboratory of Biotechnology, Department of Biological Applications and Technologies, University of Ioannina, Ioannina, Greece"},{"author_name":"Willem Stock","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Sylvia Strauss","author_inst":"The Seaweed Company, Netherlands"},{"author_name":"Heather Sugden","author_inst":"The Dove Marine Laboratory, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, United Kingdom"},{"author_name":"Ergun Taskin","author_inst":"Department of Biology, Faculty of Engineering and Natural Sciences, Manisa Celal Bayar University, Manisa, Turkiye"},{"author_name":"Thierry Thibaut","author_inst":"Aix Marseille University, University of Toulon, CNRS, IRD, MIO (Mediterranean Institute of Oceanography), Marseille, France"},{"author_name":"Gwendal Toullec","author_inst":"Technologique et Scientifique de Luminy, 163 avenue de Luminy Batiment Mediterranee, 13288 Marseille cedex 09, France"},{"author_name":"Eva Troianou","author_inst":"Kefalonia Fisheries SA, Greece"},{"author_name":"Ana Tronholm","author_inst":"Department of Biological and Environmental Sciences, University of Gothenburg, Box 463, 405 30 Goteborg, Sweden"},{"author_name":"Soultana Tsioli","author_inst":"Fisheries Research Institute (ELGO-DIMITRA), Nea Peramos, Kavala, Greece"},{"author_name":"Inci Tuney","author_inst":"Ege University, Faculty of Science, Department of Biology, Bornova-Izmir, Turkiye"},{"author_name":"Ioannis Tzovenis","author_inst":"Kefalonia Fisheries SA, Greece"},{"author_name":"Marika Ubaldi","author_inst":"Department of Life and Environmental Sciences, Universita Politecnica delle Marche, Italy"},{"author_name":"Jose Utge","author_inst":"Institut Systematique Evolution Biodiversite (ISYEB), Museum national d Histoire Naturelle, CNRS, Sorbonne Universite, EPHE, Paris, France"},{"author_name":"Lauren Vapillon","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Vasily Vishnyakov","author_inst":"Papanin Institute for Biology of Inland Waters, Russian Academy of Sciences, Borok, Yaroslavl, Russia"},{"author_name":"Sofie Vranken","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"},{"author_name":"Andrzej Woyda-Ploszczyca","author_inst":"Department of Bioenergetics, Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, Poznan, Uniwersytetu Poznanskiego"},{"author_name":"Ante Zuljevic","author_inst":"Institute of Oceanography and Fisheries, Split, Croatia"},{"author_name":"Miek Zwamborn","author_inst":"Knockvologan Studio, Isle of Mull, United Kingdom"},{"author_name":"Ronan Sulpice","author_inst":"School of Chemical and Biological Sciences, Ryan Institute, University of Galway, Ireland"},{"author_name":"Thomas Wichard","author_inst":"Friedrich Schiller University Jena, Institute for Inorganic and Analytical Chemistry, Germany"},{"author_name":"Aschwin Engelen","author_inst":"Centro de Ciencias do Mar do Algarve (CCMARCIMAR LA), Campus de Gambelas, Universidade do Algarve, 8005-139 Faro, Portugal"},{"author_name":"Sophie Steinhagen","author_inst":"Department of Marine Sciences-Tjarno, University of Gothenburg, SE-452 96 Stromstad, Sweden"},{"author_name":"Frederik Leliaert","author_inst":"Meise Botanic Garden, Nieuwelaan 38, B-1860 Meise, Belgium"},{"author_name":"Olivier De Clerck","author_inst":"Phycology Research Group, Department of Biology, Ghent University, Ghent, Belgium"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Comparative transcriptomics reveals shared and context-dependent adaptations of bovine cells across culture systems for cultivated meat","rel_doi":"10.64898\/2026.11.18.767523","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767523","rel_abs":"Developing cell-culture systems for cultivated meat requires understanding how candidate cells respond to prolonged expansion and different growth environments. However, the extent to which bovine cells share transcriptional adaptations across these conditions, or retain responses specific to their origin and cellular state, remains unclear. Here, we systematically profiled bovine umbilical cord (BUC)- and adipose tissue (BAT)-derived mesenchymal stem cells (MSCs) across different culture architectures, passage stages, and differentiation states, including immortalized BUC cells and satellite cells as a myogenic reference. We show that global transcriptomic variation is strongly associated with culture architecture, cell identity, and cellular state. Immortalization preserved several early-passage transcriptional features, particularly proliferation-related programs, while opposing selected changes associated with primary cell aging. Culture architecture induced distinct rather than uniform three-dimensional responses. Spheroid formation produced a pronounced transcriptional shift characterized by reduced proliferation-, chromatin-, and development-associated programs, alongside changes in extracellular-matrix organization, metabolism, and intracellular remodeling. Across primary umbilical cord-derived, adipose-derived, and myogenically induced umbilical cord-derived cells, scaffold-versus-plate comparisons revealed correlated but non-identical transcriptional responses. These involved changes in extracellular-matrix organization, adhesion, membrane trafficking, and developmental pathways, with endocytosis enriched across all three comparisons among the pathways examined. During myogenic induction, both satellite cells and BUC-derived cells exhibited muscle-related cytoskeletal and contractile programs, while scaffold culture further supported myogenic signatures in BUC-derived cells. These findings distinguish recurring culture-associated responses from transcriptional features tied to cell source and expansion history. They support evaluating cultivated-meat candidate cells in their intended culture systems, not solely under conventional plate conditions.","rel_num_authors":12,"rel_authors":[{"author_name":"Ivana Ribarski-Chorev","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"},{"author_name":"Moritz Burghardt","author_inst":"Department of Biomedical Engineering, Tel Aviv University, Tel Aviv-Yafo, 6997801, Israel."},{"author_name":"Shadi Tawil","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"},{"author_name":"Alon Gershkoviz","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"},{"author_name":"Dafna Shpatz","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"},{"author_name":"Gisele Schudy","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"},{"author_name":"Yarden Beh Hamo","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"},{"author_name":"Yael Gilad","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"},{"author_name":"Ilana Vainshtein","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"},{"author_name":"Adar Kfir","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"},{"author_name":"Tamir Tuller","author_inst":"Department of Biomedical Engineering, Tel Aviv University, Tel Aviv-Yafo, 6997801, Israel and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv-Yafo, "},{"author_name":"Sharon Schlesinger","author_inst":"The Department of Animal Sciences, Robert H. Smith Faculty of Agriculture, Food, and Environment,  The Hebrew University of Jerusalem,  Rehovot 7610001, Israel"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"LORELEI sequence variation modulates lineage-dependent pollen tube reception in Brassicaceae","rel_doi":"10.64898\/2026.11.18.767685","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767685","rel_abs":"Pollen tube reception (PTR) is essential for fertilization and can act as a prezygotic barrier in interspecific crosses. While core female components such as LORELEI (LRE) and FERONIA (FER) mediate conspecific PTR, their roles in heterospecific compatibility remain unclear. Here, we investigated how LRE sequence variation influences PTR outcomes with heterospecific pollen in Brassicaceae. In Arabidopsis thaliana, PTR frequently failed when ovules were pollinated with Arabidopsis lyrata or Sisymbrium irio, and loss of LRE or FER further increased pollen tube overgrowth in a pollen-species-dependent manner. Complementation of lre ovules with LRE orthologs showed distinct, donor-dependent effects: AlyLRE and SiLRE produced modest and variable improvements with A. lyrata pollen, whereas SiLRE consistently and markedly improved reception of S. irio pollen. Evolutionary analyses indicated relaxed purifying selection in the LRE lineage relative to its paralog LLG1 and nominated residues 47 and 120 as candidates for functional divergence. Consistent with this, the Lineage II-associated R120T substitution enhanced reception of S. irio pollen while partially reducing conspecific PTR. In addition, the ancestral-state E47P-R120G combination also improved heterospecific PTR without measurably compromising conspecific function. Together, these results indicate that LRE sequence diversification can modulate female-side compatibility with pollen tubes from different evolutionary lineages, potentially by altering how pollen tube-derived signals are sensed and transduced during reception.","rel_num_authors":9,"rel_authors":[{"author_name":"Emma Jong","author_inst":"School of Plant Sciences, University of Arizona, Tucson, Arizona, 85721, USA"},{"author_name":"Jennifer A Noble","author_inst":"School of Plant Sciences, University of Arizona, Tucson, Arizona, 85721, USA"},{"author_name":"Matthew J Alcaraz","author_inst":"School of Plant Sciences, University of Arizona, Tucson, Arizona, 85721, USA"},{"author_name":"Said Hafidh","author_inst":"Laboratory of Pollen Biology, Institute of Experimental Botany of the Czech Academy of Sciences, Rozvojova 263, 165 00 Prague 6, Czech Republic"},{"author_name":"Iz Varghese","author_inst":"Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02903, USA"},{"author_name":"David Honys","author_inst":"Laboratory of Pollen Biology, Institute of Experimental Botany of the Czech Academy of Sciences, Rozvojova 263, 165 00 Prague 6, Czech Republic"},{"author_name":"George P Lisi","author_inst":"Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02903, USA"},{"author_name":"Mark A Beilstein","author_inst":"The School of Plant Sciences, University of Arizona, Tucson, AZ 85721, USA"},{"author_name":"Ravishankar Palanivelu","author_inst":"School of Plant Sciences, University of Arizona, Tucson, Arizona, 85721, USA"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"The tumor suppressor role of the KRAS proto-oncogene in metastatic pancreatic cancer.","rel_doi":"10.64898\/2026.11.18.767567","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767567","rel_abs":"KRAS is the most frequently mutated proto-oncogene in human cancers. Progression to advanced disease is frequently associated with allelic imbalance of the KRAS locus with gain of the mutant allele and loss of the wild-type allele through clonal and sub-clonal loss of heterozygosity (LOH). While a large body of literature has focused on the effects of allelic imbalance on oncogene addiction through gain of the mutant allele, the role of the wild-type KRAS proto-oncogene in malignant progression has not been fully elucidated. To capture this phenomenon, we developed a first-in-class somatic mosaic and lineage tracing genetically engineered mouse model (smGMLT) of pancreatic ductal adenocarcinoma allowing for real time in vivo tracing of Kras-LOH. Longitudinal characterization of the smGMLT demonstrated the presence of a strong evolutionary bottleneck towards the selective loss of the wild-type allele at metastatic sites. Cross species analysis leveraging research autopsies and surgical specimens revealed that KRAS-LOH is associated with metastatic dissemination and shorter overall survival. Transcriptomic analysis through single-cell RNA sequencing uncovered a conserved phenomenon whereby KRAS-LOH is paralleled by an immune evasive phenotype through loss of the tumor-cell interferon response and reduced CD8+ T cell infiltration. In line with this evidence, orthotopic transplants of isogenic tumor populations differing for the Kras allelic status demonstrated that only cancer cells with Kras-LOH are are able to form tumors in immune competent animals. Restoration of the wild-type allele abrogates tumorigenesis in KrasLOH transplants in immunocompetent through activation of the TBK1-IRF axis. Altogether, these studies demonstrate that the KRAS proto-oncogene is a functional tumor suppressor in pancreatic cancer exerting its function through interferon-mediated, cell-extrinsic modulation of the tumor immune microenvironment.","rel_num_authors":37,"rel_authors":[{"author_name":"Li Zhang","author_inst":"UT MD Anderson"},{"author_name":"Enrico Gurreri","author_inst":"UT MD Anderson"},{"author_name":"Haoyu Tang","author_inst":"UT MD Anderson"},{"author_name":"Angelina Bania","author_inst":"UT MD Anderson"},{"author_name":"Mohammad J. Ibrahim","author_inst":"UT MD Anderson"},{"author_name":"Roberta Rinaldi","author_inst":"UT MD Anderson"},{"author_name":"Aashta Pandey","author_inst":"UT MD Anderson"},{"author_name":"Luca Cecchetto","author_inst":"UT MD Anderson"},{"author_name":"Elisabetta Granato","author_inst":"UT MD Anderson"},{"author_name":"Hania Khan","author_inst":"UT Southwestern"},{"author_name":"Anh Hoang","author_inst":"UT MD Anderson"},{"author_name":"Desiree Catania","author_inst":"UT MD Anderson"},{"author_name":"Calogero Carlino","author_inst":"IRCSS San Raffele Institute"},{"author_name":"Joseph R. Marszaleck","author_inst":"UT MD Anderson"},{"author_name":"Chunhua Shi","author_inst":"UT MD Anderson"},{"author_name":"Alessandro Sgambato","author_inst":"Universita' Cattolica del Sacro Cuore"},{"author_name":"Giampaolo Tortora","author_inst":"Universita' Cattolica del Sacro Cuore"},{"author_name":"Alessandro Carugo","author_inst":"IRBM"},{"author_name":"Andrea Viale","author_inst":"UT MD Anderson"},{"author_name":"Davide Cittaro","author_inst":"IRCSS San Raffele Institute"},{"author_name":"Stefano Sioletic","author_inst":"San Camillo-Forlanini Hospital"},{"author_name":"Laura Wood","author_inst":"Johns Hopkins University"},{"author_name":"David S. Klimstra","author_inst":"Yale School of Medicine"},{"author_name":"Olca Basturk","author_inst":"MSKCC"},{"author_name":"Shubam Pant","author_inst":"UT MD Anderson"},{"author_name":"Milind Javle","author_inst":"UT MD Anderson"},{"author_name":"Pavlos Msaouel","author_inst":"UT MD Anderson"},{"author_name":"Jianjun Gao","author_inst":"UT MD Anderson"},{"author_name":"Kadir C. Akdemir","author_inst":"UT MD Anderson"},{"author_name":"Linghua Wang","author_inst":"UT MD Anderson"},{"author_name":"Peter Van Loo","author_inst":"UT MD Anderson"},{"author_name":"Francesca Citron","author_inst":"UT MD Anderson"},{"author_name":"Timothy Heffernan","author_inst":"UT MD Anderson"},{"author_name":"Christine A. Iacobuzio-Donahue","author_inst":"MSKCC"},{"author_name":"Scott Kopetz","author_inst":"UT MD Anderson"},{"author_name":"Luigi Perelli","author_inst":"UT MD Anderson"},{"author_name":"Giannicola Genovese","author_inst":"UT MD Anderson"}],"rel_date":"2026-11-20","rel_site":"biorxiv"},{"rel_title":"Sputum quality and diagnostic outcomes of GeneXpert MTB\/RIF assay among adults with presumed tuberculosis in two district hospitals in Ghana: A retrospective cross-sectional study.","rel_doi":"10.64898\/2026.11.17.26368278","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.17.26368278","rel_abs":"Background: Tuberculosis remains a major public health challenge in Ghana, where GeneXpert MTB\/RIF serves as a first-line diagnostic tool. However, uncertainties about this method persist regarding specimen quality and the clinical significance of indeterminate rifampicin susceptibility results. Methods: We conducted a retrospective cross-sectional study of samples from 3,977 presumptive TB patients tested either at HopeXchange Medical Center (Kumasi) or Keta Municipal Hospital between January 2020 and December 2024. Demographic data, sputum macroscopic appearance, and GeneXpert results were analyzed using descriptive statistics and Fishers exact test. Results: Overall Mycobacterium tuberculosis (MTb) test positivity was 11.6% (461\/3977). Males accounted for 63.3% of positive results, with the highest percentage among those ages 30-40 years. Mucopurulent specimens yielded the highest positivity rate (25.4%), compared to 4.0% of salivary specimens. Blood-stained sputum specimens (n=44) showed a 15.9% positivity rate. Although confirmed rifampicin resistance was low (1.7%), 9.3% of all MTb positive samples yielded an indeterminate result. The rate of indeterminate results from samples collected at Kwadaso Municipal increased from 7.3% in 2021 to 28.6% in 2024. Conclusion: These findings validate Ghana National Tuberculosis Program (NTP) guidelines emphasizing the reliability of mucopurulent specimen collection, but challenges the routine rejection of blood-stained sputum. The rising trend of indeterminate rifampicin results requires further investigation of circulating rpoB mutation profiles and quality assurance measures. Patients with indeterminate results should be further assessed using drug susceptibility testing to rule out rifampicin resistance. The findings provide actionable evidence to refine diagnostic algorithms and improve TB care in Ghana.","rel_num_authors":15,"rel_authors":[{"author_name":"Alhassan  Osumanu Hishman","author_inst":"University for Development Studies"},{"author_name":"David Taabe","author_inst":"University for Development Studies"},{"author_name":"Joseph  Ofosu Boateng","author_inst":"University for Development Studies"},{"author_name":"Kwabena  Adade Kusi","author_inst":"University for Development Studies"},{"author_name":"Felix Kodzo  Adade Besah Sorvor","author_inst":"National Tuberculosis Control Program, Accra, Ghana"},{"author_name":"Evans  Ansu Twumasi","author_inst":"HopeXchange Medical Center, Kumasi, Ghana"},{"author_name":"Akosua  Frimpomaa Amoateng","author_inst":"HopeXchange Medical Center"},{"author_name":"Johnpaul Amenu","author_inst":"Kwame Nkrumah University of Science and Technology"},{"author_name":"Osei  Kwame Wiredu","author_inst":"Kwame Nkrumah University of Science and Technology"},{"author_name":"Emmanuel  Boateng Mensah","author_inst":"HopeXchange Medical Center, Kumasi, Ghana"},{"author_name":"Antoinette  Salim Saaiby","author_inst":"HopeXchange Medical Center, Kumasi, Ghana"},{"author_name":"Baffour  Osei Akoto","author_inst":"HopeXchange Medical Center, Kumasi, Ghana"},{"author_name":"Edward  Owusu Kwarteng","author_inst":"The University of Texas Southwestern Medical Center"},{"author_name":"Michael Cappello","author_inst":"Yale University"},{"author_name":"Peter Kojo Brenya","author_inst":"HopeXchange Medical Center"}],"rel_date":"2026-11-19","rel_site":"medrxiv"},{"rel_title":"ADSMoE: A mixture-of-experts-based transformer autoencoder for discovering multimodal Alzheimer's disease subtypes","rel_doi":"10.64898\/2026.11.16.26368224","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368224","rel_abs":"Alzheimer's disease (AD) exhibits substantial biological and clinical heterogeneity, posing critical challenges for advancing precision medicine. Existing data-driven approaches often rely on modality-specific clustering or predefined biomarker trajectories, limiting their ability to discover disease subtypes from incomplete, heterogeneous real-world data. In this study, we introduce ADSMoE, a mixture-of-experts (MoE)-based multimodal representation learning framework that jointly identifies AD subtypes as latent disease signatures while accommodating incomplete modality combinations. ADSMoE integrates a Fleximodal MoE encoder that accommodates arbitrary combinations of available modalities with a novel subtype-specific MoE decoder to capture complementary disease characteristics through expert specialization. Using data from 5,422 participants across three independent cohorts, we trained ADSMoE on the ADNI cohort and externally validated the identified subtypes in NACC and UKB without model retraining. The proposed ADSMoE identified four AD subtypes with distinct neuroimaging patterns, genetic and proteomic associations, and clinical characteristics. Benchmarking analyses demonstrated robust subtype discovery and strong biological and clinical relevance, while external validation revealed consistent subtype-associated characteristics across independent cohorts. ADSMoE advances AD subtyping by uncovering biologically and clinically meaningful AD heterogeneity from incomplete multimodal data, providing a scalable framework for disease stratification, biomarker discovery, and future precision medicine applications in AD.","rel_num_authors":10,"rel_authors":[{"author_name":"Weimin Meng","author_inst":"University of Florida"},{"author_name":"Jinqian Pan","author_inst":"University of Florida"},{"author_name":"Meichuan Yin","author_inst":"University of Florida"},{"author_name":"Pei Zhuang","author_inst":"University of Florida"},{"author_name":"Kuang Gong","author_inst":"University of Florida"},{"author_name":"Mingquan Lin","author_inst":"University of Minnesota Medical School Twin Cities Campus: University of Minnesota Twin Cities School of Medicine"},{"author_name":"Jie Xu","author_inst":"University of Florida"},{"author_name":"Matthew Burns","author_inst":"University of Florida"},{"author_name":"Yonghui Wu","author_inst":"University of Florida"},{"author_name":"Rui Yin","author_inst":"University of Florida"}],"rel_date":"2026-11-19","rel_site":"medrxiv"},{"rel_title":"Integrative Multi-Ancestry and Multi-Tissue Fine-Mapping Prioritizes Candidate Causal Genes for Risk of Breast Cancer and Its Subtypes","rel_doi":"10.64898\/2026.11.17.26368322","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.17.26368322","rel_abs":"Most breast cancer (BC) risk loci identified by genome wide association studies lie in noncoding regions, and traditional transcriptome-wide association studies (TWAS) often prioritize multiple correlated genes per locus. We applied two gene fine-mapping methods, TGVIS and M cTWAS, which jointly model gene expression, splicing and alternative polyadenylation (APA) with direct variant effects, to overall BC, estrogen receptor-negative (ER negative) BC and triple-negative BC (TNBC) in women of European and African ancestry. Using 11 BC-relevant GTEx v10 tissues, we prioritized 31, 13 and 5 candidate causal genes, respectively, in European-ancestry populations. Compared with marginal TWAS, fine-mapping reduced the number of candidate genes per locus by 72 to 88%, and credible sets explained 97 to 100% of significant marginal associations. Seven candidates were not reported by previous GTEx v8-based TWAS, including RIN3, supported only by APA, and NPAT for TNBC. Analyses across 48 tissues and brain cell types revealed brain contributions, including ARHGEF5 in oligodendrocytes. In African-ancestry populations, EN1 was prioritized for ER negative BC and TNBC through variants common in African but rare in European ancestry. These results refine BC susceptibility genes, highlight regulatory mechanisms beyond breast tissue and gene expression, and reveal the challenge of mapping GWAS variants to causal genes with currently available data.","rel_num_authors":11,"rel_authors":[{"author_name":"Mengxuan Li","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"author_name":"Yihe Yang","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"author_name":"Lingzhu Shen","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"author_name":"Jie Ping","author_inst":"Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"},{"author_name":"Guochong Jia","author_inst":"Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"},{"author_name":"Huaying Fang","author_inst":"Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA"},{"author_name":"Jirong Long","author_inst":"Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"},{"author_name":"William Schiemann","author_inst":"Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"author_name":"Hua Tang","author_inst":"Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA"},{"author_name":"Wei Zheng","author_inst":"Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"},{"author_name":"Xiaofeng Zhu","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA"}],"rel_date":"2026-11-19","rel_site":"medrxiv"},{"rel_title":"Integrative Multi-Ancestry and Multi-Tissue Fine-Mapping Prioritizes Candidate Causal Genes for Risk of Breast Cancer and Its Subtypes","rel_doi":"10.64898\/2026.11.17.26368322","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.17.26368322","rel_abs":"Most breast cancer (BC) risk loci identified by genome wide association studies lie in noncoding regions, and traditional transcriptome-wide association studies (TWAS) often prioritize multiple correlated genes per locus. We applied two gene fine-mapping methods, TGVIS and M cTWAS, which jointly model gene expression, splicing and alternative polyadenylation (APA) with direct variant effects, to overall BC, estrogen receptor-negative (ER negative) BC and triple-negative BC (TNBC) in women of European and African ancestry. Using 11 BC-relevant GTEx v10 tissues, we prioritized 31, 13 and 5 candidate causal genes, respectively, in European-ancestry populations. Compared with marginal TWAS, fine-mapping reduced the number of candidate genes per locus by 72 to 88%, and credible sets explained 97 to 100% of significant marginal associations. Seven candidates were not reported by previous GTEx v8-based TWAS, including RIN3, supported only by APA, and NPAT for TNBC. Analyses across 48 tissues and brain cell types revealed brain contributions, including ARHGEF5 in oligodendrocytes. In African-ancestry populations, EN1 was prioritized for ER negative BC and TNBC through variants common in African but rare in European ancestry. These results refine BC susceptibility genes, highlight regulatory mechanisms beyond breast tissue and gene expression, and reveal the challenge of mapping GWAS variants to causal genes with currently available data.","rel_num_authors":11,"rel_authors":[{"author_name":"Mengxuan Li","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"author_name":"Yihe Yang","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"author_name":"Lingzhu Shen","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"author_name":"Jie Ping","author_inst":"Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"},{"author_name":"Guochong Jia","author_inst":"Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"},{"author_name":"Huaying Fang","author_inst":"Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA"},{"author_name":"Jirong Long","author_inst":"Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"},{"author_name":"William Schiemann","author_inst":"Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA"},{"author_name":"Hua Tang","author_inst":"Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA"},{"author_name":"Wei Zheng","author_inst":"Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA"},{"author_name":"Xiaofeng Zhu","author_inst":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA"}],"rel_date":"2026-11-19","rel_site":"medrxiv"},{"rel_title":"Beyond spouses: primary social supporter selection among pregnant women enrolled in the Support-Moms study in southwestern Uganda - a cross-sectional study","rel_doi":"10.64898\/2026.11.16.26368248","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368248","rel_abs":"Social support during pregnancy can influence women's engagement with antenatal care and other maternal health behaviours. Maternal health programmes in sub-Saharan Africa have often emphasised male partner involvement, although women may draw on broader social networks. Evidence on whom women identify as their primary supporter during pregnancy remains limited. We examined the prevalence and factors associated with non-spousal primary supporter selection among pregnant women in southwestern Uganda. We conducted a cross-sectional analysis of baseline data from the Support-Moms study, a Type 1 hybrid effectiveness-implementation randomised controlled trial conducted in Mbarara City, Mbarara District, and Mitooma District, southwestern Uganda. Pregnant women enrolled between 27 February and 17 December 2024 identified two social supporters before randomisation; the first-nominated individual was classified as the primary supporter. The primary outcome was selection of a non-spousal primary supporter. Modified Poisson regression with robust variance was used to estimate crude and adjusted prevalence ratios (aPRs) with 95% confidence intervals (CIs). Among 824 women, 223 (27.1%; 95% CI 24.1-30.3) selected a non-spousal primary supporter. Friends (30.5%) and other relatives (28.7%) were the most frequently nominated non-spousal supporters, followed by siblings (17.9%) and mothers (16.6%). Non-spousal selection was more prevalent among women recruited in Mbarara District (aPR 1.50, 95% CI 1.09-2.08) and Mitooma District (aPR 2.52, 95% CI 1.77-3.60) than Mbarara City, and among women who were separated, divorced, widowed, or never married (aPR 2.35, 95% CI 1.76-3.14), had an unplanned pregnancy (aPR 1.39, 95% CI 1.10-1.77), had a >10-year relationship with their nominated supporter (aPR 1.93, 95% CI 1.39-2.69), or were aged <20 years (aPR 1.48, 95% CI 1.01-2.15). Although spouses were the primary supporters for most women, more than one-quarter nominated someone else, most commonly a friend or relative. These findings suggest that pregnancy support extends beyond marital relationships and may be shaped by relational status, social context, pregnancy intention, age, and established social ties. Antenatal care programmes may benefit from complementing partner-focused approaches with mechanisms to engage other support figures identified by women.","rel_num_authors":15,"rel_authors":[{"author_name":"Henry Ochola","author_inst":"Mbarara University of Science and Technology Faculty of Medicine"},{"author_name":"Esther  C. Atukunda","author_inst":"Mbarara University of Science and Technology Faculty of Medicine"},{"author_name":"Elly  B. Atuhumuza","author_inst":"Mbarara University of Science and Technology Faculty of Medicine"},{"author_name":"Jessica Haberer","author_inst":"Massachusetts General Hospital"},{"author_name":"Van  T. Nghiem","author_inst":"University of Alabama at Birmingham"},{"author_name":"Peter Waiswa","author_inst":"Makerere University School of Public Health"},{"author_name":"Micheal Kanyesigye","author_inst":"Mbarara University of Science and Technology"},{"author_name":"Leevan Tibaijuka","author_inst":"Mbarara University of Science and Technology Faculty of Development Studies"},{"author_name":"Charles Lugaaju","author_inst":"Mbarara University of Science and Technology Faculty of Development Studies"},{"author_name":"Justus Asasira","author_inst":"Mbarara University of Science and Technology"},{"author_name":"Stuart Turanzomwe","author_inst":"Kabale University"},{"author_name":"Celestino Obua","author_inst":"Mbarara University of Science and Technology"},{"author_name":"Mark  J. Siedner","author_inst":"Massachusetts General Hospital"},{"author_name":"Lynn  T. Matthews","author_inst":"Yale School of Medicine"},{"author_name":"Godfrey  R. Mugyenyi","author_inst":"Mbarara University of Science and Technology Faculty of Medicine"}],"rel_date":"2026-11-19","rel_site":"medrxiv"},{"rel_title":"Early Time-Restricted Eating Reduces Fat Mass In Morning Chronotype Adults With Overweight\/Obesity","rel_doi":"10.64898\/2026.11.17.26368370","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.17.26368370","rel_abs":"Time-restricted eating (TRE) is a promising strategy to improve weight management and metabolic health, but its efficacy may vary depending on the coherence between the eating window and individual chronotype. In a randomized 12-week intervention of morning chronotype adults with overweight or obesity, early TRE (06:00h-14:00h) led to greater reductions in body fat mass compared to late TRE (12:00h-20:00h) and active control (three meals per day). Continuous glucose monitoring revealed enhanced circadian glucose rhythmicity and increased glycemic variability in early TRE, whereas postprandial glucose excursions were attenuated in late TRE. Early TRE induced the most pronounced systemic multi-omic changes, characterized by distinct transcriptional and metabolic programs, including reduced triglyceride and increased sphingomyelin levels. We found that in morning chronotype, early TRE and late TRE elicit distinct adaptations in body composition, glucose and lipid metabolism, and altered transcriptional and metabolic signatures. ClinicalTrials.gov registration no. NCT04618133.","rel_num_authors":16,"rel_authors":[{"author_name":"Nicholas E. Phillips","author_inst":"Service of Endocrinology, Diabetology, and Metabolism, Department of Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Friedrich C. Jassil","author_inst":"Service of Endocrinology, Diabetology, and Metabolism, Department of Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Loic Metz","author_inst":"The Thoracic and Endocrine Surgery Division, Department of Surgery, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Andrew D. Biancolin","author_inst":"The Thoracic and Endocrine Surgery Division, Department of Surgery, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Julie Mareschal","author_inst":"Service of Endocrinology, Diabetology, and Metabolism, Department of Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Flore Sinturel","author_inst":"The Thoracic and Endocrine Surgery Division, Department of Surgery, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"C\u00e9line Joris","author_inst":"Service of Endocrinology, Diabetology, and Metabolism, Department of Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Juan Sanchez-Avila","author_inst":"Molecular Discovery Platform, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria"},{"author_name":"Alexandra Hemmer","author_inst":"Service of Endocrinology, Diabetology, and Metabolism, Department of Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Oksana Fiammingo","author_inst":"The Thoracic and Endocrine Surgery Division, Department of Surgery, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"St\u00e9phanie Blanc","author_inst":"Service of Endocrinology, Diabetology, and Metabolism, Department of Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Dylan Gendre","author_inst":"The Thoracic and Endocrine Surgery Division, Department of Surgery, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Marcel Salath\u00e9","author_inst":"Digital Epidemiology Lab, School of Life Science, School of Computer and Communication Sciences, EPFL, Lausanne, Switzerland"},{"author_name":"Jardena J. Puder","author_inst":"Service of Obstetrics, Department of Women-Mother-Child, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland"},{"author_name":"Charna Dibner","author_inst":"The Thoracic and Endocrine Surgery Division, Department of Surgery, Geneva University Hospitals (HUG), Geneva, Switzerland"},{"author_name":"Tinh-Hai Collet","author_inst":"Service of Endocrinology, Diabetology, and Metabolism, Department of Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland"}],"rel_date":"2026-11-19","rel_site":"medrxiv"},{"rel_title":"TET2-mutant clonal hematopoiesis alters neutrophil maturation and granularity","rel_doi":"10.64898\/2026.11.17.26368301","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.17.26368301","rel_abs":"The effects of clonal hematopoiesis (CH) on neutrophil development and function in human blood remain largely unexplored. Here, we use primary peripheral blood and bone marrow samples to characterize changes in neutrophil maturation and granule production that occur in CH.","rel_num_authors":14,"rel_authors":[{"author_name":"Elina K Cook","author_inst":"Queen's University"},{"author_name":"Marco M Buttigieg","author_inst":"Queen's University"},{"author_name":"Yi Z Luo","author_inst":"Queen's University"},{"author_name":"Andrew Tian","author_inst":"Queen's University"},{"author_name":"Akshaj Darbar","author_inst":"Queen's University"},{"author_name":"Caitlyn Vlasschaert","author_inst":"Queen's University"},{"author_name":"Richard N Armstrong","author_inst":"University of Oxford"},{"author_name":"Amy JM McNaughton","author_inst":"Queen's University"},{"author_name":"David Good","author_inst":"Queen's University"},{"author_name":"Rena Buckstein","author_inst":"Sunnybrook Health Sciences Centre"},{"author_name":"Graeme R Quest","author_inst":"Queen's University"},{"author_name":"Jacqueline Boultwood","author_inst":"University of Oxford"},{"author_name":"Alexander G Bick","author_inst":"Vanderbilt University Medical Center"},{"author_name":"Michael J Rauh","author_inst":"Queen's University"}],"rel_date":"2026-11-19","rel_site":"medrxiv"},{"rel_title":"Excess of de novo substitutions in the genomes of individuals with newly acquired germline TP53 mutations","rel_doi":"10.64898\/2026.11.19.26364643","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.19.26364643","rel_abs":"Inherited defects in the tumour suppressor gene TP53 cause Li-Fraumeni syndrome, a highly penetrant predisposition to childhood and adult cancers. About half of affected individuals carry a variant absent from both parents, and these are the patients missed by family-history-based testing criteria. Where and when such variants arise, in which parental gamete or after fertilisation, remains unresolved, as primary family data are scarce. We addressed this using whole-genome and linked-read sequencing of five family quartets, each comprising a proband with a confirmed newly arisen pathogenic TP53 variant, a closely age-matched unaffected sibling, and both parents, drawn from a cohort of 429 families meeting clinical criteria for the syndrome; matching for age controls for the strong dependence of mutation counts on parental age. Every proband carried a distinct heterozygous missense change in the DNA-binding domain of p53, and read-based phasing traced four of five to the paternal chromosome. Genome-wide, probands carried a significant excess of newly arisen single-nucleotide changes relative to their siblings, which persisted after correction for parental age and was detected on the paternal chromosome. No comparable excess was found for insertions, deletions, structural rearrangements or repeat expansions, and the excess mutations matched the two clock-like processes operating in all cells rather than any distinct mechanism. These features are hard to reconcile with an event confined to the parental germ cells, and instead point to TP53 variants that arise shortly after fertilisation and sweep the embryo, carrying neighbouring mutations with them. Consistent with such sweeps occurring throughout life, TP53 mutations in two large public tumour-genome collections were more clonal than other driver mutations, and the most clonal were present in more cells than the tumour itself, as expected when a cancer emerges within a pre-existing mutant patch of normal tissue. We propose that constitutional TP53 variants and these mutant patches form one continuum, distinguished principally by timing: a sweep during the first cleavage divisions produces a variant present throughout the body, whereas the same advantage acting later confines the clone to one tissue. This reframes a subset of Li-Fraumeni syndrome as an early developmental rather than strictly germline event, with implications for testing, counselling and surveillance.","rel_num_authors":10,"rel_authors":[{"author_name":"Mathieu Parmentier","author_inst":"IRIBHM - Jacques E. Dumont, Universite libre de Bruxelles (ULB), Brussels, Belgium"},{"author_name":"Matthew D. Montierth","author_inst":"Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"author_name":"Ruonan Li","author_inst":"Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"author_name":"Carlos Vera Recio","author_inst":"Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"author_name":"Gilda P. Chau","author_inst":"Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"author_name":"Bingshan Li","author_inst":"Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA"},{"author_name":"Rui Chen","author_inst":"Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA"},{"author_name":"Guillermina Lozano","author_inst":"Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"author_name":"Maxime Tarabichi","author_inst":"IRIBHM - Jacques E. Dumont, Universite libre de Bruxelles (ULB), Brussels, Belgium"},{"author_name":"Wenyi Wang","author_inst":"Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"rel_date":"2026-11-19","rel_site":"medrxiv"},{"rel_title":"Broader functional and memory antibody responses in adult females than males in response to seasonal H3N2 vaccine virus","rel_doi":"10.64898\/2026.11.17.26368332","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.17.26368332","rel_abs":"Females of reproductive ages often mount greater antibody responses than males following influenza vaccination, but the breadth and depth of these differences, including antibody-dependent Fc receptor (FcR)-mediated functions have not been explored. Plasma samples were collected from male and female healthcare workers (range of 21-48y; mean of 31y) at 0, 28, and 180 days post-vaccination (DPV) during the 2022-2023 influenza vaccine season to assess antibody responses to A\/H1N1, A\/H3N2, and B\/Victoria vaccine viruses. Females had greater A\/H3N2, but not A\/H1N1 or B\/Victoria, neutralizing antibody (nAb) responses compared to males through 180 DPV, with differences being most pronounced among A\/H3N2 responders ([&ge;]4 fold-change in nAb titers). Memory B cells isolated from female responders secreted more IgG in response to ex vivo H3 stimulation than those from males at 28 and 180 DPV. Before vaccination, female responders had greater anti-H3 IgG responses and Fc{gamma}RIIB (CD32b) antibody binding than males, with females maintaining greater responses through 180 DPV. Female responders had greater H3-specific antibody-dependent monocyte phagocytosis (ADMP) and natural killer cell (ADNK) secretion of IFN{gamma} and CCL4 prior to and after vaccination, with ADMP positively correlating with greater H3N2 neutralization through 180 DPV in females only. Among responders, the durability of ADMP, ADNK, and nAb in females as compared to males defined the sex differences in influenza-vaccine induced immunity. The greater Fc{gamma}R-binding antibodies prior to vaccination in females might improve the durability of both neutralizing and non-neutralizing antibody responses to diverse vaccines, including next generation influenza vaccines.","rel_num_authors":11,"rel_authors":[{"author_name":"Han-Sol Park","author_inst":"W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health"},{"author_name":"Anna Yin","author_inst":"Johns Hopkins University Bloomberg School of Public Health"},{"author_name":"Maclaine A. Parish","author_inst":"W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health"},{"author_name":"Jingping Hu","author_inst":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine"},{"author_name":"Ainslee Zou","author_inst":"W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health"},{"author_name":"Rishi Pandey","author_inst":"W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health"},{"author_name":"Katherine Z.J. Fenstermacher","author_inst":"Department of Emergency Medicine, The Johns Hopkins School of Medicine"},{"author_name":"Richard E. Rothman","author_inst":"Department of Emergency Medicine, The Johns Hopkins School of Medicine"},{"author_name":"Andrew Pekosz","author_inst":"Johns Hopkins Bloomberg School of Public Health"},{"author_name":"Franklin R. Toapanta","author_inst":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine"},{"author_name":"Sabra L. Klein","author_inst":"W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health"}],"rel_date":"2026-11-19","rel_site":"medrxiv"},{"rel_title":"ARC-Impute: robust reference-guided spatial gene imputation through regularised cell-to-spot mapping","rel_doi":"10.64898\/2026.11.17.767312","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.17.767312","rel_abs":"Motivation: Reference-guided spatial imputation uses single-cell RNA sequencing references to predict genes that are unmeasured in spatial transcriptomics data. Limited shared-gene overlap can leave the mapping of reference cells to spatial locations ambiguous: different assignments may reconstruct observed genes similarly yet yield different imputed expression and cell-type estimates. This gives rise to local assignment ambiguity, source-target mismatch and reference-transfer instability. Results: We present ARC-Impute, which regularises cell-to-spot mapping through anchor-residual optimisation, target-guided reference curation and routing, and twin-panel consistency. Across 17 human and mouse datasets spanning spot-based and single-cell technologies, ARC-Impute ranked first for held-out Pearson correlation throughout and exceeded the dataset-specific baseline mean by 47.3% on average. It also achieved the strongest spot-level cell-type composition recovery across three pseudospot benchmarks and retained leading accuracy and consistency under reference and training-gene perturbations. Cross-validated predictions revealed systematic differences in gene imputability. Availability and implementation: Code and workflows at https:\/\/github.com\/ethanhaan\/arc-impute.","rel_num_authors":4,"rel_authors":[{"author_name":"Ethan Han","author_inst":"School of Computer Science, The University of Sydney, Australia"},{"author_name":"Andrew Zhang","author_inst":"School of Computer Science, The University of Sydney, Australia"},{"author_name":"Jinman Kim","author_inst":"School of Computer Science, The University of Sydney, Australia"},{"author_name":"Jean Yang","author_inst":"School of Mathematics and Statistics, The University of Sydney, Australia"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"High-Throughput Coded Aperture Raman Imaging with Total Internal Reflection","rel_doi":"10.64898\/2026.11.18.767730","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767730","rel_abs":"Spontaneous Raman microscopy provides label-free molecular fingerprints of biological tissues, but its low scattering efficiency limits the throughput required for large-area hyperspectral imaging. Here we introduce total internal reflection Raman (TIRR) microscopy, an architecture that exploits repeated internal reflections within a thin sapphire substrate to generate extended evanescent excitation without dividing the incident laser power among independent illumination spots. Combined with programmable Hadamard-coded detection, TIRR recovers spatially resolved Raman spectra with an effective spatial resolution of approximately 3.5 um and a spectral linewidth of approximately 10 cm-1. Hyperspectral imaging of human skin and colon tissues reveals heterogeneous Raman contrast across submillimeter-scale fields of view. Compared with confocal Raman microscopy, TIRR achieves a directly measured 9.0-fold reduction in acquisition time at lower excitation power, corresponding to a 20.1-fold power- and signal-to-noise-normalized acquisition-efficiency advantage. We further demonstrate compressive reconstruction using low-sequency Hadamard patterns, preserving high spectral and spatial fidelity in both the development dataset and an independent tissue specimen. This approach provides an additional nominal 2.1-fold acceleration, suggesting a potential combined normalized throughput enhancement approaching 40-fold. Finally, co-registration with spatial p21 annotations in a human skin section reveals exploratory Raman spectral differences associated with cellular senescence. TIRR thus establishes a programmable approach to accelerated spontaneous Raman imaging while retaining the multidimensional spectral information needed for molecular tissue analysis.","rel_num_authors":9,"rel_authors":[{"author_name":"Salvatore Sorrentino","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Koseki J. Kobayashi-Kirschvink","author_inst":"University of Chicago"},{"author_name":"Ke Zhang","author_inst":"Massachusetts General Hospital"},{"author_name":"Haochun Huang","author_inst":"Massachusetts General Hospital"},{"author_name":"Judy Zhou","author_inst":"Massachusetts General Hospital"},{"author_name":"Lloyd Bod","author_inst":"Harvard Medical School"},{"author_name":"Jian Shu","author_inst":"MGH\/Harvard Medical School"},{"author_name":"Jeon Woong Kang","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Peter T.C. So","author_inst":"Massachusetts Institute of Technology"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Multiple Glycans and IFITM Proteins Mediate Human Coronavirus OC43 entry","rel_doi":"10.64898\/2026.11.18.767684","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767684","rel_abs":"Human coronavirus (HCoV)-OC43 is the most prevalent seasonal coronavirus, causing colds, and occasional severe disease. HCoV-OC43 attachment is reportedly mediated by 9-O acetylated sialic acid (9-O-Ac-Sia); no proteinaceous receptor has been identified. Using genome-wide CRISPR-cas9 screens, we identify several host factors that mediate HCoV-OC43 entry. First, we identify NXPE3, an esterase, as required for HCoV-OC43 attachment and infection, both in vitro and in vivo, and demonstrate a previously unknown role for NXPE3 in 9-O-Ac-Sia synthesis. However, we further show that single residue substitutions in HCoV-OC43 spike, in the S1A domain at the 9-O-Ac-Sia binding site, or two substitutions in the S1B domain, confer 9-O-Ac-Sia independence and a switch to heparan sulfate-dependent entry. Additionally, we find that IFITM1\/2\/3 proteins act post-attachment to drive HCoV-OC43 virion-cell fusion and entry, irrespective of which attachment mechanism is used. Thus, flexible use of glycan attachment factors enables HCoV-OC43 to access fusion-driving IFITM proteins during entry.","rel_num_authors":10,"rel_authors":[{"author_name":"Manivel Lodha","author_inst":"Rockefeller University"},{"author_name":"Masashi Iwamoto","author_inst":"Rockefeller University"},{"author_name":"Michael Tartell","author_inst":"Rockefeller University"},{"author_name":"Marie Canis","author_inst":"Rockefeller University"},{"author_name":"Noah Schuster","author_inst":"University of Iowa"},{"author_name":"Daniel Poston","author_inst":"Rockefeller University"},{"author_name":"Yiska Weisblum","author_inst":"Hebrew University of Jerusalem"},{"author_name":"Stanley Perlman","author_inst":"University of Iowa"},{"author_name":"Theodora Hatziioannou","author_inst":"Rockefeller University"},{"author_name":"Paul Bieniasz","author_inst":"Rockefeller University"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Multiple Glycans and IFITM Proteins Mediate Human Coronavirus OC43 entry","rel_doi":"10.64898\/2026.11.18.767684","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767684","rel_abs":"Human coronavirus (HCoV)-OC43 is the most prevalent seasonal coronavirus, causing colds, and occasional severe disease. HCoV-OC43 attachment is reportedly mediated by 9-O acetylated sialic acid (9-O-Ac-Sia); no proteinaceous receptor has been identified. Using genome-wide CRISPR-cas9 screens, we identify several host factors that mediate HCoV-OC43 entry. First, we identify NXPE3, an esterase, as required for HCoV-OC43 attachment and infection, both in vitro and in vivo, and demonstrate a previously unknown role for NXPE3 in 9-O-Ac-Sia synthesis. However, we further show that single residue substitutions in HCoV-OC43 spike, in the S1A domain at the 9-O-Ac-Sia binding site, or two substitutions in the S1B domain, confer 9-O-Ac-Sia independence and a switch to heparan sulfate-dependent entry. Additionally, we find that IFITM1\/2\/3 proteins act post-attachment to drive HCoV-OC43 virion-cell fusion and entry, irrespective of which attachment mechanism is used. Thus, flexible use of glycan attachment factors enables HCoV-OC43 to access fusion-driving IFITM proteins during entry.","rel_num_authors":10,"rel_authors":[{"author_name":"Manivel Lodha","author_inst":"Rockefeller University"},{"author_name":"Masashi Iwamoto","author_inst":"Rockefeller University"},{"author_name":"Michael Tartell","author_inst":"Rockefeller University"},{"author_name":"Marie Canis","author_inst":"Rockefeller University"},{"author_name":"Noah Schuster","author_inst":"University of Iowa"},{"author_name":"Daniel Poston","author_inst":"Rockefeller University"},{"author_name":"Yiska Weisblum","author_inst":"Hebrew University of Jerusalem"},{"author_name":"Stanley Perlman","author_inst":"University of Iowa"},{"author_name":"Theodora Hatziioannou","author_inst":"Rockefeller University"},{"author_name":"Paul Bieniasz","author_inst":"Rockefeller University"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Deletion of two candidate depolymerases with overlapping genetic effects increases PHA yield in Rhodopseudomonas palustris TIE-1","rel_doi":"10.64898\/2026.11.19.767437","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767437","rel_abs":"Polyhydroxyalkanoate (PHA) is a microbial carbon-storage polymer with potential as a renewable bioplastic, but intracellular remobilization can limit polymer retention. The metabolically versatile bacterium Rhodopseudomonas palustris TIE-1 accumulates PHA during photoheterotrophic growth, yet the enzymes that control PHA turnover in this organism remain incompletely studied. We identified PhaZ2 (Rpal_0568) as a second candidate PHA depolymerase that is evolutionarily and architecturally distinct from the previously annotated PhaZ1 (Rpal_0578). Deleting either PhaZ1 or PhaZ2 alone did not substantially increase PHA content under tested growth conditions, whereas the double mutant accumulated 2.3-fold and 1.7-fold more PHA than wild type under non-nitrogen-fixing and nitrogen-fixing photoheterotrophic conditions, respectively, supporting overlapping roles in PHA turnover. All deletion strains showed longer doubling times but reached final culture densities similar to wild type. The double mutant showed its strongest retention phenotype under severe but growth-permissive nutrient limitation, including 3.7-fold more PHA than wild type at 33% phosphorus availability. A two-stage cultivation strategy that separated biomass formation from nutrient-limited storage raised volumetric PHA titer to 0.180 mg per mL culture in the double mutant, 1.5-fold more than wild type and approximately 3.4-fold higher than single-stage 33% phosphorus limitation and 4.0-fold higher than single-stage 8% nitrogen limitation (cross-experiment comparison), despite lower PHA content per unit biomass. Finally, an LC-MS-calibrated FTIR spectroscopy model predicted PHA content with an R2 of 0.928 (n = 15) and reproduced the major biological trends. These results identify genetically redundant candidate depolymerases as targets for improving PHA retention in TIE-1 and establish a cultivation and screening framework for strain engineering. Importance Persistent pollution from petroleum-based plastics has intensified the need for biodegradable plastics produced from renewable resources. Polyhydroxyalkanoate (PHA) is a microbially synthesized bioplastic, but microbial cells can also consume the stored polymer, reducing its net yield. The metabolically versatile, photosynthetic purple non-sulfur bacterium (PNSB) Rhodopseudomonas palustris TIE-1 is a promising production organism because it can photosynthesize, assimilate atmospheric nitrogen, and utilize diverse carbon sources. We show that two candidate PHA depolymerases, PhaZ1 and PhaZ2, likely have overlapping roles in PHA turnover. Removing both candidates increased polymer retention, particularly when nitrogen or phosphorus was limited, and a two-stage cultivation strategy further increased PHA titer to 0.180 mg per mL of culture. We also developed a rapid infrared spectroscopy method to track polymer content across strains and growth conditions. These findings offer complementary genetic, cultivation, and screening strategies for improving microbial bioplastic production and may help advance sustainable alternatives to petroleum-derived plastics.","rel_num_authors":5,"rel_authors":[{"author_name":"Yantong Chen","author_inst":"Washington University in St. Louis"},{"author_name":"Tahina Onina Ranaivoarisoa","author_inst":"Washington University in St. Louis"},{"author_name":"Riyaz Ditter","author_inst":"Washington University in St. Louis"},{"author_name":"Joshua A. V. Blodgett","author_inst":"Washington University in St Louis"},{"author_name":"Arpita Bose","author_inst":"Washington University"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Targeting host eIF4A with zotatifin inhibits Bundibugyo virus and other filoviruses","rel_doi":"10.64898\/2026.11.18.767653","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767653","rel_abs":"Filoviruses, including Ebola and Marburg viruses, depend on host eIF4A helicase activity for replication. Zotatifin is a first in class, clinical stage eIF4A inhibitor that acts as a molecular glue, stabilizing the interaction between eIF4A and selected polypurine rich RNA sequences, thereby inhibiting RNA unwinding and ribosomal scanning. Here, we identify pronounced polypurine enrichment in the 5'untranslated regions (5'UTRs) of the seven major filoviral protein-coding genes NP, VP35, VP40, GP, VP30, VP24, and L across four virus species, including Bundibugyo virus (BDBV). Consistent with these findings, zotatifin inhibits the replication of Ebola, Marburg, Sudan, Tai Forest, and Bundibugyo viruses at low nanomolar concentrations. Zotatifin has been administered to humans in oncology and COVID19 clinical studies. Clinical pharmacokinetic pharmacodynamic (PKPD) modeling indicates that exposures resulting in inhibition of BDBV replication are achievable in humans at tolerated doses following subcutaneous administration. Together, these findings support the repurposing of zotatifin as a host directed antiviral candidate against BDBV and other filoviruses, with potential applications in preparedness for future outbreaks.","rel_num_authors":12,"rel_authors":[{"author_name":"Katarzyna Bogucka-Janczi","author_inst":"KRAS Research GmbH, Mainz, Germany"},{"author_name":"Hajime Yurugi","author_inst":"KRAS Research GmbH, Mainz,Germany"},{"author_name":"Nadine Biedenkopf","author_inst":"Philipps-University Marburg"},{"author_name":"Franziska Kraft","author_inst":"Philipps-University Marburg, Marburg, Germany"},{"author_name":"Olena Shtanko","author_inst":"Texas biomedical Research institute, San Antonio , USA"},{"author_name":"Vladimir Goncalves Magalhaes","author_inst":"Insitutue of Virology, Goethe University, Frankfurt"},{"author_name":"Sandra Ciesek","author_inst":"Institute of Virology, Goethe University, Frankfurt"},{"author_name":"Zhuoyi Song","author_inst":"Department of Urology, University of California, San Francisco, USA"},{"author_name":"Davide Ruggero","author_inst":"University of California, San Francisco"},{"author_name":"Victor Moyo","author_inst":"SJP BiotecGmbH, Meilen, Switzerland"},{"author_name":"Tawanda Gumbo","author_inst":"7Phase Advance AI Inc, Dallas, Texas, USA"},{"author_name":"Krishnaraj Rajalingam","author_inst":"Johannes Gutenberg University of Mainz"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"A cytoskeletal toggle switch controls amnion architecture and fate","rel_doi":"10.64898\/2026.11.13.766348","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.13.766348","rel_abs":"Binary cellular decisions are generally attributed to gene regulatory networks, with cytoskeletal-driven shape changes often treated as an output. Yet, whether the cytoskeleton can itself implement switch-like logic to drive abrupt morphological transitions remains unknown. In the primate amniotic sac, the extraembryonic amnion derives directly from the columnar epiblast and abruptly flattens into a squamous epithelium to form a highly asymmetric cavity. Here, we identify a cytoskeletal switch driving this developmental bifurcation in human gastrula models. Mutual inhibition between actomyosin and keratin networks generates two mechanical attractors: amnion cells flip into a keratin-rich, squamous shape, while the epiblast remains myosin-rich and columnar. Ectopic activation of YAP1-TEAD signaling triggers the myosin-keratin switch without inducing amnion specification, establishing that the switch is not simply a consequence of fate changes. Conversely, preventing the switch disrupts amnion specification, showing that this shape bifurcation gates lineage commitment. Single-cell transcriptomics across cytoskeletal perturbations revealed a transcriptional signature for the toggle switch, which is recapitulated in vivo in the human and marmoset amnion. Together, our findings show that the cytoskeleton acts not only as an effector of tissue shape but as a decision-making module, implementing the same toggle switch logic as gene regulatory networks to drive morphological bifurcations.","rel_num_authors":10,"rel_authors":[{"author_name":"Chloe Roffay","author_inst":"Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna 1030, Austria"},{"author_name":"Oliver M. Drozdowski","author_inst":"Institute of Science and Technology Austria, Klosterneuburg 3400, Austria."},{"author_name":"Sarah Jay","author_inst":"Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna 1030, Austria"},{"author_name":"Cindy Horenburg","author_inst":"Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna 1030, Austria"},{"author_name":"Maria Novatchkova","author_inst":"Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna 1030, Austria"},{"author_name":"Elias Jantsch","author_inst":"Institute of Science and Technology Austria, Klosterneuburg 3400, Austria"},{"author_name":"Alberto Moreno-Cencerrado","author_inst":"Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna 1030, Austria"},{"author_name":"Nicolas Rivron","author_inst":"Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC), Vienna, Austria"},{"author_name":"Edouard Hannezo","author_inst":"Institute of Science and Technology Austria, Klosterneuburg 3400, Austria"},{"author_name":"Diana Pinheiro","author_inst":"Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna 1030, Austria"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Modelling vortex interactions reveals distinct patterns of brain reconfiguration following psilocybin and escitalopram","rel_doi":"10.64898\/2026.11.06.764626","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.06.764626","rel_abs":"Major depressive disorder is a leading cause of disability, yet how interventions reorganise brain dynamics remains poorly understood. Here, we investigated how psilocybin and escitalopram reshape brain dynamics in depression using pre- and post-treatment resting-state functional magnetic resonance imaging (fMRI) from a double-blind randomised controlled trial (NCT03429075). We compared two whole-brain modelling approaches: conventional signal-space modelling describing interactions between regional brain signals, and vortex-space modelling capturing interactions between evolving patterns of local synchronisation. This represents the first application of vortex-space modelling to a psychiatric disorder. Vortex space was more sensitive than signal space in most analyses, including distinguishing treatment-related brain states, relating baseline connectivity to clinical improvement and predicting response to escitalopram. Our results further revealed distinct patterns of reorganisation following the two interventions. Psilocybin produced widespread increases in vortex-space effective connectivity and reduced network modularity, whereas escitalopram showed no comparable changes. Despite these differences, greater increases in brain turbulence (i.e., spatiotemporal variability in local synchronisation) were associated with greater symptom reduction in both treatments, with a significant post-treatment increase in responders. These findings suggest that psilocybin and escitalopram may reorganise brain dynamics in markedly different ways and yet share dynamical features associated with clinical improvement. Overall, vortex-space modelling offers a promising framework for characterising brain dynamics in depression and its successful treatment.","rel_num_authors":8,"rel_authors":[{"author_name":"Alvaro Acosta-Gordo","author_inst":"University College London"},{"author_name":"Paulina Clara Dagnino","author_inst":"Universitat Pompeu Fabra"},{"author_name":"Yonatan Sanz Perl","author_inst":"Universitat Pompeu Fabra"},{"author_name":"Robin Carhart-Harris","author_inst":"University of California, San Francisco"},{"author_name":"David Erritzoe","author_inst":"Imperial College London"},{"author_name":"David J Nutt","author_inst":"Imperial College London"},{"author_name":"Morten L Kringelbach","author_inst":"University of Oxford"},{"author_name":"Gustavo Deco","author_inst":"Universitat Pompeu Fabra"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Data-Driven Decomposition of Precisely Aligned Fiber-Orientation-Preserving Probabilistic Tractography Connectomes with Non-Negative Matrix Factorization","rel_doi":"10.64898\/2026.11.08.765179","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.08.765179","rel_abs":"The major goals of the Human Connectome Project (HCP) were to characterize the structural and functional connectivity of the human brain. Although there has been tremendous work done for functional connectivity, including application of a variety of data driven decomposition approaches, structural connectivity from the HCP has seen less attention. This work presents a collection of methodological advances that, in combination, enable similar approaches to be applied to diffusion tractography data. Here, we use multi-modal non-linear volumetric alignment with FSL's MultiMOdal Registration Framework (MMORF) to precisely align white matter tracts and globular gray matter nuclei, use the White matter Hierarchical Modelling (WHIM) method to align voxel-wise fiber orientations, enable efficient GPU-accelerated computation and storage of full resolution probabilistic gray matter x white matter x fiber sparse tractography matrices in precise alignment across individuals using the aforementioned MMORF and WHIM alignments together with areal-feature-based cortical surface registration. These tractography dense connectomes can be averaged across individuals and sparse, computationally efficient non-negative matrix factorization (NMF) can be applied to perform data-driven decompositions into white matter tracts and gray matter projection territories. The primary outputs of this effort to date are 1) A set of HCP software pipelines enabling such analyses, 2) A new unbiased HCP-derived volumetric standard space that is representative of the young adult brain and follows ACPC orientation conventions across individuals. 3) Reproducible NMF decompositions of HCP young adult tractography data into white matter tracts and gray matter projection territories, which could be projected using non-negative dual regression back to individuals. These data represent a starting point for a new generation of data-driven atlasing efforts for human white matter, and these methods can be applied to study the white matter in development, aging, and brain diseases.","rel_num_authors":12,"rel_authors":[{"author_name":"Alexander Zhou","author_inst":"Radiology, Washington Univ. in St. Louis, St. Louis"},{"author_name":"Timothy S Coalson","author_inst":"Radiology, Washington Univ. in St. Louis, St. Louis, MO"},{"author_name":"Burke Q Rosen","author_inst":"Neuroscience, Washington Univ. in St. Louis, Saint Louis, MO"},{"author_name":"Hossein Rafipoor","author_inst":"Univ. of Oxford, Oxford, United Kingdom"},{"author_name":"Frederik J Lange","author_inst":"Univ. of Oxford, Oxford, United Kingdom"},{"author_name":"Naofumi Yoshida","author_inst":"Lab. for Brain Connectomics Imaging, RIKEN Ctr. for Biosystems Dynamics Res., Kobe"},{"author_name":"Andrea Yang","author_inst":"Neuroscience, Washington Univ. in St. Louis, Saint Louis, MO"},{"author_name":"Takuya Hayashi","author_inst":"RIKEN"},{"author_name":"Stamatios Sotiropoulos","author_inst":"University of Nottingham"},{"author_name":"Saad Jbabdi","author_inst":"University of Oxford"},{"author_name":"David C Van Essen","author_inst":"Washington University in St. Louis"},{"author_name":"Matthew F Glasser","author_inst":"Washington University"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Bioresorbable permanent-magnet beacons for tracking internal biomechanics during free movement","rel_doi":"10.64898\/2026.11.07.760898","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.07.760898","rel_abs":"Perioperative complications represent a global health burden that can be reduced through timely interventions guided by continuous physiological monitoring. Bioresorbable sensors excel through natural degradation without subsequent surgical extraction, but motion artefacts disrupt their accurate measurement. We synthesize bioresorbable permanent-magnet nanocomposites from aligned iron nanowires as implantable beacons. These beacons intrinsically generate magnetic fields responsive to biomechanical changes, thereby enabling wireless and chipless monitoring. An artificial-intelligence-enhanced wearable magnetic-field camera decodes these spatial maps into calibrated values that tolerate vigorous movement. The system achieves a displacement-equivalent mean absolute error of 2.74 m. Experiments in rat models demonstrate intracranial pressure tracking with clinical-grade accuracy during vigorous activities, and longitudinal monitoring of intracranial hypertension associated with ischaemic stroke during natural behaviours.","rel_num_authors":21,"rel_authors":[{"author_name":"Zhongyi Nie","author_inst":"Peking University"},{"author_name":"Xiang Lin","author_inst":"Peking University"},{"author_name":"Ji Wan","author_inst":"Peking University"},{"author_name":"Jie Xu","author_inst":"Peking University"},{"author_name":"Kedong Wu","author_inst":"Peking University"},{"author_name":"Yan Wang","author_inst":"Peking University Health Science Center"},{"author_name":"Chong Zhang","author_inst":"Peking University"},{"author_name":"Chendong Yang","author_inst":"Peking University"},{"author_name":"Ruyue Zhong","author_inst":"Peking University"},{"author_name":"Ning Sun","author_inst":"Peking University"},{"author_name":"Weitao Man","author_inst":"Beijing Tsinghua Changgung Hospital, Tsinghua University"},{"author_name":"Yingda Huang","author_inst":"Peking University"},{"author_name":"Shaotong Zhang","author_inst":"Peking University"},{"author_name":"Denghua Wu","author_inst":"Peking University"},{"author_name":"Yiran Wang","author_inst":"Peking University"},{"author_name":"Yaozheng Wang","author_inst":"Peking University"},{"author_name":"Minki Hong","author_inst":"Korea University"},{"author_name":"Yujie Sun","author_inst":"Peking University"},{"author_name":"Hongjie Hu","author_inst":"Peking University"},{"author_name":"Jahyun Koo","author_inst":"Korea University"},{"author_name":"Mengdi Han","author_inst":"Peking University"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Single-cell analysis identifies concurrent type 2 and interferon programs in experimental eosinophilic esophagitis","rel_doi":"10.64898\/2026.11.18.767761","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767761","rel_abs":"Background & Aims: Eosinophilic esophagitis (EoE) is a chronic, type 2 cytokine-driven allergic disease of the esophagus. How the immune and structural cell landscape of the esophagus changes between healthy and inflamed tissue requires further investigation. Methods: CD45-enriched esophageal cells from naive and oxazolone (OXA)-challenged wild-type mice were profiled by single-cell RNA sequencing. A cytokine-gated gene expression score identified type 2 program-high cells. Findings were compared with published human esophageal datasets, validated histologically, and examined in Il13ra1-\/- mice. Results: A total of 62,245 esophageal cells were analyzed. ILC2s accounted for most type 2 cytokine-expressing lymphocytes in naive mice, whereas Th2 cells accounted for approximately 80% following OXA challenge. ILC2s concurrently lost Il5, Il13 and Gata3 expression while retaining Areg. Resident memory-like CD8 T cells became the largest lymphoid population. Mast cells switched from a connective tissue-type to a mucosal-type and partly cycling state, which was confirmed by increased MCPT1 cells. Esophageal eosinophils displayed a signature resembling skin eosinophils of atopic dermatitis rather than gastrointestinal eosinophils. Il13ra1-\/- mice were protected from epithelial proliferation, thickening and eosinophilia. An interferon-associated program characterized lymphoid, myeloid and structural compartments, and its epithelial component was conserved in human EoE. Conclusions: Th2 cells and mucosal-type mast cells are the dominant sources of type 2 cytokines in experimental EoE. This study further identifies a conserved interferon-associated program that accompanies the type 2 response in the immune and structural compartments of the esophagus and highlights it as a candidate contributor to EoE pathology.","rel_num_authors":10,"rel_authors":[{"author_name":"Anish Dsilva","author_inst":"Tel Aviv University"},{"author_name":"Kristina Handler","author_inst":"University of Zurich"},{"author_name":"Tali Baron","author_inst":"Tel Aviv University"},{"author_name":"Michal Itan","author_inst":"Tel Aviv University"},{"author_name":"Shmulik Avlas","author_inst":"Tel Aviv University"},{"author_name":"Israel Zan Bar","author_inst":"Tel Aviv University"},{"author_name":"Chen Varol","author_inst":"Sourasky Medical Center and Tel Aviv University"},{"author_name":"Marc Rothenberg","author_inst":"Cincinnati Children's Hospital Medical Center"},{"author_name":"Isabelle C Arnold","author_inst":"University of Zurich"},{"author_name":"Ariel Munitz","author_inst":"Tel Aviv University"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Common organization of collective dynamics across divergent self-organized neural architectures","rel_doi":"10.64898\/2026.11.18.767733","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767733","rel_abs":"Brain organoids and other model neuronal networks build synaptic circuits through self-organization, and different protocols yield markedly different architectures, letting us test how collective dynamics depend on large-scale organization. We compared organoids of layered cortical-like structure against networks of cell-body clusters joined by axonal cables, quantifying the reproducible patterns of population activity in each. Bursts occurred in both architectures and comprised several collective patterns in each, so no single recurring template describes them. Recurrent activation sequences capture only part of this organization, sequence participation is graded, and neurons that rarely join a sequence still contribute to the shared dynamics. The patterns also pick out overlapping neuronal groups with propagation-like spatial order. Although the patterns differed between tissue models, their organization was conserved, and remained unchanged under pharmacological increases in network activity. Recurrent sequences therefore represent one manifestation of a broader collective organization that emerges across distinct self-organized neural architectures.","rel_num_authors":4,"rel_authors":[{"author_name":"Zehui Zhao","author_inst":"Emory University"},{"author_name":"Liang Yang","author_inst":"Yale University"},{"author_name":"Ilya Nemenman","author_inst":"Emory University"},{"author_name":"Andre Levchenko","author_inst":"Yale University"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Body-wide microbial ecosystem reorganization across the cognitive impairment spectrum in Parkinsons disease","rel_doi":"10.64898\/2026.11.17.767360","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.17.767360","rel_abs":"Cognitive impairment (CI) is a major determinant of disability in Parkinsons disease (PD), yet how microbial alterations across multiple body sites accompany cognitive dysfunction remains poorly understood. We characterized microbial communities from five body sites (stool, saliva, tongue, nasal cavity, and axilla) in 150 participants spanning healthy controls, PD with mild cognitive impairment (PD-MCI), and PD dementia (PDD), generating 616 samples for 16S rRNA gene sequencing. Multi-Omics Factor Analysis v2 (MOFA2) identified a multisite microbial signature with prominent oral and gut contributions that varied across clinical groups (Factor 8; {beta} = -0.58, p < 0.0001). MintTea analysis identified stable multisite microbial assemblies associated with cognitive status, including a module distinguishing PD-MCI from PDD (in-sample AUROC = 0.810). Core microbiome analysis revealed a net reduction of 45 genus-site core memberships across four anatomical sites in cognitively impaired participants, including reduced prevalence of the butyrate-associated genus Roseburia. Multivariable models incorporating microbial signatures and demographic covariates explained an average of 35.4% of cognitive-outcome variance, with microbial features contributing an additional 8.0 percentage points beyond age, sex, and education. Procrustes analysis revealed a pronounced, non-linear pattern of weakening cross-site microbial community correspondence at the dementia stage. The Global Body-wide Organization Index remained relatively stable between HC (0.335) and PD-MCI (0.341) but declined to 0.257 in PDD, representing a 23% reduction relative to HC. Together, these findings identify disease-associated multisite microbial signatures and altered core-community composition across the PD cognitive impairment spectrum, supporting further investigation of multisite microbiome profiling for cognitive stratification.","rel_num_authors":8,"rel_authors":[{"author_name":"Muzaffer Ar\u0131kan","author_inst":"Istanbul Universitesi Fen Fakultesi"},{"author_name":"Busranur Delice","author_inst":"Istanbul Medipol Universitesi Uluslararasi Tip Fakultesi"},{"author_name":"Zeynep Y\u0131ld\u0131z","author_inst":"Fatih Sultan Mehmet Vakif Universitesi"},{"author_name":"Tu\u011f\u00e7e Kahraman Demir","author_inst":"Biruni Universitesi"},{"author_name":"Nesrin H. Y\u0131lmaz","author_inst":"Istanbul Medipol University"},{"author_name":"Aysu \u015een","author_inst":"Bakirkoy Research and Training Hospital for Psychiatric and Neurological Diseases"},{"author_name":"L\u00fctf\u00fc Hano\u011flu","author_inst":"Istanbul Medipol University"},{"author_name":"Suleyman Yildirim","author_inst":"Istanbul Medipol Universitesi Uluslararasi Tip Fakultesi"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"A trade-off shaping leaf mesophyll architecture emerges from a stochastic geometry model","rel_doi":"10.64898\/2026.11.18.767598","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767598","rel_abs":"Leaf mesophyll architecture has a great impact on plant functions, including photosynthesis. Yet, understanding the principles governing growth, stability, and interspecific variation of leaf mesophyll architecture remains elusive. Here, we develop a computational framework based on stochastic space tessellation to simulate two-dimensional paradermal slices of leaf spongy mesophyll across 40 vascular plant species using three data-derived parameters: leaf porosity, cell arm length, and cell arm diameter. The framework successfully reconstructs leaf slices while preserving six biological, topological, and cell-level traits, with one- to three-armed cell geometries generally outperforming circular cells. Importantly, we further develop a theoretical model based on stochastic geometry that closely agrees with the simulations and reveals that leaf porosity strongly influences cell wall construction cost, while cell-arm statistics shape this relationship. Our parsimoniously parameterized model provides a basis for optimizing leaf architecture to maximize carbon dioxide uptake while minimizing cell wall construction costs.","rel_num_authors":6,"rel_authors":[{"author_name":"Milad Rahimi-Majd","author_inst":"University of Potsdam"},{"author_name":"Aleca M. Borsuk","author_inst":"New York Botanical Garden"},{"author_name":"Hosein Masoomy","author_inst":"University of Potsdam"},{"author_name":"Nancy C. Walker","author_inst":"Yale University"},{"author_name":"Craig R. Brodersen","author_inst":"Yale University"},{"author_name":"Zoran Nikoloski","author_inst":"University of Potsdam"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Cell-type-resolved methylation analysis using bulk long-read sequencing across human tissues","rel_doi":"10.64898\/2026.11.18.767445","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767445","rel_abs":"DNA methylation shapes cellular identity and changes with aging and disease, but most human methylomes come from bulk tissue, which mixes signal across many cell types. A methylation change at the bulk tissue level can reflect a change in cellular composition or an intrinsic shift within a cell type, and the two cannot be separated from bulk data. Single-cell and sorted-cell methods resolve cell types directly, but their cost and workflow complexity pose challenges to large studies. Long-read sequencing of single DNA molecules can directly detect DNA methylation on each read. We built COMET (Cell-of-Origin from METhylation), a framework that uses cell-type-specific methylation to assign individual long reads to cell types from standard bulk long-read sequencing. COMET detects changes in cell-type composition robustly even from shallow bulk long-read data, quantifies methylation level of repetitive DNA within each cell type, and, with deeper sequencing, resolves methylation differences between health and disease in individual cell types. We applied COMET to 140 human blood samples, 104 human brain samples and 59 human colon samples. In blood, we found epigenetic aging clock is primarily driven by shifts in cell-type composition, and that APOE4 carriers have myeloid-specific methylation changes. In brain, we found sex-biased change in cell-type composition with age, resolved methylation and hydroxymethylation separately within each cell type. In colon, we found a consistent expansion of fibroblasts in tumors relative to matched normal tissue, localized methylation loss at LINE-1 in fibroblast cells, and identified tumor- and cell-type-specific hypermethylation in epithelial cells at the promoters of known colorectal cancer genes. By resolving cell-type-specific methylation directly from bulk long-read data, this approach opens broad study of cell-type epigenetics across human tissues in aging and disease.","rel_num_authors":31,"rel_authors":[{"author_name":"Hao Chen","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Edward A. Mead","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Yanchun Zhang","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Nikolaos Karvelas","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Zhangying Chen","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Emma L. Thorn","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Yu Fan","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Mi Ni","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Casidhe-Nicole Bethancourt","author_inst":"Columbia University Irving Medical Center"},{"author_name":"David A. Cohen","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Gordon Fan-Huang","author_inst":"Albert Einstein College of Medicine"},{"author_name":"Zi Yan","author_inst":"Albert Einstein College of Medicine"},{"author_name":"Eric Bouhassira","author_inst":"Albert Einstein College of Medicine"},{"author_name":"Salima Soualhi","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Alexey Kozlenkov","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Jamshid Abdul-Ghafar","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Slim Mzoughi","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Ernesto Guccione","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Stella Dracheva","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Louis J. Cohen","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Rachel Brody","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Alexander W. Charney","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Hao Wu","author_inst":"University of Pennsylvania"},{"author_name":"Rahul M. Kohli","author_inst":"University of Pennsylvania"},{"author_name":"Kurt W. Farrell","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Jan Vijg","author_inst":"Albert Einstein College of Medicine"},{"author_name":"Joel T. Gabre","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Deirdre J. Cohen","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Fanny M. Elahi","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"John F. Crary","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Gang Fang","author_inst":"Icahn School of Medicine at Mount Sinai"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Cell-type-resolved methylation analysis using bulk long-read sequencing across human tissues","rel_doi":"10.64898\/2026.11.18.767445","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767445","rel_abs":"DNA methylation shapes cellular identity and changes with aging and disease, but most human methylomes come from bulk tissue, which mixes signal across many cell types. A methylation change at the bulk tissue level can reflect a change in cellular composition or an intrinsic shift within a cell type, and the two cannot be separated from bulk data. Single-cell and sorted-cell methods resolve cell types directly, but their cost and workflow complexity pose challenges to large studies. Long-read sequencing of single DNA molecules can directly detect DNA methylation on each read. We built COMET (Cell-of-Origin from METhylation), a framework that uses cell-type-specific methylation to assign individual long reads to cell types from standard bulk long-read sequencing. COMET detects changes in cell-type composition robustly even from shallow bulk long-read data, quantifies methylation level of repetitive DNA within each cell type, and, with deeper sequencing, resolves methylation differences between health and disease in individual cell types. We applied COMET to 140 human blood samples, 104 human brain samples and 59 human colon samples. In blood, we found epigenetic aging clock is primarily driven by shifts in cell-type composition, and that APOE4 carriers have myeloid-specific methylation changes. In brain, we found sex-biased change in cell-type composition with age, resolved methylation and hydroxymethylation separately within each cell type. In colon, we found a consistent expansion of fibroblasts in tumors relative to matched normal tissue, localized methylation loss at LINE-1 in fibroblast cells, and identified tumor- and cell-type-specific hypermethylation in epithelial cells at the promoters of known colorectal cancer genes. By resolving cell-type-specific methylation directly from bulk long-read data, this approach opens broad study of cell-type epigenetics across human tissues in aging and disease.","rel_num_authors":31,"rel_authors":[{"author_name":"Hao Chen","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Edward A. Mead","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Yanchun Zhang","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Nikolaos Karvelas","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Zhangying Chen","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Emma L. Thorn","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Yu Fan","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Mi Ni","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Casidhe-Nicole Bethancourt","author_inst":"Columbia University Irving Medical Center"},{"author_name":"David A. Cohen","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Gordon Fan-Huang","author_inst":"Albert Einstein College of Medicine"},{"author_name":"Zi Yan","author_inst":"Albert Einstein College of Medicine"},{"author_name":"Eric Bouhassira","author_inst":"Albert Einstein College of Medicine"},{"author_name":"Salima Soualhi","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Alexey Kozlenkov","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Jamshid Abdul-Ghafar","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Slim Mzoughi","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Ernesto Guccione","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Stella Dracheva","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Louis J. Cohen","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Rachel Brody","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Alexander W. Charney","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Hao Wu","author_inst":"University of Pennsylvania"},{"author_name":"Rahul M. Kohli","author_inst":"University of Pennsylvania"},{"author_name":"Kurt W. Farrell","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Jan Vijg","author_inst":"Albert Einstein College of Medicine"},{"author_name":"Joel T. Gabre","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Deirdre J. Cohen","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Fanny M. Elahi","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"John F. Crary","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Gang Fang","author_inst":"Icahn School of Medicine at Mount Sinai"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Expanded representation and function of PDF neurons in the mosquito circadian network","rel_doi":"10.64898\/2026.11.19.767825","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.19.767825","rel_abs":"Female Aedes aegypti mosquitoes can transmit pathogens when they bite humans, their preferred hosts, and this host-seeking drive is tightly gated by time of day. Daily rhythms depend on the molecular clock and communication among clock neurons, yet mosquito circadian network organization remains poorly understood. Using a mosquito-specific PERIOD antibody, we mapped the putative clock network of Aedes aegypti and found that neurons expressing the neuropeptide Pigment-Dispersing Factor (PDF) make up a much larger proportion of clock neurons compared to other insects, indicating a divergent network organization. PDF neurons are required for normal rhythms across insects, but whether their importance scales with their abundance in the network is unknown. We therefore tested the functional role of this expanded PDF neuron population in mosquitoes: we show that electrically silencing Aedes aegypti PDF neurons abolished the separation of daily activity into morning and evening peaks and led to misaligned clock protein rhythms across circadian neurons, even under entraining light-dark cycles. Thus, in a network built around an unusually large PDF population, PDF neuron activity plays an outsized role in behavioral timing and network synchrony.","rel_num_authors":3,"rel_authors":[{"author_name":"Linhan Dong","author_inst":"Columbia University"},{"author_name":"Anna V. Plank","author_inst":"Columbia University"},{"author_name":"Laura B. Duvall","author_inst":"Columbia University"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Rage bait: a neurofunctional signature of moral outrage elicited by social media","rel_doi":"10.64898\/2026.11.18.767526","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767526","rel_abs":"Moral outrage is ubiquitous online, with powerful emotional and motivational consequences for social life. Combining naturalistic fMRI during exposure to short-form social-media videos depicting moral violations with predictive modeling, we developed a neurofunctional signature of subjective moral outrage (MONS) in discovery\/validation (n=80\/30) cohorts. MONS predicted experienced outrage and punishment tendencies across cohorts. Positive predictive weights encompassed regions implicated in mentalizing, threat detection and action initiation (precuneus, posterior cingulate, periaqueductal gray, hypothalamus, cerebellum), whereas negative weights involved valuation and behavioral flexibility systems (amygdala, orbitofrontal cortex). Across 11 datasets (n=478), MONS captured anger and disgust but was dissociable from general negative affect and affective arousal. Notably, MONS did not predict perceived moral wrongness in conventional moral judgment paradigms, suggesting that moral outrage is not reducible to more cognitive moral evaluation. Findings provide a moral outrage neurofunctional model that delineates its relationship to other affective states and distinguishes it from traditional moral judgment.","rel_num_authors":15,"rel_authors":[{"author_name":"Xianyang Gan","author_inst":"University of Electronic Science and Technology of China"},{"author_name":"Ran Zhang","author_inst":"Southwest University"},{"author_name":"Feng Zhou","author_inst":"Southwest University"},{"author_name":"Lisa Wagels","author_inst":"RWTH-Aachen University"},{"author_name":"Heng Jiang","author_inst":"University of Electronic Science and Technology of China"},{"author_name":"Junjie Wang","author_inst":"University of Electronic Science and Technology of China"},{"author_name":"Yanan Qing","author_inst":"University of Electronic Science and Technology of China"},{"author_name":"Xi Yang","author_inst":"North Sichuan Medical College"},{"author_name":"Jingxian He","author_inst":"University of Electronic Science and Technology of China"},{"author_name":"Zihao Zheng","author_inst":"University of Electronic Science and Technology of China"},{"author_name":"Ting Xu","author_inst":"Southwest University"},{"author_name":"Klaus Mathiak","author_inst":"RWTH-Aachen University"},{"author_name":"Bin Jiang","author_inst":"The University of Hong Kong"},{"author_name":"Dezhong Yao","author_inst":"University of Electronic Science and Technology of China"},{"author_name":"Benjamin Becker","author_inst":"The University of Hong Kong"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Scaffold-Mediated Cellular and Acellular Delivery of Inducible BMP2-Lentivirus Promotes Atrophic Nonunion Fracture Healing without Heterotopic Ossification","rel_doi":"10.64898\/2026.11.18.767681","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767681","rel_abs":"Nonunions occur in 5-10% of fracture patients, and current treatments are expensive with variable success. Controllable, localized delivery of BMP2 using porous, degradable scaffolds may be a promising alternative. We designed tube-shaped cryogel scaffolds (chitosan-gelatin, CG; chitosan-agarose-gelatin, CAG) to deliver a doxycycline-inducible BMP2-lentivirus vector (BMP2-LV). Results showed that CAG scaffolds have larger pores, higher toughness, and better cell infiltration than CG scaffolds. When scaffolds were implanted subcutaneously in mice and treated with continuous doxycycline, x-ray radiographs and microCT showed mineralization in scaffolds seeded with adipose-derived stem cells (BMP2-LV-ASC) but not acellular scaffolds (BMP2-LV) 4-weeks after implantation. Scaffolds that were implanted at the site of an established femoral nonunion 4-weeks after fracture and treated with continuous doxycycline showed improved healing with CG\/CAG BMP2-LV and BMP2-LV-ASC compared to scaffold-only controls. At 2-weeks post implantation, microCT and histology showed that BMP2-expressing scaffolds promoted increased callus mineralization relative to scaffold-only. At 8-weeks post implantation, microCT and histology showed near-complete bone bridging in BMP2-treated groups compared to still visible fracture lines in the scaffold-only groups. However, CG\/CAG BMP2-LV-ASC groups also showed heterotopic ossification. Finally, we demonstrated that heterotopic ossification was eliminated at 8-weeks post implantation in CG BMP2-LV-ASC groups by restricting doxycycline treatment to the first 3 days after implantation. We conclude that lentiviral BMP2 delivery using cellularized and acellular cryogel scaffolds enhanced fracture healing in a nonunion model, and that a 3-day period of BMP2 induction using an inducible system was sufficient to promote healing without the complication of heterotopic ossification.","rel_num_authors":9,"rel_authors":[{"author_name":"Leyi Chen","author_inst":"Washington University in St. Louis"},{"author_name":"Yu Seon Kim","author_inst":"Washington University in St. Louis"},{"author_name":"Katherine Hixon","author_inst":"Dartmouth College"},{"author_name":"Nicole Gould","author_inst":"Washington University in St. Louis"},{"author_name":"Andre Coello","author_inst":"Washington University in St. Louis"},{"author_name":"Mariam Obaji","author_inst":"Washington University in St. Louis"},{"author_name":"Tiffany Lee","author_inst":"Washington University in St. Louis"},{"author_name":"Farshid Guilak","author_inst":"Washington University and Shriners Hospitals for Children"},{"author_name":"Matthew Silva","author_inst":"Washington University School of Medicine"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Shaped by shape: costs and topology drive host-parasite evolution in spatial networks","rel_doi":"10.64898\/2026.11.18.767619","rel_link":"http:\/\/biorxiv.org\/content\/10.64898\/2026.11.18.767619","rel_abs":"How disease spreads across space is well studied, but how the topology of spatial networks shapes host-parasite evolution is less understood. Host-parasite interactions unfold across spatial networks in which populations differ in the number of neighbours, yet most theory has focused on regular networks such as grids. Here, we embed a multilocus gene-for-gene infection model into a metapopulation to investigate host-parasite coevolution across empirically inspired and synthetic spatial networks. We find that variation in the number of neighbours generates spatial variation in local host density and parasite prevalence, creating a network-wide mosaic of ecological conditions for selection. Greater variation in the number of neighbours, or higher degree heterogeneity, promotes the evolution of host resistance. The same degree heterogeneity leads to reduced parasite infectivity in well-connected patches versus higher infectivity in patches with fewer neighbours. Both outcomes arise because populations with fewer neighbours experience net host outflux and reduced prevalence, whereas populations with more neighbours accumulate hosts and experience different selective pressures. Dispersal both drives and homogenises host resistance across the network, while maintaining spatial structure in parasite infectivity. We here identify a topology-epidemiology-evolution feedback impacting coevolution even when populations experience identical environmental conditions. Across network types, coevolutionary outcomes are driven by the network's degree heterogeneity, which can be quantified using the Herfindahl-Hirschman Index in real landscapes. Our results provide testable predictions for how changes in network topology can shape the evolution of host resistance and parasite infectivity.","rel_num_authors":5,"rel_authors":[{"author_name":"Saismit Naik","author_inst":"University of Montpellier"},{"author_name":"Jhelam N. Deshpande","author_inst":"University of California San Diego"},{"author_name":"Iago Bonnici","author_inst":"CNRS"},{"author_name":"Oliver Kaltz","author_inst":"Institut des Sciences de l'Evolution"},{"author_name":"Emanuel A. Fronhofer","author_inst":"ISEM, University of Montpellier, CNRS, IRD, EPHE,"}],"rel_date":"2026-11-19","rel_site":"biorxiv"},{"rel_title":"Hybrid Video and Instance Segmentation for Surgical Scene Understanding in Robotic Mitral Valve Surgery","rel_doi":"10.64898\/2026.11.16.26367936","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26367936","rel_abs":"ObjectiveArtificial intelligence-based surgical scene segmentation is fundamental to surgical scene understanding. However, the optimal segmentation strategy for robotic cardiac surgery remains unknown. We developed and evaluated a hybrid segmentation framework combining Mask R-CNN and Segment Anything Model 2 (SAM2) for surgical scene recognition during the entry phase of robotic mitral valve surgery.\n\nMethodsIntraoperative videos from ten robotic mitral valve operations performed at two institutions were analyzed. Seven anatomical structures and surgical object classes (ascending aorta, diaphragm, lung, pericardium, right atrium, robotic arms, and sutures) were manually annotated from 2172 image frames. We created three patient-level training, validation, and test splits after ruling out any split where an object class was completely missing from validation or test. Three segmentation approaches were compared: Mask R-CNN, Mask R-CNN-prompted SAM2 for all seven classes, and a hybrid late-fusion model combining SAM2 for anatomical structures and Mask R-CNN for robotic arms and sutures. Model performance was assessed using pixel accuracy, mean intersection over union (IoU), and Dice score.\n\nResultsAcross the three patient-level splits, the hybrid late-fusion model achieved the highest average overall segmentation performance, with pixel accuracy of 0.79-0.91, mean IoU of 0.64-0.74, and mean Dice of 0.76-0.84. At the object level, late-fusion Dice scores across the three splits were 0.86-0.96 for aorta, 0.38-0.90 for diaphragm, 0.77-0.92 for lung, 0.48-0.77 for pericardium, 0.68-0.90 for right atrium, 0.95-0.97 for robotic arms, and 0.66-0.76 for sutures. Mask R-CNN-prompted SAM2 outperformed Mask R-CNN for the aorta in all three splits and for the lung, pericardium, diaphragm, and right atrium in two of three splits, whereas Mask R-CNN was more reliable for sutures, including Dice scores of 0.76 vs 0.21 and 0.66 vs 0.53 in Splits 2 and 3. By combining prompted SAM2 for anatomy with Mask R-CNN for robotic arms and sutures, late fusion achieved the highest mean Dice in two of three splits (0.84 and 0.76) and the highest mean Dice averaged across all three splits; all-object SAM2 propagation performed slightly better in the remaining split (0.81 vs 0.80).\n\nConclusionsA hybrid segmentation framework combining SAM2 and Mask R-CNN achieved the highest overall segmentation performance in two of three patient-level splits and performed comparably to the best-performing model in the remaining split. These findings suggest that object-specific hybrid segmentation strategies may improve surgical scene segmentation during robotic mitral valve surgery.","rel_num_authors":15,"rel_authors":[{"author_name":"Christina Waldron","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Rohit Ravindra Gulve","author_inst":"Yale School of Medicine"},{"author_name":"Nikhil Bhasin","author_inst":"Yale University"},{"author_name":"Zaid Al-Shoha","author_inst":"Cornell University"},{"author_name":"Heidi Eren","author_inst":"Columbia University"},{"author_name":"Nashita Bhuiyan","author_inst":"New York University"},{"author_name":"Mina Zaky","author_inst":"Yale University School of Medicine"},{"author_name":"Danial Ahmad","author_inst":"Yale University - MEDSUR Cardiac-Adult Cardiac"},{"author_name":"Viswajit Kandula","author_inst":"Columbia University Vagelos College of Physicians and Surgeons"},{"author_name":"Sriharsha Talapaneni","author_inst":"Yale University - MEDSUR Cardiac-Adult Cardiac"},{"author_name":"Ebony Jernigan","author_inst":"Yale University - MEDSUR Surgical Education"},{"author_name":"Marc Pelletier","author_inst":"Yale University - MEDSUR Cardiac-Adult Cardiac"},{"author_name":"Nasir Rahim","author_inst":"Yale University - MEDSUR Cardiac-Adult Cardiac"},{"author_name":"Arnar Geirsson","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Makoto Mori","author_inst":"Yale School of Medicine"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Hybrid Video and Instance Segmentation for Surgical Scene Understanding in Robotic Mitral Valve Surgery","rel_doi":"10.64898\/2026.11.16.26367936","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26367936","rel_abs":"ObjectiveArtificial intelligence-based surgical scene segmentation is fundamental to surgical scene understanding. However, the optimal segmentation strategy for robotic cardiac surgery remains unknown. We developed and evaluated a hybrid segmentation framework combining Mask R-CNN and Segment Anything Model 2 (SAM2) for surgical scene recognition during the entry phase of robotic mitral valve surgery.\n\nMethodsIntraoperative videos from ten robotic mitral valve operations performed at two institutions were analyzed. Seven anatomical structures and surgical object classes (ascending aorta, diaphragm, lung, pericardium, right atrium, robotic arms, and sutures) were manually annotated from 2172 image frames. We created three patient-level training, validation, and test splits after ruling out any split where an object class was completely missing from validation or test. Three segmentation approaches were compared: Mask R-CNN, Mask R-CNN-prompted SAM2 for all seven classes, and a hybrid late-fusion model combining SAM2 for anatomical structures and Mask R-CNN for robotic arms and sutures. Model performance was assessed using pixel accuracy, mean intersection over union (IoU), and Dice score.\n\nResultsAcross the three patient-level splits, the hybrid late-fusion model achieved the highest average overall segmentation performance, with pixel accuracy of 0.79-0.91, mean IoU of 0.64-0.74, and mean Dice of 0.76-0.84. At the object level, late-fusion Dice scores across the three splits were 0.86-0.96 for aorta, 0.38-0.90 for diaphragm, 0.77-0.92 for lung, 0.48-0.77 for pericardium, 0.68-0.90 for right atrium, 0.95-0.97 for robotic arms, and 0.66-0.76 for sutures. Mask R-CNN-prompted SAM2 outperformed Mask R-CNN for the aorta in all three splits and for the lung, pericardium, diaphragm, and right atrium in two of three splits, whereas Mask R-CNN was more reliable for sutures, including Dice scores of 0.76 vs 0.21 and 0.66 vs 0.53 in Splits 2 and 3. By combining prompted SAM2 for anatomy with Mask R-CNN for robotic arms and sutures, late fusion achieved the highest mean Dice in two of three splits (0.84 and 0.76) and the highest mean Dice averaged across all three splits; all-object SAM2 propagation performed slightly better in the remaining split (0.81 vs 0.80).\n\nConclusionsA hybrid segmentation framework combining SAM2 and Mask R-CNN achieved the highest overall segmentation performance in two of three patient-level splits and performed comparably to the best-performing model in the remaining split. These findings suggest that object-specific hybrid segmentation strategies may improve surgical scene segmentation during robotic mitral valve surgery.","rel_num_authors":15,"rel_authors":[{"author_name":"Christina Waldron","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Rohit Ravindra Gulve","author_inst":"Yale School of Medicine"},{"author_name":"Nikhil Bhasin","author_inst":"Yale University"},{"author_name":"Zaid Al-Shoha","author_inst":"Cornell University"},{"author_name":"Heidi Eren","author_inst":"Columbia University"},{"author_name":"Nashita Bhuiyan","author_inst":"New York University"},{"author_name":"Mina Zaky","author_inst":"Yale University School of Medicine"},{"author_name":"Danial Ahmad","author_inst":"Yale University - MEDSUR Cardiac-Adult Cardiac"},{"author_name":"Viswajit Kandula","author_inst":"Columbia University Vagelos College of Physicians and Surgeons"},{"author_name":"Sriharsha Talapaneni","author_inst":"Yale University - MEDSUR Cardiac-Adult Cardiac"},{"author_name":"Ebony Jernigan","author_inst":"Yale University - MEDSUR Surgical Education"},{"author_name":"Marc Pelletier","author_inst":"Yale University - MEDSUR Cardiac-Adult Cardiac"},{"author_name":"Nasir Rahim","author_inst":"Yale University - MEDSUR Cardiac-Adult Cardiac"},{"author_name":"Arnar Geirsson","author_inst":"Columbia University Irving Medical Center"},{"author_name":"Makoto Mori","author_inst":"Yale School of Medicine"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Combined genome-wide association studies in humans and cattle: Cross-species genetic insights into dizygotic twinning","rel_doi":"10.64898\/2026.11.16.26367253","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26367253","rel_abs":"To leverage independent genetic evidence from multiple species, we developed a cross-species gene-based GWAS meta-analysis framework and applied this to Dizygotic Twinning (DZT) in humans and cattle. After meta-analysis within species, we converted human and cattle GWAS summary statistics to gene-level association signals within each species, mapped genes across species through human-cattle orthology, and then combined gene-level evidence for orthologous genes across the two species. DZT is defined as giving birth to multiple offspring after a single pregnancy resulting from spontaneous multiple ovulation. In humans, DZT occurs in about 1% of pregnancies with heritability estimates of 20% to 30% whilst in cattle DZT occurs in 1-5% of pregnancies and heritability is estimated at about 11%. Here, we present the largest human GWAS meta-analysis including data from 1,395,285 participants. We identified 16 genetic regions of interest, including 12 independent loci from the SNP based analyses and 4 genes identified in the gene-based MAGMA analyses. Among the prioritized genes are follicle stimulation hormone receptor (FSHR) and growth differentiation factor 9 (GDF9), that both are involved in ovarian folliculogenesis. Cattle GWAS summary statistics were based on data from 2,656 Irish Holstein bulls with estimated breeding values for predisposition to twinning based on 2,238,936 birth records, and 86,391 German Holstein dams. After combining the gene-level analyses for 13,225 genes mapped as orthologous across the human and cattle data we identify FSHR as a central locus for DZT in both humans and cattle. We find evidence of additional associations, including ACVR2A, which plays a role in embryonic implantation and TUFM, which has previously been implicated in premature ovarian insufficiency. Our approach provides a promising framework for future cross-species comparative GWAS studies. It shows benefits for gene discovery and gene prioritization and in our application expands available functional follow-up data, allowing us to leverage cattle eQTL data to resolve human GWAS loci. The method and underlying philosophy presented here are transferable to other shared phenotypes across several species.","rel_num_authors":64,"rel_authors":[{"author_name":"Nikki Hubers","author_inst":"National Centre for Registry Based Research, Aarhus University, Aarhus, Denmark; The SMARTBiomed Pioneer Centre, Aarhus University, Aarhus, Denmark"},{"author_name":"Marijn Schipper","author_inst":"Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, the Neth"},{"author_name":"Scott Gordon","author_inst":"QIMR Berghofer Medical Research Institute"},{"author_name":"Jaakko Leinonen","author_inst":"FIMM, HiLife, University of Helsinki, Finland"},{"author_name":"Arni Gunnarsson","author_inst":"deCODE Genetics"},{"author_name":"Christian M Page","author_inst":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway; Department of Physical Health and Aging, Norwegian Institute of Public Heal"},{"author_name":"Marianne Nygaard","author_inst":"The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense, Denmark"},{"author_name":"Charlotte KL Pahnke","author_inst":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany"},{"author_name":"Robert Karlsson","author_inst":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"author_name":"Teemu Palviainen","author_inst":"FIMM, HiLife, University of Helsinki, Finland"},{"author_name":"Jamee M Berg","author_inst":"Dept. of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center"},{"author_name":"Tanguy Rubat du Merac","author_inst":"Human Genetics Ph.D. Program, Vanderbilt School of Medicine, Vanderbilt University, Nashville, TN, USA; Department of Otolaryngology - Head & Neck Surgery, Vand"},{"author_name":"Kaito Kawakami","author_inst":"Social, Genetic and Developmental Psychiatry Centre, King's College London"},{"author_name":"Wangjingyi Liao","author_inst":"Queen Mary University of London"},{"author_name":"Elham Assary","author_inst":"King's College London"},{"author_name":"Maryam Kazemi Naeini","author_inst":"Department of Twin Research, Kings College London"},{"author_name":"Martje Bos","author_inst":"Department of Psychiatry, University of Groningen, University Medical Center Groningen, The Netherlands"},{"author_name":"Ilja M Nolte","author_inst":"Department of Epidemiology, University of Groningen, University Medical Center Groningen, The Netherlands"},{"author_name":"Peter J van der Most","author_inst":"Department of Epidemiology, University of Groningen, University Medical Center Groningen, The Netherlands"},{"author_name":"- Lifelines Cohort Study and Biobank","author_inst":""},{"author_name":"Scott Gallagher","author_inst":"Harvard Medical School, Harvard University"},{"author_name":"Samantha LP Schilit","author_inst":"Harvard Medical School, Harvard University, Brigham and Womens Hospital, Boston"},{"author_name":"Anastasia A. Goula","author_inst":"Amsterdam University Medical Center"},{"author_name":"Yuri Milaneschi","author_inst":"Amsterdam UMC - VUMC location: Amsterdam UMC Locatie VUmc"},{"author_name":"Rene Pool","author_inst":"Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands, Amsterdam public health research institute, Amsterdam, the Nether"},{"author_name":"Jenny van Dongen","author_inst":"Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands, Amsterdam Reproduction & Development research institute, Amsterda"},{"author_name":"Christiaan de Leeuw","author_inst":"Vrije Universiteit Amsterdam"},{"author_name":"Jeffrey Beck","author_inst":"Avera McKennan Hospital & University Health Center, Sioux Falls, South Dakota, USA."},{"author_name":"Erik Ehli","author_inst":"Avera McKennan Hospital & University Health Center, Sioux Falls, South Dakota, USA."},{"author_name":"Vera Fuentes-Moreno","author_inst":"Institute of Parasitology and Biomedicine Lopez-Neyra, CSIC, Granada, Spain"},{"author_name":"Emma Vlasiuk","author_inst":"Department of Pathology and Molecular Medicine, University of Otago, Christchurch, New Zealand"},{"author_name":"Yoon Mi Hur","author_inst":"Kookmin University, Seongbok-gu, Seoul, KR"},{"author_name":"Bruno REVERSADE","author_inst":"GIS, A*STAR"},{"author_name":"Velja Mijatovic","author_inst":"Department of Reproductive Medicine, Amsterdam UMC, The Netherlands"},{"author_name":"Claudio D Stern","author_inst":"Department of Cell & Developmental Biology, University College London, Gower Street, London WC1E 6BT, U.K."},{"author_name":"Harold Snieder","author_inst":"Department of Epidemiology, University of Groningen, University Medical Center Groningen, The Netherlands"},{"author_name":"Kaare Christensen","author_inst":"The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense, Denmark;Department of Clinical Genetics, Odense University Hospit"},{"author_name":"Frances MK Williams","author_inst":"King's College London"},{"author_name":"Robert Plomin","author_inst":"Social, Genetic and Developmental Psychiatry Centre, King's College London"},{"author_name":"Miina Ollikainen","author_inst":"FIMM, HiLife, University of Helsinki, Finland & Minerva Foundation Institute for Medical Research, Helsinki, Finland"},{"author_name":"Patrik KE Magnusson","author_inst":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"author_name":"Mirko Ruks","author_inst":"Faculty of Sociology, Bielefeld University, Bielefeld, Germany"},{"author_name":"Carlo Maj","author_inst":"Centre for Human Genetics, University of Marburg, Marburg, Germany   Institute for Genomic Statistics and Bioinformatics, University of Bonn, Bonn,  Germany"},{"author_name":"Christian Kandler","author_inst":"Faculty of Psychology and Sports Sciences, Department of Psychology, Bielefeld University, Bielefeld Germany"},{"author_name":"Andreas J Forstner","author_inst":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany; Institute of Neuroscience and Medicine (INM-1), R"},{"author_name":"Cynthia Casson Morton","author_inst":"Brigham and Women's Hospital"},{"author_name":"Daniel I. Chasman","author_inst":"Brigham and Women's Hospital and Harvard Medical School"},{"author_name":"William Iacono","author_inst":"Department of Psychology, University of Minnesota"},{"author_name":"Jennifer R Harris","author_inst":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway"},{"author_name":"Taru Tukiainen","author_inst":"Institute for Molecular Medicine Finland"},{"author_name":"Martin A Kennedy","author_inst":"University of Otago, Christchurch"},{"author_name":"Gonneke Willemsen","author_inst":"Faculty of Health, Sports and Social Work, Inholland University of Applied Sciences, Haarlem, the Netherlands; Amsterdam Reproduction & Development Research Ins"},{"author_name":"Cornelis B Lambalk","author_inst":"Amsterdam Reproduction & Development research institute, Amsterdam, the Netherlands"},{"author_name":"Hreinn Stefansson","author_inst":"deCODE Genetics"},{"author_name":"Jaakko Kaprio","author_inst":"University of Helsinki\/FIMM"},{"author_name":"Grant W Montgomery","author_inst":"The Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia."},{"author_name":"Jouke Jan Hottenga","author_inst":"Neurological Disorder Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha P.O. Box 5825, Qa"},{"author_name":"Hamdi Mbarek","author_inst":"Qatar Genome, Doha, Qatar"},{"author_name":"Christin Schmidtmann","author_inst":"IT Solutions for Animal Production w.V. (vit), Verden, Germany"},{"author_name":"Laura Huneke","author_inst":"IT Solutions for Animal Production w.V. (vit), Verden, Germany"},{"author_name":"Donnagh P Berry","author_inst":"Teagasc, Animal & Grassland Research and Innovation Centre, Moorepark, Fermoy, Co. Cork, P61 P302, Ireland."},{"author_name":"Brian W Kirkpatrick","author_inst":"Department of Animal and Dairy Science, University of Wisconsin-Madison, Madison, WI, USA"},{"author_name":"Nicholas G Martin","author_inst":"QIMR Berghofer Medical Research Institute"},{"author_name":"Dorret I Boomsma","author_inst":"Department of complex traits Genetics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands, Amsterdam Reproduction & Development research institute, Amster"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Combined genome-wide association studies in humans and cattle: Cross-species genetic insights into dizygotic twinning","rel_doi":"10.64898\/2026.11.16.26367253","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26367253","rel_abs":"To leverage independent genetic evidence from multiple species, we developed a cross-species gene-based GWAS meta-analysis framework and applied this to Dizygotic Twinning (DZT) in humans and cattle. After meta-analysis within species, we converted human and cattle GWAS summary statistics to gene-level association signals within each species, mapped genes across species through human-cattle orthology, and then combined gene-level evidence for orthologous genes across the two species. DZT is defined as giving birth to multiple offspring after a single pregnancy resulting from spontaneous multiple ovulation. In humans, DZT occurs in about 1% of pregnancies with heritability estimates of 20% to 30% whilst in cattle DZT occurs in 1-5% of pregnancies and heritability is estimated at about 11%. Here, we present the largest human GWAS meta-analysis including data from 1,395,285 participants. We identified 16 genetic regions of interest, including 12 independent loci from the SNP based analyses and 4 genes identified in the gene-based MAGMA analyses. Among the prioritized genes are follicle stimulation hormone receptor (FSHR) and growth differentiation factor 9 (GDF9), that both are involved in ovarian folliculogenesis. Cattle GWAS summary statistics were based on data from 2,656 Irish Holstein bulls with estimated breeding values for predisposition to twinning based on 2,238,936 birth records, and 86,391 German Holstein dams. After combining the gene-level analyses for 13,225 genes mapped as orthologous across the human and cattle data we identify FSHR as a central locus for DZT in both humans and cattle. We find evidence of additional associations, including ACVR2A, which plays a role in embryonic implantation and TUFM, which has previously been implicated in premature ovarian insufficiency. Our approach provides a promising framework for future cross-species comparative GWAS studies. It shows benefits for gene discovery and gene prioritization and in our application expands available functional follow-up data, allowing us to leverage cattle eQTL data to resolve human GWAS loci. The method and underlying philosophy presented here are transferable to other shared phenotypes across several species.","rel_num_authors":64,"rel_authors":[{"author_name":"Nikki Hubers","author_inst":"National Centre for Registry Based Research, Aarhus University, Aarhus, Denmark; The SMARTBiomed Pioneer Centre, Aarhus University, Aarhus, Denmark"},{"author_name":"Marijn Schipper","author_inst":"Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, the Neth"},{"author_name":"Scott Gordon","author_inst":"QIMR Berghofer Medical Research Institute"},{"author_name":"Jaakko Leinonen","author_inst":"FIMM, HiLife, University of Helsinki, Finland"},{"author_name":"Arni Gunnarsson","author_inst":"deCODE Genetics"},{"author_name":"Christian M Page","author_inst":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway; Department of Physical Health and Aging, Norwegian Institute of Public Heal"},{"author_name":"Marianne Nygaard","author_inst":"The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense, Denmark"},{"author_name":"Charlotte KL Pahnke","author_inst":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany"},{"author_name":"Robert Karlsson","author_inst":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"author_name":"Teemu Palviainen","author_inst":"FIMM, HiLife, University of Helsinki, Finland"},{"author_name":"Jamee M Berg","author_inst":"Dept. of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center"},{"author_name":"Tanguy Rubat du Merac","author_inst":"Human Genetics Ph.D. Program, Vanderbilt School of Medicine, Vanderbilt University, Nashville, TN, USA; Department of Otolaryngology - Head & Neck Surgery, Vand"},{"author_name":"Kaito Kawakami","author_inst":"Social, Genetic and Developmental Psychiatry Centre, King's College London"},{"author_name":"Wangjingyi Liao","author_inst":"Queen Mary University of London"},{"author_name":"Elham Assary","author_inst":"King's College London"},{"author_name":"Maryam Kazemi Naeini","author_inst":"Department of Twin Research, Kings College London"},{"author_name":"Martje Bos","author_inst":"Department of Psychiatry, University of Groningen, University Medical Center Groningen, The Netherlands"},{"author_name":"Ilja M Nolte","author_inst":"Department of Epidemiology, University of Groningen, University Medical Center Groningen, The Netherlands"},{"author_name":"Peter J van der Most","author_inst":"Department of Epidemiology, University of Groningen, University Medical Center Groningen, The Netherlands"},{"author_name":"- Lifelines Cohort Study and Biobank","author_inst":""},{"author_name":"Scott Gallagher","author_inst":"Harvard Medical School, Harvard University"},{"author_name":"Samantha LP Schilit","author_inst":"Harvard Medical School, Harvard University, Brigham and Womens Hospital, Boston"},{"author_name":"Anastasia A. Goula","author_inst":"Amsterdam University Medical Center"},{"author_name":"Yuri Milaneschi","author_inst":"Amsterdam UMC - VUMC location: Amsterdam UMC Locatie VUmc"},{"author_name":"Rene Pool","author_inst":"Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands, Amsterdam public health research institute, Amsterdam, the Nether"},{"author_name":"Jenny van Dongen","author_inst":"Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands, Amsterdam Reproduction & Development research institute, Amsterda"},{"author_name":"Christiaan de Leeuw","author_inst":"Vrije Universiteit Amsterdam"},{"author_name":"Jeffrey Beck","author_inst":"Avera McKennan Hospital & University Health Center, Sioux Falls, South Dakota, USA."},{"author_name":"Erik Ehli","author_inst":"Avera McKennan Hospital & University Health Center, Sioux Falls, South Dakota, USA."},{"author_name":"Vera Fuentes-Moreno","author_inst":"Institute of Parasitology and Biomedicine Lopez-Neyra, CSIC, Granada, Spain"},{"author_name":"Emma Vlasiuk","author_inst":"Department of Pathology and Molecular Medicine, University of Otago, Christchurch, New Zealand"},{"author_name":"Yoon Mi Hur","author_inst":"Kookmin University, Seongbok-gu, Seoul, KR"},{"author_name":"Bruno REVERSADE","author_inst":"GIS, A*STAR"},{"author_name":"Velja Mijatovic","author_inst":"Department of Reproductive Medicine, Amsterdam UMC, The Netherlands"},{"author_name":"Claudio D Stern","author_inst":"Department of Cell & Developmental Biology, University College London, Gower Street, London WC1E 6BT, U.K."},{"author_name":"Harold Snieder","author_inst":"Department of Epidemiology, University of Groningen, University Medical Center Groningen, The Netherlands"},{"author_name":"Kaare Christensen","author_inst":"The Danish Twin Registry, Department of Public Health, University of Southern Denmark, Odense, Denmark;Department of Clinical Genetics, Odense University Hospit"},{"author_name":"Frances MK Williams","author_inst":"King's College London"},{"author_name":"Robert Plomin","author_inst":"Social, Genetic and Developmental Psychiatry Centre, King's College London"},{"author_name":"Miina Ollikainen","author_inst":"FIMM, HiLife, University of Helsinki, Finland & Minerva Foundation Institute for Medical Research, Helsinki, Finland"},{"author_name":"Patrik KE Magnusson","author_inst":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"author_name":"Mirko Ruks","author_inst":"Faculty of Sociology, Bielefeld University, Bielefeld, Germany"},{"author_name":"Carlo Maj","author_inst":"Centre for Human Genetics, University of Marburg, Marburg, Germany   Institute for Genomic Statistics and Bioinformatics, University of Bonn, Bonn,  Germany"},{"author_name":"Christian Kandler","author_inst":"Faculty of Psychology and Sports Sciences, Department of Psychology, Bielefeld University, Bielefeld Germany"},{"author_name":"Andreas J Forstner","author_inst":"Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany; Institute of Neuroscience and Medicine (INM-1), R"},{"author_name":"Cynthia Casson Morton","author_inst":"Brigham and Women's Hospital"},{"author_name":"Daniel I. Chasman","author_inst":"Brigham and Women's Hospital and Harvard Medical School"},{"author_name":"William Iacono","author_inst":"Department of Psychology, University of Minnesota"},{"author_name":"Jennifer R Harris","author_inst":"Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway"},{"author_name":"Taru Tukiainen","author_inst":"Institute for Molecular Medicine Finland"},{"author_name":"Martin A Kennedy","author_inst":"University of Otago, Christchurch"},{"author_name":"Gonneke Willemsen","author_inst":"Faculty of Health, Sports and Social Work, Inholland University of Applied Sciences, Haarlem, the Netherlands; Amsterdam Reproduction & Development Research Ins"},{"author_name":"Cornelis B Lambalk","author_inst":"Amsterdam Reproduction & Development research institute, Amsterdam, the Netherlands"},{"author_name":"Hreinn Stefansson","author_inst":"deCODE Genetics"},{"author_name":"Jaakko Kaprio","author_inst":"University of Helsinki\/FIMM"},{"author_name":"Grant W Montgomery","author_inst":"The Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia."},{"author_name":"Jouke Jan Hottenga","author_inst":"Neurological Disorder Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha P.O. Box 5825, Qa"},{"author_name":"Hamdi Mbarek","author_inst":"Qatar Genome, Doha, Qatar"},{"author_name":"Christin Schmidtmann","author_inst":"IT Solutions for Animal Production w.V. (vit), Verden, Germany"},{"author_name":"Laura Huneke","author_inst":"IT Solutions for Animal Production w.V. (vit), Verden, Germany"},{"author_name":"Donnagh P Berry","author_inst":"Teagasc, Animal & Grassland Research and Innovation Centre, Moorepark, Fermoy, Co. Cork, P61 P302, Ireland."},{"author_name":"Brian W Kirkpatrick","author_inst":"Department of Animal and Dairy Science, University of Wisconsin-Madison, Madison, WI, USA"},{"author_name":"Nicholas G Martin","author_inst":"QIMR Berghofer Medical Research Institute"},{"author_name":"Dorret I Boomsma","author_inst":"Department of complex traits Genetics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands, Amsterdam Reproduction & Development research institute, Amster"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Limited English Proficiency and Rates of Dilated Eye Examinations Among U.S. Adults with Diabetes","rel_doi":"10.64898\/2026.11.16.26368231","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368231","rel_abs":"PurposeTo determine whether English proficiency is associated with diabetic retinopathy screening rates among patients with diabetes in the United States.\n\nDesignA retrospective, cross-sectional study.\n\nParticipantsIndividuals with diabetes who responded to the Medicare Expenditure Panel Survey (MEPS), a nationally representative survey of U.S. households (2013-2022).\n\nMethodsSurvey-weighted, multivariable logistic regression.\n\nMain Outcome MeasuresAdjusted odds ratio (aOR) of 1) having ever received a dilated fundus examination (DFE) and 2) having received consecutive year DFEs.\n\nResultsThe analytic sample included 11,441 respondents representing a weighted sample of 15,107,166 U.S. civilians with diabetes per year from 2013-2022. The mean age was 62 years (SD: 14 years), and 50% were female. Individuals with limited English proficiency (LEP) comprised 11.6% of the cohort. Respondents with LEP had lower odds of ever having received a DFE compared to English-proficient respondents (aOR=0.729, 95% CI: 0.541-0.976). The association between having consecutive year DFEs and English proficiency was non-significant (aOR=1.189, 95% CI: 0.917-1.541). In sensitivity analyses using a definition of LEP as speaking English less than \"well,\" LEP was associated with lower odds of ever having a DFE (aOR=0.632, 95% CI: 0.460-0.869) and higher odds of consecutive year exams (aOR=1.415, 95% CI: 1.057-1.896).\n\nConclusionsLEP status was associated with lower odds of ever having had a DFE and equal or greater odds of having consecutive year DFEs. Efforts to reduce language-related disparities for patients with LEP should focus on improving initial access to ophthalmologic care.","rel_num_authors":3,"rel_authors":[{"author_name":"Stanley Z Lam","author_inst":"Weill Cornell Medicine"},{"author_name":"Emily Xing","author_inst":"Weill Cornell Medicine"},{"author_name":"Grace Sun","author_inst":"Weill Cornell Medicine"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Modifiable and Context-Specific Factors Associated with Dementia in the Democratic Republic of the Congo: A Community-Derived Cross-Sectional Study","rel_doi":"10.64898\/2026.11.16.26368211","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368211","rel_abs":"Background: Evidence linking social, behavioral, and environmental factors to dementia in Central Africa remains limited. Objective: To examine associations between 16 factors and dementia status in the Democratic Republic of the Congo (DRC), and quantify incremental model fit beyond age and sex. Methods: This cross sectional analysis included 721 participants (232 cognitively unimpaired; 489 with dementia, including 247 with suspected Alzheimers disease). Logistic regression jointly modeled 16 factors, age, sex, and missing-category indicators. Continuous covariates with missing values were mean-imputed and standardized. Model fit was assessed using Nagelkerke pseudo R squared, likelihood-ratio testing, and 1,000 bootstrap replicates. Results: Nagelkerke pseudo-R2 increased from 0.106 with age and sex to 0.368 after adding the factors (change in R2 = 0.262; bootstrap 95% CI: 0.241-0.371; chi-square(27) = 163.62, p < 0.001). Poverty (adjusted odds ratio [aOR] = 2.34, 95% CI: 1.52-3.60), low resilience (aOR = 1.84, 95% CI: 1.18-2.86), and depression (aOR = 1.53, 95% CI: 1.02-2.31) were associated with higher dementia odds. Higher education (aOR = 0.51, 95% CI: 0.39-0.66, per standard deviation increase) and obesity (aOR = 0.31, 95% CI: 0.10-0.90) showed inverse associations; obesity data were 79.9% missing. Alcohol consumption and PM2.5 exposure were not significantly associated with dementia. Conclusions: Poverty, lower resilience, depression, and education were associated with dementia status in this nonrepresentative cohort. Incremental model fit does not quantify preventable dementia burden, and causality cannot be inferred from these cross-sectional data.","rel_num_authors":16,"rel_authors":[{"author_name":"Jean Ikanga","author_inst":"Emory University School of Medicine, Department of Rehabilitation Medicine, Atlanta, GA 30322, USA; University of Kinshasa and Catholic University of Congo, Sch"},{"author_name":"Saranya Sundaram Patel","author_inst":"Emory University School of Medicine, Department of Rehabilitation Medicine, Atlanta, GA 30322, USA; One Rehab, Dallas, TX, USA"},{"author_name":"Peng Zhang","author_inst":"Emory University School of Medicine, Department of Human Genetics, Atlanta, GA 30322, USA"},{"author_name":"Jingjing Yang","author_inst":"Emory University School of Medicine, Department of Human Genetics, Atlanta, GA 30322, USA"},{"author_name":"Caterina Obenauf","author_inst":"Emory University School of Medicine, Department of Rehabilitation Medicine, Atlanta, GA 30322, USA; University of Tennessee, Department of Psychology and Neuros"},{"author_name":"Guy Gikelekele","author_inst":"University of Kinshasa and Catholic University of Congo, School of Medicine, Department of Psychiatry, Kinshasa, Democratic Republic of the Congo"},{"author_name":"Emmanuel Epenge","author_inst":"University of Kinshasa, Department of Neurology, Kinshasa, Democratic Republic of the Congo; Protestant University of Congo, School of Medicine, Kinshasa, Democ"},{"author_name":"Japhet Magolu Potshi","author_inst":"University of Kinshasa, Department of Neurology, Kinshasa, Democratic Republic of the Congo"},{"author_name":"Topina Tomadia","author_inst":"Memory Clinic of Kinshasa, Kinshasa, Democratic Republic of the Congo"},{"author_name":"Joseph Phuati Tsangu","author_inst":"University of Kinshasa, Department of Anesthesiology and Reanimation, Kinshasa, Democratic Republic of the Congo"},{"author_name":"Samuel Mampunza","author_inst":"University of Kinshasa and Catholic University of Congo, School of Medicine, Department of Psychiatry, Kinshasa, Democratic Republic of the Congo; Protestant Un"},{"author_name":"Lelo Mananga","author_inst":"University of Kinshasa, Department of Neurology, Kinshasa, Democratic Republic of the Congo"},{"author_name":"Justine Bukabau","author_inst":"University of Kinshasa, Department of Internal Medicine, Kinshasa, Democratic Republic of the Congo"},{"author_name":"Thomas Karikari","author_inst":"University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, USA"},{"author_name":"Alden L. Gross","author_inst":"Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD, USA"},{"author_name":"Alvaro Alonso","author_inst":"University of Navarra, School of Medicine, Department of Preventive Medicine and Public Health, Pamplona, Spain"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Genetic, Hormonal, and Psychosocial Factors Underly Sex Differences in Psychotic-Like Experience Trajectories in Adolescence","rel_doi":"10.64898\/2026.11.16.26368188","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368188","rel_abs":"Psychotic-like experiences (PLEs) are common during adolescence (prevalence: 17-60%), however, sex differences in the biopsychosocial factors associated with PLEs, particularly pubertal development and sex hormones, and PLE trajectories remains less understood. Here, we leverage data from the Adolescent Brain Cognitive Development (ABCD) Study to examine genetic, psychosocial, and hormonal correlates of PLE risk and persistence in 7,870 adolescents reporting at least one PLE across baseline to year 3 follow-up. Among individuals of European ancestry, higher genetic risk for schizophrenia was positively associated with PLEs. Sex stratified multivariate linear regression analyses revealed sex-specific differences in associations between social factors and the outcome, with parent acceptance ({beta} = -0.09, p = 2.47x10-02 in males; {beta} = -0.44, p = 1.5x10-20 in females) and overt aggression ({beta} = 0.038, p = 1.67x10-02 in males; {beta} = -0.081, p = 1.53x10-05 in females) showing differing directions and magnitudes of effect in males and females. Pubertal development in males and females and age of menarche are associated with PLE risk, while mediation analyses identified estradiol in females as a mediator of the association between puberty and PLEs in premenarchal females. Lastly, multivariate logistic regression analyses and Analysis of Variance showed that higher exposure to psychosocial risk factors, such as discrimination (OR = 1.47, p = 1.11x10-04) and social victimization (OR = 1.05, p = 2.02x10-02), earlier pubertal development, and earlier age of menarche predict membership to the persistent PLE trajectory. These findings highlight sex- specific social correlates of adolescent PLEs and implicate pubertal timing and hormonal pathways in PLE risk and persistence. Understanding how genetic, social, and biological factors jointly shape PLE trajectories may help inform early identification of psychosis risk.","rel_num_authors":7,"rel_authors":[{"author_name":"Cara Ly","author_inst":"Yale University School of Medicine"},{"author_name":"Chaoyu Liu","author_inst":"Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London"},{"author_name":"Julia Ciarcia","author_inst":"Yale University School of Medicine"},{"author_name":"Seoyeon Lee","author_inst":"Yale University School of Medicine"},{"author_name":"Keira J.A. Johnston","author_inst":"Yale"},{"author_name":"Adrianna P Kepinska","author_inst":"Cardiff University"},{"author_name":"Laura M Huckins","author_inst":"University of Bath"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Widening racial and ethnic disparities in Helicobacter pylori infection in the United States: a Bayesian meta-analytic catalytic model of age-specific forces of infection","rel_doi":"10.64898\/2026.11.16.26367144","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26367144","rel_abs":"BackgroundHelicobacter pylori is the main cause of non-cardia gastric cancer. In the U.S. H. pylori seroprevalence has declined. However, whether all subgroups have benefited equally from this change is unclear. Further, prevalence alone cannot indicate when infection risk is most acute and thus when to target prevention efforts like screening.\n\nMethodsWe synthesized age-stratified H. pylori seroprevalence data from 36 U.S. studies (N=56,845; 1965-2014), identified via literature search through September 2022. We fitted Bayesian hierarchical catalytic epidemic models to estimate, by race\/ethnicity (for each of five race\/ethnicity groups) and birth cohort (pre-1960 vs. 1960+, or continuous), the maximum proportion infected, age-specific force of infection (FOI), and the age at half-maximum seroprevalence.\n\nFindingsDisparities in maximum prevalence worsened in the 1960+ birth cohort, with the absolute Hispanic-Non-Hispanic White (NHW) gap widening from 33.2 to 51.4 percentage points. FOIs peaked at the youngest ages for the Non-Hispanic American Indian\/Alaska Native (AI\/AN) and Non-Hispanic Black (NHB) populations. Age patterns varied independently of burden; Hispanic and AI\/AN populations reached similar peak prevalence (83.0% vs 76.1%) for the 1960+ birth cohort, yet the age at half-maximum seroprevalence was 19.3 years (95%CrI: 14.9, 23.5) vs 3.20 years (95%CrI: 1.99, 4.63). Continuous birth-cohort analyses supported these findings.\n\nInterpretationNational declines in H. pylori mask widening racial and ethnic disparities. In AI\/AN and NHB populations, seroprevalence rises steeply in early childhood, well before adulthood-targeted screen-and-treat programs would intervene. Moreover, similar peak prevalence can mask different age patterns of infection, and should be accounted for when guiding prevention strategies.\n\nFundingNational Cancer Institute U01CA265729 and U01CA319219\n\nResearch in ContextO_ST_ABSEvidence before this studyC_ST_ABSWe used studies reporting Helicobacter pylori seroprevalence in U.S. populations from a recent systematic scoping review covering publications through 2022. Reported U.S. seroprevalence has declined over successive birth cohorts, and prevalence is consistently higher among Hispanic, Non-Hispanic Black, American Indian and Alaska Native, and Asian and Pacific Islander populations than among non-Hispanic White populations. Recent estimates mainly derive from limited populations, such as veterans or single integrated health systems. American Indian, Alaska Native, Asian, and Pacific Islander participants are also often grouped into a single \"other\" category. Catalytic epidemic models have been used to estimate age-specific force of infection for H. pylori in Mexico, Japan, and in a recent analysis of two NHANES cycles. However, none of these studies have estimated forces of infection separately for all five Surveillance, Epidemiology, and End Results program (SEER) racial and ethnic groups in the U.S. or across more than two survey periods. There has also been a lack of quantitative evidence for differences in the approximate age distribution of infection risk across race\/ethnic groups and birth cohorts and how racial disparities in infection burden have changed over time.\n\nAdded value of the studyWe applied modified catalytic epidemic models to estimate age-specific prevalence and rates of infection for each of the five race\/ethnic SEER categories and by birth cohort. To additionally probe differences in when infection is typically concentrated by race\/ethnicity and birth cohort group, we computed the age at which each group reaches half its maximum seroprevalence.\n\nOur approach pools data across distinct study sources and populations, accommodates study-specific heterogeneity and variation between race\/ethnicity groups, and improves estimates in data-limited groups. Importantly, we improve the robustness of our key findings by applying a range of model extensions that accommodate distinct latent assumptions in catalytic epidemic models, namely the fundamental nature of the relationship between forces of infection and age and birth cohort effects. Our results reaffirm notable absolute and relative disparities in predicted prevalence and the risk of infection among race\/ethnic minority groups, which have been intensified in more recent birth cohorts. We also demonstrate that infection trajectories maintain relatively distinct (early-age or later-onset) age trends across race\/ethnic groups and within the same subgroup across birth cohorts.\n\nImplications of all the available evidenceThere is an ever-increasing need for evaluating expanded screen-and-treat programs for H. pylori, as population-level declines in prevalence have concealed notable worsening disparities in burden across race\/ethnic groups. Screening strategies should be tailored to population-specific age-specific patterns in infection risk, with testing prioritized in early life where seroprevalence rises steeply in childhood, as in AI\/AN and Non-Hispanic Black populations, and at first clinical contact for immigrants from high-incidence regions, whose infections likely predate arrival.","rel_num_authors":10,"rel_authors":[{"author_name":"Tigist Menkir","author_inst":"Stanford University"},{"author_name":"Jorge Roa-Contreras","author_inst":"Stanford University"},{"author_name":"Yadira Peralta","author_inst":"Center for Research and Teaching in Economics"},{"author_name":"Chelsea Taylor","author_inst":"Boston Children's Hospital"},{"author_name":"Mercedes McMahon","author_inst":"Boston Children's Hospital"},{"author_name":"Jennifer Yeh","author_inst":"Boston Children's Hospital"},{"author_name":"M Constanza Camargo","author_inst":"National Cancer Institute"},{"author_name":"Robert Huang","author_inst":"Stanford University"},{"author_name":"Uri Ladabaum","author_inst":"Stanford University"},{"author_name":"Fernando Alarid-Escudero","author_inst":"Stanford University"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Swab-based molecular testing near the point-of-care for childhood tuberculosis: a prospective diagnostic accuracy study","rel_doi":"10.64898\/2026.11.16.26368102","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368102","rel_abs":"BackgroundSwab-based molecular testing for tuberculosis (TB) could provide a near point-of-care (nPOC) diagnostic for children. We evaluated the accuracy of two swab-based nPOC platforms to detect pediatric pulmonary TB.\n\nMethodsWe prospectively enrolled children under 15 years with presumptive TB in Uganda and South Africa. They completed TB evaluation including sputum molecular testing and culture. Two tongue swabs were collected and tested with MiniDock MTB (Pluslife Biotech, China) and Truenat MTB Ultima (Molbio Diagnostics, India), and one swab was dipped in sputum for testing with MiniDock MTB. We calculated the sensitivity and specificity of each index test against a culture-based standard and compared them with sputum molecular testing and smear microscopy.\n\nFindingsWe included 335 children, among whom median age was 3 years (IQR 1-6), 53% were female, 11% were living with HIV, and 16% had microbiologically confirmed TB. Tongue swabs were collected in all children, with invalid test rates of less than 3%. Against a culture-based standard, the sensitivities of tongue swab MiniDock MTB and MTB Ultima were 50% (95% CI 33.4-66.6) and 50% (95% CI 28.2-71.8), respectively, and specificities were [&ge;]98% for both. Sputum swab MiniDock MTB had similar sensitivity to sputum Xpert Ultra (85.7% vs. 75.0%, p=0.45), but substantially higher sensitivity than tongue swab MiniDock MTB (+23.1%, p=0.03) and sputum smear microscopy (+46.4%, p<0.001).\n\nInterpretationSputum swab testing had similar accuracy to sputum Xpert Ultra in children. Tongue swab testing had moderate accuracy, and has value to identify microbiologically confirmed cases when sputum is not available.\n\nFundingNational Institutes of Health, United States Department of State Bureau of Global Health Security and Diplomacy, and South African Medical Research Council\n\nRESEARCH IN CONTEXTO_ST_ABSEvidence before this studyC_ST_ABSWe evaluated the literature from October 2021 to October 2026 for studies in any language on oral swab molecular testing for M. tuberculosis (MTB). We included diagnostic accuracy studies and excluded work on extrapulmonary TB, screening and early assay development, and searched PubMed and Google Scholar with the terms \"swab\" AND \"tuberculosis\" AND \"diagnosis.\" Manual quantitative polymerase chain reaction (qPCR) testing on tongue swabs has high accuracy to detect pulmonary TB in adults (80-93% sensitive and >98% specificity), with similar accuracy to sputum samples. Translation to semi-automated PCR assays such as Xpert Ultra have had high specificity but variable sensitivity (59-76%). Newer assays have been developed that are designed specifically for swab testing, and are small, portable, and can be used near the point-of-care (nPOC). Studies in adults have found that nPOC tongue swab testing is feasible, sensitive (75-86%), and specific (>96%). Testing can also be performed by dipping a swab in sputum, offering higher accuracy than tongue swabs and similar performance to sputum Xpert Ultra. However, the evidence in children has been limited to Xpert Ultra tongue swab testing, with low sensitivity (7-19%).\n\nAdded value of this studyTo our knowledge, this is the first assessment of two swab-based nPOC assays for childhood TB: MiniDock MTB and MTB Ultima. In two high TB-burden settings of South Africa and Uganda, we prospectively enrolled children with presumptive TB and determined the accuracy of tongue and sputum swab testing. We found that tongue swab testing detected about half of children with culture-confirmed TB; sputum swab testing had substantially higher sensitivity than tongue swabs, and similar performance to sputum Xpert Ultra, meeting the World Health Organization (WHO) target accuracy for an nPOC sputum molecular TB test.\n\nImplications of all the available evidenceThe recent WHO guidelines endorsed sputum swab testing in adults and adolescents, and tongue swabs if sputum is not available. Similarly, we found that a single platform can enable nPOC molecular testing for TB among children, with sputum swab accuracy comparable to Xpert Ultra when sputum is available, and tongue swabs providing a simple, non-invasive approach to increase microbiological confirmation and potentially reduce delays in treatment when sputum is not available.","rel_num_authors":14,"rel_authors":[{"author_name":"Devan Jaganath","author_inst":"Department of Pediatrics, Division of Pediatric Infectious Diseases, University of California, San Francisco"},{"author_name":"Aggrey Ainebyona","author_inst":"Uganda Tuberculosis Implementation Research Consortium, WALIMU"},{"author_name":"Juaneta Luiz","author_inst":"Department of Paediatrics and Child Health, South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town"},{"author_name":"Hayley Poore","author_inst":"Department of Medicine, Division of Pulmonary Diseases and Critical Care, University of California Irvine"},{"author_name":"Denise Banze","author_inst":"Instituto Nacional de Saude (INS), Centro de Investigacao e Treino em Saude da Polana Canico (CISPOC)"},{"author_name":"Robert Castro","author_inst":"Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California San Francisco"},{"author_name":"Seda Yerlikaya","author_inst":"Heidelberg University Medical Faculty Heidelberg, Heidelberg University Hospital, Department of Infectious Disease and Tropical Medicine"},{"author_name":"Payam Nahid","author_inst":"Institute for Global Health Sciences, University of California San Francisco"},{"author_name":"Claudia Denkinger","author_inst":"Heidelberg University Medical Faculty Heidelberg, Heidelberg University Hospital, Department of Infectious Disease and Tropical Medicine"},{"author_name":"Cattamanchi Adithya","author_inst":"Department of Medicine, Division of Pulmonary Diseases and Critical Care, University of California Irvine"},{"author_name":"Celso Khosa","author_inst":"Instituto Nacional de Saude (INS), Centro de Investigacao e Treino em Saude da Polana Canico (CISPOC)"},{"author_name":"Heather J Zar","author_inst":"Department of Paediatrics and Child Health, South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town"},{"author_name":"Nilesh Bhatt","author_inst":"Elizabeth Glaser Pediatric AIDS Foundation, Washington DC"},{"author_name":"Eric Wobudeya","author_inst":"Uganda Tuberculosis Implementation Research Consortium, WALIMU"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Transparent Implementation and Benchmarking of ACMG\/AMP Variant Classification in fastVEP","rel_doi":"10.64898\/2026.11.16.26368228","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368228","rel_abs":"BackgroundThe ACMG\/AMP framework is the standard for germline sequence variant interpretation, but applying it in scalable automated software requires operational choices that the original framework and later ClinGen guidance do not always specify. We implemented an ACMG\/AMP classification engine within fastVEP and evaluated which implementation choices improved agreement with expert-curated classifications without increasing concerning opposite-direction calls.\n\nMethodsThe classifier implements all 28 ACMG\/AMP criteria and can evaluate 15 from a sites-only VCF using nine public evidence sources. For selecting the optimal classifier, we compared symmetric and hybrid evidence-combining schemes, pathogenic class cutoffs, population-frequency thresholds, and benign-evidence thresholds against 673,660 ClinVar variants with review status of two stars or higher from April 2026. Clinical geneticists reviewed opposite-direction calls. We then applied the selected final classifier unchanged to 116,078 variants that newly reached the two-star threshold in the October 2026 ClinVar release.\n\nResultsThe final fastVEP ACMG\/AMP classifier uses the Tavtigian point scale on the pathogenic side and the 2015 ACMG\/AMP combining table on the benign side. Using the 2015 table on both sides reduced pathogenic-side recall from 62.5 to 57.1 percent and lost 4,900 same-direction calls while avoiding 10 opposite-direction pathogenic calls. Using points on both sides increased benign-side recall from 66.4 to 77.0 percent, but increased opposite-direction benign calls from 27 to 399 and reduced recall of ClinVar uncertain variants from 97.1 to 69.5 percent. The 6-point Likely pathogenic cutoff was retained because lowering it to 5 points increased pathogenic-side recall to 73.9 percent but also classified 6,003 additional ClinVar uncertain variants and 17 additional ClinVar benign-side variants as pathogenic-side. The final classifier reproduced ClinVars exact five-tier class for 431,727 variants or 64.1 percent and its pathogenic, benign, or uncertain direction for 534,335 variants or 79.3 percent. Only 51 calls or 0.0076 percent were opposite in direction to ClinVar. On the later variants, same-direction agreement was 72.6 percent and 20 calls were opposite in direction.\n\nConclusionsThe rules used to combine evidence affected classification more than several individual numeric thresholds. The hybrid scheme increased pathogenic-side recall while preventing a single Supporting benign criterion from producing a directional call. This conservative operating profile is suited to large-scale variant triage because it makes high-confidence calls while leaving variants uncertain when the available evidence does not support expert-level resolution. fastVEP is a research and decision-support tool and does not replace case-specific expert review.","rel_num_authors":3,"rel_authors":[{"author_name":"Kuan-lin Huang","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Mythily Ganapathi","author_inst":"Columbia University"},{"author_name":"Wendy Chung","author_inst":"Boston Children's Hospital"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Adverse Events and Baseline Psychological Distress Among Dementia Family Care Partners in the Tele-STELLA Study","rel_doi":"10.64898\/2026.11.16.26368229","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368229","rel_abs":"BACKGROUNDAdverse event (AE) narratives may reveal physical and psychological challenges experienced by family care partners of people living with Alzheimers disease and related dementias.\n\nOBJECTIVETo characterize care partner AEs during the national Tele-STELLA study and explore differences in baseline psychological characteristics by AE category and subcategory.\n\nMETHODSThis descriptive, exploratory analysis included 43 AEs reported by 36 care partners. Narratives were classified as Physical, Psychological, or Random\/Other. Baseline depressive symptoms, grief, and behavioral reactivity were compared between care partners with and without each AE type within this sample.\n\nRESULTSPhysical events accounted for 48.8% of AEs, Psychological events for 39.5%, and Random\/Other events for 11.6%. Infections predominated among Physical events; stress\/distress accounted for half of the Psychological events and care-recipient aggression accounted for the other half of the Psychological events. Psychological AEs were associated with higher baseline grief and behavioral reactivity. Stress\/distress-related AEs were associated with higher depressive symptoms and reactivity, whereas aggression-related AEs were associated with greater grief.\n\nCONCLUSIONSCare partner AE narratives captured heterogeneous physical and psychological experiences. Classification may complement conventional assessments of care partner health and distress. These exploratory findings do not establish causality or predictive validity and warrant prospective study.\n\nCLINICAL TRIAL REGISTRY NAME, URL, AND REGISTRATION NUMBERClinicalTrials.gov, https:\/\/clinicaltrials.gov\/study\/NCT04627662, NCT04627662","rel_num_authors":5,"rel_authors":[{"author_name":"Christine McClure","author_inst":"Oregon Health & Science University"},{"author_name":"Hailey Chatterton","author_inst":"Oregon Health & Science University"},{"author_name":"Heather Franklin","author_inst":"Oregon Health & Science University"},{"author_name":"Aimee Mooney","author_inst":"Oregon Health & Science University"},{"author_name":"Allison Lindauer","author_inst":"OHSU - Oregon Health & Science University"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Central motor cortical repetitive transcranial magnetic stimulation at 5 Hz or 10 Hz combined with cerebellar 1 Hz stimulation for ataxia in multiple system atrophy of the cerebellar type: a retrospective cohort study of efficacy and predictors of response","rel_doi":"10.64898\/2026.11.16.26368149","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368149","rel_abs":"ObjectiveTo evaluate the efficacy of central motor cortical repetitive transcranial magnetic stimulation (rTMS) at different frequencies (5 Hz and 10 Hz) combined with cerebellar 1 Hz stimulation on the core domains of ataxia in patients with multiple system atrophy of the cerebellar type (MSA-C), and to explore the independent predictors of the response.\n\nMethodsIn this retrospective study, 48 patients with a confirmed diagnosis of MSA-C were included. All patients received bilateral cerebellar hemispheric 1 Hz rTMS as background therapy and were divided according to the frequency of central cortical stimulation into a control group (cerebellar 1 Hz stimulation only, n=15), a 5 Hz combination group (n=16) and a 10 Hz combination group (n=17). Ataxia severity before and after treatment was assessed with the International Cooperative Ataxia Rating Scale (ICARS); absolute improvements and improvement rates were calculated for each subscore and for the total score. Continuous variables were described as mean {+\/-} standard deviation (SD) or median (interquartile range) according to normality; within-group pre-post comparisons used the Wilcoxon signed-rank test, and between-group comparisons used one-way analysis of variance (ANOVA) or the Kruskal-Wallis H test with Bonferroni correction. Clinical response was defined by an absolute improvement threshold ({Delta}ICARS total score [&ge;]8 points), and independent influencing factors were analysed by Firth-penalised logistic regression; sensitivity analyses were performed with a total-score improvement rate [&ge;]20% (and with [&ge;]15% and [&ge;]30% as alternative thresholds), and robustness results are reported for the {Delta}ICARS [&ge;]10-point criterion. Missing cognitive and mood scale scores were imputed by multiple imputation by chained equations (MICE; m=5; the mean of the five imputations constituted the analysis dataset) and then included in the analysis. Subgroup and interaction analyses were performed according to the median disease duration (2 years) and median age (57 years).\n\nResultsAfter treatment, the ICARS total score in the overall cohort was significantly lower than at baseline (median difference 7.0 points, P<0.001), and posture and gait (ICARS1), limb kinetic function (ICARS2) and speech function (ICARS3) all improved significantly (P<0.001 for all), whereas oculomotor disorders (ICARS4) did not improve significantly (P=0.799). Efficacy differed significantly among the three groups: median total-score improvement rates were 10.7%, 20.3% and 21.9%, respectively (P=0.004); when a total-score improvement rate [&ge;]20% was used to define clinically significant efficacy, the response rates of the three groups were 6.7%, 50.0% and 58.8% (P=0.006), and both the 10 Hz and 5 Hz groups were significantly better than the control group (Bonferroni-corrected P=0.006 and P=0.040), with no statistically significant difference between the two frequencies. Domain-specific comparison showed statistically significant between-group differences in both the absolute improvement and the improvement rate of limb kinetic function (P=0.013 and P=0.005), with the 10 Hz group significantly better than the control group. When clinical response was defined as {Delta}ICARS [&ge;]8 points, the response rates of the three groups were 20.0%, 56.2% and 64.7% (P=0.029); Firth-penalised multivariable regression showed that baseline ICARS total score was an independent predictor of clinical response (OR=1.076, 95% CI 1.013-1.143, P=0.017), whereas 5 Hz (OR=4.298, 95% CI 0.757-24.412, P=0.100) and 10 Hz (OR=5.847, 95% CI 0.885-38.640, P=0.067) stimulation did not reach independent statistical significance after adjustment. When response was defined as {Delta}ICARS [&ge;]10 points, the response rates were 0%, 43.8% and 47.1% (P=0.007), and there were no responders in the control group. Subgroup analysis showed a significant groupxage interaction (P=0.020); the clinical response rate of patients aged [&ge;]57 years receiving 10 Hz stimulation was 85.7% (exploratory finding; small subgroup sample). The groupxduration interaction was not statistically significant (P=0.210).\n\nConclusionsCentral 5 Hz and 10 Hz rTMS combined with cerebellar 1 Hz stimulation both significantly improved the symptoms of ataxia in patients with MSA-C, and the efficacy was domain-specific, with the greatest improvement in the limb kinetic domain; sensitivity analyses across multiple criteria ({Delta}ICARS [&ge;]8 points, improvement rate [&ge;]20%, {Delta}ICARS [&ge;]10 points) consistently supported the efficacy benefit of high-frequency stimulation in the same direction, but stimulation frequency did not reach independent predictive statistical significance after adjustment, and baseline ICARS total score was significantly associated with absolute improvement. Age may have a modifying effect on the efficacy of stimulation frequency (exploratory finding; small sample). This study provides preliminary support for the efficacy of the central 10 Hz combined with cerebellar 1 Hz regimen; the optimal stimulation parameters and independent predictors remain to be verified in larger prospective studies.","rel_num_authors":6,"rel_authors":[{"author_name":"Mengyang Wang","author_inst":"Sanbo Brain Hospital, Capital Medical University"},{"author_name":"Yongli Wang","author_inst":"Sanbo Brain Hospital, Capital Medical University"},{"author_name":"Minghui Wang","author_inst":"Sanbo Brain Hospital, Capital Medical University"},{"author_name":"Yixian Han","author_inst":"Sanbo Brain Hospital, Capital Medical University"},{"author_name":"Jiali Pan","author_inst":"Sanbo Brain Hospital, Capital Medical University"},{"author_name":"Yongkang Zhou","author_inst":"Sanbo Brain Hospital, Capital Medical University"}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Traumatic microbleeds are associated with unfavorable outcome out to 1 year after mild traumatic brain injury","rel_doi":"10.64898\/2026.11.15.26367999","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.15.26367999","rel_abs":"ImportanceTraumatic microbleeds (TMB) are commonly observed in mild TBI (mTBI). However, questions remain regarding their long-term prognostic significance.\n\nObjectiveDetermine whether traumatic microbleeds predict unfavorable outcome after mild traumatic brain injury (mTBI)\n\nDesignThe prospective longitudinal observational Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study enrolled acute TBI patients presenting to Emergency Departments (ED) at 18 U.S. Level 1 trauma centers between 2\/26\/2014-08\/08\/2018. CT and MRI were evaluated using the National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) TBI Common Data Elements. Outcome was assessed using the Glasgow Outcome Scale-Extended (GOSE-TBI) at 2 weeks and 3, 6, and 12 months post-injury.\n\nSetting18 U.S. Level 1 trauma centers\n\nParticipants929 GCS 13-15 patients [&ge;]17 years old (38.5 {+\/-} 16.5 years, 66% male) who underwent clinical head CT [&le;]24 hours and brain MRI at 2 weeks post-injury and had at least one GOSE-TBI outcome score during 1 year follow-up.\n\nExposure(s)Acute non-penetrating head trauma\n\nMain Outcome(s) and Measure(s)Frequency and co-occurrence of CT and MR features; incomplete recovery (GOSE-TBI <8 vs. =8) and unfavorable outcome (GOSE-TBI <5 vs. [&ge;]5) at 2 weeks and 3, 6, and 12 months\n\nResultsGeneralized estimating equation models showed that TMBs and\/or IVH were strongly associated with unfavorable outcome (GOSE-TBI <5 vs. [&ge;]5) at 3, 6, and 12 months post-injury, but not with incomplete recovery (GOSE-TBI <8 vs. =8). For prediction of GOSE-TBI <5 vs. [&ge;]5, TMBs surpassed the importance of all demographic and baseline clinical predictors throughout the 1-year follow-up period. For prediction of incomplete recovery (GOSE-TBI <8 vs. =8), brain contusions, subarachnoid hemorrhage, and subdural hematoma were more important throughout the 12-month follow-up period.\n\nConclusions and RelevanceTraumatic microbleeds (TMB) are common in mTBI. The presence of [&ge;]4 TMBs and\/or IVH is strongly associated with unfavorable outcome (GOSE-TBI <5) after mTBI out to at least 1 year, even after controlling for other neuroimaging abnormalities and demographic and clinical predictors. Better understanding of the implications of TMBs for long-term functional outcome may inform rehabilitation planning.\n\nKEY POINTSO_ST_ABSQuestionC_ST_ABSDo traumatic microbleeds predict unfavorable outcome after mild traumatic brain injury (mTBI)?\n\nFindingsIn this cohort study of 929 mTBI patients, traumatic microbleeds were common; [&ge;]4 TMBs in at least 2 distinct regions of the brain were observed in 11.3% of participants on brain MRI performed 2 weeks post-injury. TMBs were associated more strongly with intraventricular hemorrhage (IVH) than with other neuroimaging findings including brain contusions, subarachnoid hemorrhage, and subdural and epidural hematomas. The presence of [&ge;]4 TMBs on brain MRI, or any TMB or IVH on head CT, were strongly associated with unfavorable outcome (GOSE-TBI <5) out to 12 months after mTBI. Specifically, these neuroimaging findings had odds ratios (OR) of 8.3 [2.4-29.2], 7.5 [1.8-30.8], and 5.4 [1.6-18.0] for GOSE-TBI <5 vs. [&ge;]5 at post-injury months 3, 6, and 12, respectively. These far exceeded the ORs for other predictors including other CT and MRI findings, admission GCS score (13 vs15), age, sex, years of education, history of neuropsychiatric disorder, history of prior TBI, and contemporaneous major extracranial injury.\n\nMeaningTMBs and IVH are associated with each other, and with unfavorable outcome (GOSE-TBI <5) out to at least 12 months after mild TBI. The association persists after controlling for other CT and MRI findings, socio-demographic factors, and clinical characteristics.","rel_num_authors":19,"rel_authors":[{"author_name":"Esther L. Yuh","author_inst":"Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA"},{"author_name":"Sonia Jain","author_inst":"Biostatistics Research Center, Herbert Wertheim School of Public Health, University of California, San Diego, CA"},{"author_name":"Xiaoying Sun","author_inst":"Biostatistics Research Center, Herbert Wertheim School of Public Health, University of California, San Diego, CA"},{"author_name":"Sandra P. Rincon","author_inst":"Department of Radiology, Massachusetts General Hospital, Boston, MA"},{"author_name":"Pratik Mukherjee","author_inst":"Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA"},{"author_name":"John K. Yue","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"Amy J. Markowitz","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"Christine L. Mac Donald","author_inst":"Department of Neurological Surgery, University of Washington, Seattle, WA"},{"author_name":"Gabriela G. Satris","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"Sabrina R. Taylor","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"Joseph T. Giacino","author_inst":"Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA"},{"author_name":"Michael W. McCrea","author_inst":"Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI"},{"author_name":"Murray B. Stein","author_inst":"Department of Psychiatry, University of California at San Diego, CA"},{"author_name":"Nancy R. Temkin","author_inst":"Department of Neurological Surgery, University of Washington, Seattle, WA"},{"author_name":"Ramon R. Diaz-Arrastia","author_inst":"Department of Neurology, University of Pennsylvania, Philadelphia, PA"},{"author_name":"Claudia S. Robertson","author_inst":"Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX"},{"author_name":"David O. Okonkwo","author_inst":"Department of Neurological Surgery, University of Pittsburgh, PA"},{"author_name":"Geoffrey T. Manley","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"- TRACK-TBI Investigators","author_inst":""}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Traumatic microbleeds are associated with unfavorable outcome out to 1 year after mild traumatic brain injury","rel_doi":"10.64898\/2026.11.15.26367999","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.15.26367999","rel_abs":"ImportanceTraumatic microbleeds (TMB) are commonly observed in mild TBI (mTBI). However, questions remain regarding their long-term prognostic significance.\n\nObjectiveDetermine whether traumatic microbleeds predict unfavorable outcome after mild traumatic brain injury (mTBI)\n\nDesignThe prospective longitudinal observational Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study enrolled acute TBI patients presenting to Emergency Departments (ED) at 18 U.S. Level 1 trauma centers between 2\/26\/2014-08\/08\/2018. CT and MRI were evaluated using the National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) TBI Common Data Elements. Outcome was assessed using the Glasgow Outcome Scale-Extended (GOSE-TBI) at 2 weeks and 3, 6, and 12 months post-injury.\n\nSetting18 U.S. Level 1 trauma centers\n\nParticipants929 GCS 13-15 patients [&ge;]17 years old (38.5 {+\/-} 16.5 years, 66% male) who underwent clinical head CT [&le;]24 hours and brain MRI at 2 weeks post-injury and had at least one GOSE-TBI outcome score during 1 year follow-up.\n\nExposure(s)Acute non-penetrating head trauma\n\nMain Outcome(s) and Measure(s)Frequency and co-occurrence of CT and MR features; incomplete recovery (GOSE-TBI <8 vs. =8) and unfavorable outcome (GOSE-TBI <5 vs. [&ge;]5) at 2 weeks and 3, 6, and 12 months\n\nResultsGeneralized estimating equation models showed that TMBs and\/or IVH were strongly associated with unfavorable outcome (GOSE-TBI <5 vs. [&ge;]5) at 3, 6, and 12 months post-injury, but not with incomplete recovery (GOSE-TBI <8 vs. =8). For prediction of GOSE-TBI <5 vs. [&ge;]5, TMBs surpassed the importance of all demographic and baseline clinical predictors throughout the 1-year follow-up period. For prediction of incomplete recovery (GOSE-TBI <8 vs. =8), brain contusions, subarachnoid hemorrhage, and subdural hematoma were more important throughout the 12-month follow-up period.\n\nConclusions and RelevanceTraumatic microbleeds (TMB) are common in mTBI. The presence of [&ge;]4 TMBs and\/or IVH is strongly associated with unfavorable outcome (GOSE-TBI <5) after mTBI out to at least 1 year, even after controlling for other neuroimaging abnormalities and demographic and clinical predictors. Better understanding of the implications of TMBs for long-term functional outcome may inform rehabilitation planning.\n\nKEY POINTSO_ST_ABSQuestionC_ST_ABSDo traumatic microbleeds predict unfavorable outcome after mild traumatic brain injury (mTBI)?\n\nFindingsIn this cohort study of 929 mTBI patients, traumatic microbleeds were common; [&ge;]4 TMBs in at least 2 distinct regions of the brain were observed in 11.3% of participants on brain MRI performed 2 weeks post-injury. TMBs were associated more strongly with intraventricular hemorrhage (IVH) than with other neuroimaging findings including brain contusions, subarachnoid hemorrhage, and subdural and epidural hematomas. The presence of [&ge;]4 TMBs on brain MRI, or any TMB or IVH on head CT, were strongly associated with unfavorable outcome (GOSE-TBI <5) out to 12 months after mTBI. Specifically, these neuroimaging findings had odds ratios (OR) of 8.3 [2.4-29.2], 7.5 [1.8-30.8], and 5.4 [1.6-18.0] for GOSE-TBI <5 vs. [&ge;]5 at post-injury months 3, 6, and 12, respectively. These far exceeded the ORs for other predictors including other CT and MRI findings, admission GCS score (13 vs15), age, sex, years of education, history of neuropsychiatric disorder, history of prior TBI, and contemporaneous major extracranial injury.\n\nMeaningTMBs and IVH are associated with each other, and with unfavorable outcome (GOSE-TBI <5) out to at least 12 months after mild TBI. The association persists after controlling for other CT and MRI findings, socio-demographic factors, and clinical characteristics.","rel_num_authors":19,"rel_authors":[{"author_name":"Esther L. Yuh","author_inst":"Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA"},{"author_name":"Sonia Jain","author_inst":"Biostatistics Research Center, Herbert Wertheim School of Public Health, University of California, San Diego, CA"},{"author_name":"Xiaoying Sun","author_inst":"Biostatistics Research Center, Herbert Wertheim School of Public Health, University of California, San Diego, CA"},{"author_name":"Sandra P. Rincon","author_inst":"Department of Radiology, Massachusetts General Hospital, Boston, MA"},{"author_name":"Pratik Mukherjee","author_inst":"Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA"},{"author_name":"John K. Yue","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"Amy J. Markowitz","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"Christine L. Mac Donald","author_inst":"Department of Neurological Surgery, University of Washington, Seattle, WA"},{"author_name":"Gabriela G. Satris","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"Sabrina R. Taylor","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"Joseph T. Giacino","author_inst":"Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA"},{"author_name":"Michael W. McCrea","author_inst":"Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI"},{"author_name":"Murray B. Stein","author_inst":"Department of Psychiatry, University of California at San Diego, CA"},{"author_name":"Nancy R. Temkin","author_inst":"Department of Neurological Surgery, University of Washington, Seattle, WA"},{"author_name":"Ramon R. Diaz-Arrastia","author_inst":"Department of Neurology, University of Pennsylvania, Philadelphia, PA"},{"author_name":"Claudia S. Robertson","author_inst":"Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX"},{"author_name":"David O. Okonkwo","author_inst":"Department of Neurological Surgery, University of Pittsburgh, PA"},{"author_name":"Geoffrey T. Manley","author_inst":"Department of Neurological Surgery, University of California, San Francisco, CA"},{"author_name":"- TRACK-TBI Investigators","author_inst":""}],"rel_date":"2026-11-18","rel_site":"medrxiv"},{"rel_title":"Cervicovaginal metabolites mediate the relationship between vaginal microbiota and risk for Chlamydia trachomatis infection","rel_doi":"10.64898\/2026.11.16.26368223","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.16.26368223","rel_abs":"BackgroundChlamydia trachomatis (CT) remains the most prevalent bacterial sexually transmitted infection and a cause of adverse reproductive outcomes. Epidemiologic studies describe bacterial vaginosis (BV) as a major risk factor for CT infection. Emerging data suggest that BV-associated bacteria and their metabolites contribute to CT susceptibility. Here, we measured the role of specific bacteria in incident CT and evaluated a hypothesized causal role between the vaginal microbiota, its metabolites, and CT risk.\n\nMethodsWe conducted a nested case-control study of Kenyan women who engage in transactional sex from the Mombasa Cohort who acquired CT versus those who did not, and compared their vaginal microbiome and metabolome at the visit preceding CT acquisition. We determined CT infection and total bacterial load using qPCRs. 16S rRNA sequencing was used to characterize the genital microbiome, and BV status was determined using Nugent-Hillier and Amsel scoring criteria. Metabolites were measured using targeted liquid chromatography-mass spectrometry from a subset of women.\n\nFindingsWomen with BV, high vaginal microbial diversity, and community state types III and IV were significantly more likely to have CT at their next visit. CT infection itself did not alter vaginal microbial diversity. More specifically, both concentrations and relative abundances of Lactobacillus crispatus and several BV-associated bacteria (Sneathia sanguinegens, Umbribacter vaginalis, Prevotella amnii, Hoylesella\/Prevotella timonensis, and Ureaplasma urealyticum) were predictive of CT outcomes. Vaginal metabolites differed between cases and controls pre-CT, including Tyramine, reduced and oxidized Glutathione, and sucrose. In a mediation analysis, the vaginal metabolome significantly mediated the relationship between the microbiome and CT infection.\n\nInterpretationWe show for the first time that the association between BV and CT risk is mediated by differences in the metabolome. Identification of the mechanisms underlying increased CT risk with BV can inform interventions to reduce infections in high-risk women.\n\nFundingUS NIH (R01AI13214401-A1)\n\nResearch in contextO_ST_ABSEvidence before this studyC_ST_ABSChlamydia trachomatis (CT) remains the most reported bacterial sexually transmitted infection globally and can lead to serious adverse health outcomes. Previous studies have pointed to an association between the vaginal microbiota composition, particularly the presence of bacterial vaginosis (BV)-associated taxa, and chlamydia susceptibility. However, most studies have been cross-sectional, measuring the microbiome at the time of infection. The few longitudinal studies specifically assessing the microbiome dynamics preceding CT infection have generally been limited by small sample sizes or infrequent sampling. Further, the mechanisms underlying this relationship remain unclear.\n\nAdded value of this studyIn this nested case-control study, we evaluated the vaginal microbiome preceding CT acquisition and compared participants who subsequently acquired infection with matched controls who remained uninfected. We found that women who acquired CT had a significantly higher vaginal microbial diversity in the past 1-2 months, while the CT infection itself did not lead to broad changes in the microbiome, suggesting directionality to this relationship. Participants who acquired CT were >2-fold more likely to have BV by Nugent-Hillier or Amsel criteria at the previous visit. Having a diverse community state type IV was associated with the strongest likelihood of CT acquisition. More specifically, women who acquired CT were more likely to have a microbiome characterized by the depletion of Lactobacillus crispatus and higher abundances of Sneathia sanguinegens, Umbribacter vaginalis, Prevotella amnii, Hoylesella (Prevotella) timonensis, and Ureaplasma urealyticum. To assess the possible mechanism through which the microbiome influenced CT risk, we measured the cervicovaginal metabolome in a subset of participants. We found that 70% of the effect of the vaginal microbiome on CT acquisition risk could be explained by the metabolome, highlighting the role of bacterial metabolites in CT susceptibility. Overall, by focusing on samples collected prior to infection acquisition, with a short period between visits, our study contributes robust temporal evidence that the vaginal microbiome impacts CT susceptibility rather than simply being correlated, with the presence of CT, with metabolites potentially playing a key role in this relationship.\n\nImplications of all the available evidenceOur findings support the concept that the vaginal microbiome is a potentially modifiable risk factor for CT acquisition, with specific BV-associated bacteria, alongside L. crispatus depletion, identified as key modulators of risk. This study is a step towards confirming the directionality of the microbiome-CT infection relationship and establishing potential mechanisms through which the microbiome influences CT risk. These findings, along with previous literature, have the potential to lead to microbiome or metabolite-targeted interventions that would reduce the risk of CT acquisition.","rel_num_authors":14,"rel_authors":[{"author_name":"Smritee Dabee","author_inst":"Seattle Childrens Research Institute, Seattle, WA, USA"},{"author_name":"Mor Tsamir-Rimon","author_inst":"Department of Human Genetics and Computational Medicine, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel"},{"author_name":"Omolara Akingba","author_inst":"Department of Global Health, University of Washington, Seattle, WA, USA"},{"author_name":"John Kinuthia","author_inst":"Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya"},{"author_name":"James W MacDonald","author_inst":"Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA"},{"author_name":"Theo K Bammler","author_inst":"Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA"},{"author_name":"Daniel Raftery","author_inst":"Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA"},{"author_name":"Kevin Hybiske","author_inst":"Department of Global Health, University of Washington, Seattle, WA, USA"},{"author_name":"Ken Tapia","author_inst":"Department of Epidemiology, University of Washington, Seattle, WA, USA"},{"author_name":"Walter Jaoko","author_inst":"Department of Medical Microbiology and Immunology, University of Nairobi, Nairobi, Kenya"},{"author_name":"Elhanan Borenstein","author_inst":"Department of Human Genetics and Computational Medicine, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel"},{"author_name":"Jennifer E Balkus","author_inst":"Department of Epidemiology, University of Washington, Seattle, WA, USA"},{"author_name":"R. Scott McClelland","author_inst":"Department of Global Health, University of Washington, Seattle, WA, USA"},{"author_name":"Heather B Jaspan","author_inst":"Seattle Childrens Research Institute, Seattle, WA, USA"}],"rel_date":"2026-11-17","rel_site":"medrxiv"},{"rel_title":"The genetic architecture of wisdom and its relationship with health, personality, and cognition","rel_doi":"10.64898\/2026.11.10.26367758","rel_link":"http:\/\/medrxiv.org\/content\/10.64898\/2026.11.10.26367758","rel_abs":"Wisdom is a personality trait composed of self-reflection, pro-social behaviors, emotional regulation, acceptance of divergent perspectives, decisiveness, social advising, and spirituality. Greater levels of wisdom are linked to better overall health, well-being, happiness, life satisfaction, and resilience. However, the underlying genetic architecture of wisdom remains unexplored. We assessed wisdom using responses to the SD-WISE-7 in 153,384 23andMe research-consented participants and conducted a multi-ancestry GWAS. We identified one genome-wide significant locus (rs2325631, p=1.41E-08) near MANEA on chromosome 6. Wisdom was heritable (h2SNP=0.03{+\/-}4.50E-03) and genetically correlated with numerous traits, including greater subjective well-being, openness, and risk tolerance, and lower neuroticism and loneliness. Crucially, wisdom was genetically distinct from intelligence and the cognitive component of educational attainment. Wisdom polygenic scores were associated with psychosocial outcomes, but not cognitive performance in All of Us. This study advances our understanding of wisdom as a heritable trait that could guide interventions to improve human health.","rel_num_authors":13,"rel_authors":[{"author_name":"Fabrizio Malatesta","author_inst":"Department of Psychiatry, University of California San Diego, La Jolla, CA, USA"},{"author_name":"Hayley Thorpe","author_inst":"Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada"},{"author_name":"Jean Gonzalez","author_inst":"Department of Psychiatry, University of California San Diego, La Jolla, CA, USA"},{"author_name":"John J Meredith","author_inst":"Department of Psychiatry, University of California San Diego, La Jolla, CA, USA"},{"author_name":"Laura Vilar-Rib\u00f3","author_inst":"Department of Psychiatry, University of California San Diego, La Jolla, CA, USA"},{"author_name":"Natasia Courchesne-Krak","author_inst":"Department of Psychiatry, University of California San Diego, La Jolla, CA, USA"},{"author_name":"Daniel Gustavson","author_inst":"Institute for Behavioral Genetics; Department of Psychology and Neuroscience, University of Colorado Boulder, CO, USA"},{"author_name":"- 23andMe Research Team","author_inst":"-"},{"author_name":"Vinh Tran","author_inst":"23andMe Research Institute, Palo Alto, CA, USA"},{"author_name":"Shubham Saini","author_inst":"23andMe Research Institute, Palo Alto, CA, USA"},{"author_name":"Emily M. Rios","author_inst":"23andMe Research Institute, Palo Alto, CA, USA"},{"author_name":"Abraham Palmer","author_inst":"Department of Psychiatry; Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA"},{"author_name":"Sandra Sanchez-Roige","author_inst":"Department of Psychiatry; Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA"}],"rel_date":"2026-11-17","rel_site":"medrxiv"}]}